Washington University in St. Louis

Washington University Open Scholarship
Arts & Sciences Electronic Theses and
Dissertations

Arts & Sciences

Summer 8-15-2016

The Role of Epidermal Enhancer 923 in the Chromatin
Architecture and Transcriptional Regulation of the Epidermal
Differentiation Complex
Inez Oh
Washington University in St. Louis

Follow this and additional works at: https://openscholarship.wustl.edu/art_sci_etds
Part of the Biology Commons

Recommended Citation
Oh, Inez, "The Role of Epidermal Enhancer 923 in the Chromatin Architecture and Transcriptional
Regulation of the Epidermal Differentiation Complex" (2016). Arts & Sciences Electronic Theses and
Dissertations. 880.
https://openscholarship.wustl.edu/art_sci_etds/880

This Dissertation is brought to you for free and open access by the Arts & Sciences at Washington University Open
Scholarship. It has been accepted for inclusion in Arts & Sciences Electronic Theses and Dissertations by an
authorized administrator of Washington University Open Scholarship. For more information, please contact
digital@wumail.wustl.edu.

WASHINGTON UNIVERSITY IN ST. LOUIS
Division of Biology and Biomedical Sciences
Human and Statistical Genetics

Dissertation Examination Committee:
Cristina de Guzman Strong, Chair
Shiming Chen
John Edwards
Eugene Oltz
Gary Stormo

The Role of Epidermal Enhancer 923 in the Chromatin Architecture and
Transcriptional Regulation of the Epidermal Differentiation Complex
by
Inez Ying Li Oh

A dissertation presented to the
Graduate School of Arts & Sciences
of Washington University in
partial fulfillment of the
requirements for the degree
of Doctor of Philosophy

August 2016
St. Louis, Missouri

© 2016, Inez Ying Li Oh

Table of Contents
List of Figures ................................................................................................................................. v!
List of Tables ................................................................................................................................. vi!
Acknowledgments......................................................................................................................... vii!
ABSTRACT OF THE DISSERTATION ....................................................................................... x!
Chapter 1: Introduction ................................................................................................................... 1!
1.1! Overview ............................................................................................................................ 1!
1.2 What is an Enhancer? ............................................................................................................ 2!
1.3! Development of the Epidermis ........................................................................................... 4!
1.4! Epidermal Differentiation Complex ................................................................................... 6!
1.5 Regulation of EDC gene expression ..................................................................................... 8!
1.5.1! Understanding gene regulation: Pre-Human Genome Era........................................................ 8!
1.5.2! EDC loci in other mammals: Identifying Conserved Noncoding Elements by Comparative
Genomics in the Post-Human Genome Era......................................................................................... 10!
1.5.3! Coordinate regulation of EDC gene expression...................................................................... 11!

1.6 The Role of Chromatin Architecture in the Control of Gene Expression ........................... 12!
1.6.1 The formation and biology of enhancer-promoter chromatin loops .......................................... 13!
1.6.2 Higher-level chromatin architecture: Topologically Associated Domains (TAD) and
Chromosome Territories (CT) ............................................................................................................. 15!
1.6.3 Involvement of cohesin and CTCF in forming active chromatin hubs ...................................... 16!
1.6.4 Super-enhancers and the role of Mediator ................................................................................. 18!

1.7 References .......................................................................................................................... 20!
Chapter 2: Regulation of the Dynamic Chromatin Architecture of the Epidermal Differentiation
Complex is Mediated by a c-Jun/AP-1-Modulated Enhancer ...................................................... 28!
2.1! Abstract ............................................................................................................................ 29!
2.2! Introduction ...................................................................................................................... 29!
2.3! Results .............................................................................................................................. 32!
2.3.1 ! 923 is an epidermal-specific enhancer responsive to the spatial and temporal cues in the
developing mouse epidermis ............................................................................................................... 32!
2.3.2 ! The dynamic chromatin architecture of the EDC .................................................................. 33!
2.3.3 ! AP-1 transcription factor binding is required for 923 enhancer activity and EDC gene
expression ............................................................................................................................................ 37!

ii

2.3.4 ! The c-Jun/AP-1/923 axis regulates the EDC transcriptome by modulating the chromatin
architecture .......................................................................................................................................... 40!

2.4! Discussion ........................................................................................................................ 42!
2.5! Materials and Methods ..................................................................................................... 45!
2.5.1 ! Mice ....................................................................................................................................... 45!
2.5.2 ! LacZ staining and Immunohistochemistry............................................................................. 46!
2.5.3 ! Chromosomal conformation capture (3C) assay.................................................................... 46!
2.5.4 ! RNA isolation and analysis .................................................................................................... 47!
2.5.5 ! Luciferase assay ..................................................................................................................... 48!
2.5.6 ! Transcription factor binding prediction ................................................................................. 48!
2.5.7 ! AP-1 binding inhibition assay ................................................................................................ 48!
2.5.8 ! Chromatin Immunoprecipitation ............................................................................................ 48!

2.6! Supplementary Material ................................................................................................... 48!
2.7! References ........................................................................................................................ 49!
Chapter 3: Proximal and distal regulation of EDC genes identified in mice with a deletion of an
EDC enhancer by CRISPR/Cas9 genome editing ........................................................................ 52!
3.1! Abstract ............................................................................................................................ 53!
3.2! Introduction ...................................................................................................................... 53!
3.3! Results .............................................................................................................................. 54!
3.3.1 ! Generation of an Allelic Series of the EDC 923 enhancer in mice using CRISPR/Cas9
Genome Editing................................................................................................................................... 54!
3.3.2 ! 923 deletion mice were viable and appeared normal ............................................................. 55!
3.3.3 ! Skin barrier appears normal in 923 deletion mice ................................................................. 58!
3.3.4 The 923 enhancer is required for dose-dependent expression of proximal gene Ivl, Smcp,
Lce6a, and distal Crnn and Lce3 genes ............................................................................................... 61!
3.3.5 Loss of 923-driven proximal gene expression results in a compensatory increase in the
expression of Sprr gene family members ............................................................................................ 64!

3.4! Discussion ........................................................................................................................ 64!
3.5! Materials and Methods ..................................................................................................... 68!
3.5.1 ! Mice ....................................................................................................................................... 68!
3.5.2 Generation of 923 alleles in mice by CRISPR/Cas9 genome editing ....................................... 69!
3.5.3 Histology and Immunohistochemistry ...................................................................................... 69!
3.5.4 RNA analyses ............................................................................................................................ 70!
3.5.5 Dye penetration barrier assays .................................................................................................. 71!

iii

3.5.6 Cornified envelope preparations ............................................................................................... 71!

3.6! Supplementary Material ................................................................................................... 71!
3.7! References ........................................................................................................................ 72!
Chapter 4: Genome-wide Chromatin Architecture of the EDC .................................................... 74!
4.1! Abstract ............................................................................................................................ 74!
4.2! Introduction ...................................................................................................................... 75!
4.3! Results .............................................................................................................................. 78!
4.3.1 ! Generation and sequencing of 4C-seq libraries ..................................................................... 78!
4.3.2 ! Quality assessment of 4C sequencing data ............................................................................ 79!
4.3.3 4C-seq identifies the EDC as a topologically associated domain ............................................. 82!
4.3.4 Keratinocyte-specific cis-interactions with the 923 enhancer and Flg promoter were observed
within the EDC .................................................................................................................................... 84!
4.3.5 Keratinocyte-specific trans-interactions with the 923 enhancer and Flg promoter were observed
near epidermal differentiation genes ................................................................................................... 90!

4.4! Discussion ........................................................................................................................ 91!
4.5! Materials and Methods ..................................................................................................... 97!
4.5.1 ! Circular chromosome conformation capture library preparation........................................... 97!
4.5.2 ! Data Analysis ......................................................................................................................... 98!

4.6! Supplementary Material ................................................................................................... 99!
4.7! References ...................................................................................................................... 100!
Chapter 5: Conclusions ............................................................................................................... 102!
5.1! Summary ........................................................................................................................ 102!
5.2! Future Directions ............................................................................................................ 107!
5.3! References ...................................................................................................................... 111!
Appendix A ................................................................................................................................. 113!
Appendix B ................................................................................................................................. 122!
Appendix C ................................................................................................................................. 128!

iv

List of Figures
Figure 2.1: 923 is sensitive to spatio-temporal cues during
mouse embryonic epidermal development .................................................................34
Figure 2.2: The Chromatin State of the Mouse EDC is Dynamic ................................................36
Figure 2.3: PhastCons (vertebrate conserved) blocks 1 and 4 are required
for 923 enhancer activity ............................................................................................38
Figure 2.4: c-Jun/AP-1 transcription factor binding to PhastCons block 1 is required
for 923 enhancer activity ............................................................................................39
Figure 2.5: c-Jun/AP-1 activity is required for 923-mediated chromatin state remodeling
to activate EDC gene expression ................................................................................41
Figure 3.1: CRISPR/Cas9 targeting strategy ................................................................................56
Figure 3.2: 923 deletion mice are viable and appear normal ........................................................57
Figure 3.3: Normal histology of 923 deletion mouse epidermis ..................................................59
Figure 3.4: Normal cornified envelope morphology in 923 deletion and partial deletion mice ...60
Figure 3.5: Normal patterning of skin barrier development in 923 deletion mice .......................62
Figure 3.6: Deletion of 923 results in loss of proximal and distal gene expression .....................63
Figure 4.1: Custom primers for 4C-seq library preparation .........................................................80
Figure 4.2: 4C-seq reveals an EDC TAD and an enrichment of EDC reads
in keratinocyte libraries ..............................................................................................83
Figure 4.3: Keratinocyte-specific chromatin interactions identified
between the 923 enhancer and Yap1 ..........................................................................92
Figure 4.4: Keratinocyte-specific chromatin interactions identified
between the Flg promoter and Trp63 .........................................................................93
Figure 4.5: Distribution of CTCF binding sites across the EDC ..................................................96

v

List of Tables
Table 4.1: Numbers of enriched 4C-seq reads in keratinocyte libraries
based on subtraction of T-cell reads ...........................................................................86
Table 4.2: Regulatory element annotations of enriched 4C-seq reads
in keratinocyte libraries based on subtraction of T-cell reads ....................................86
Table 4.3: GREAT-predicted cis-regulatory targets of 4C-seq reads enriched
in 923 enhancer viewpoint differentiating keratinocytes (923 KerD)
relative to T-cells ........................................................................................................89
Table 4.4: GREAT-predicted cis-regulatory targets of 4C-seq reads enriched
in Flg promoter viewpoint differentiating keratinocytes (Flg KerD)
relative to T-cells ........................................................................................................89
Table 4.5: 4C-identified trans-interactions ..................................................................................92
Table 4.6: Numbers of enriched 4C-seq reads in keratinocyte libraries
relative to T-cells based on MACS peak calls ...........................................................93

vi

Acknowledgments
I would like to thank my mentor, Dr. Cristina de Guzman Strong, who has provided me
with invaluable guidance, not only in the pursuit of my scientific goals, but also in dealing with
all that life throws my way.
I would like to acknowledge all past and present members of the de Guzman Strong lab
who have helped make the lab a supportive and friendly workplace. Thank you for making every
work day enjoyable by interspersing intense scientific discussion with equally intense
conversations about Harry Potter, food, musical theater, and everything else under the sun. I
consider you to be some of my most valued friends. My graduate student experience would not
have been the same without you.
I would like to thank my thesis committee for their encouragement and guidance
throughout this journey, and for helping me believe that I have what it takes to succeed.
Finally, I would like to acknowledge my family and my friends who have provided
advice and unwavering support in all my endeavors. Thank you for being there for me through
all the highs and lows of life.
This work has been made possible by many sources of funding and with the help of many
individuals.
For the work in Chapter 2, we thank members of the de Guzman Strong lab and Anne
Bowcock for critical reading of the manuscript, Jun Cheng (NHGRI) for generating the
transgenic mice, and the Genome Technology Access Center (GTAC, Genetics, Washington
University School of Medicine) for Illumina sequencing and advice. This work was supported by
NIH [R00AR055948 (C.S.), P30CA091842 and UL1RR024992 (GTAC)] and Washington
University Faculty Diversity Scholar Award [C.S].

vii

For the work in Chapter 3, we thank Renate Lewis at the Hope Center for the design and
targeting of the gRNAs, Mia Wallace at the Mouse Core facility for the mice, and Toni Sinnwell
and Eric Tycksen of the Washington University Genome Technology Access Center for the
RNA-seq libraries and preliminary analyses. The work cited in this chapter was performed in a
facility supported by NCRR grant C06RR015502, by the Genome Technology Access Center in
the Department of Genetics for genomic analysis with partial support from NCI Caner Center
Support Grant P30CA91842 (Siteman Cancer Center) and ICTS/CTSA ULTR000448 from
National Center for Research Resources (NCRR) and by NIAMS R01AR065523 of the National
Institutes of Health and NIH Roadmap for Medical Research.
For the work in Chapter 4, we thank Eugene Oltz for sharing the P5424 T cell line, Kinjal
Majumder for discussions about experimental design, Toni Sinnwell and Seth Crosby of the
Washington University Genome Technology Access Center for assistance with the design of
custom sequencing primers and sequencing of the 4C-seq libraries. This work was funded by
NIAMS R01AR065523 of the National Institutes of Health and NIH Roadmap for Medical
Research.

Inez Oh
Washington University in St. Louis
August 2016

viii

Dedicated to my father, Jackson,
who started me on the path of scientific discovery,

and to my very patient and loving husband, Zac,
expert in “The Care and Handling of a PhD Student”.

ix

ABSTRACT OF THE DISSERTATION
The Role of Epidermal Enhancer 923 in the Chromatin Architecture and
Transcriptional Regulation of the Epidermal Differentiation Complex
by
Inez Ying Li Oh
Doctor of Philosophy in Biology and Biomedical Sciences
Human and Statistical Genetics
Washington University in St. Louis, 2016
Cristina de Guzman Strong, PhD, Chair
The epidermis covers the surface of the skin and provides a functional barrier across the entire
body. Epidermal cells or keratinocytes proliferate in the innermost basal layer and migrate
upwards into the suprabasal spinous and granular layers as they differentiate, and finally into the
terminally differentiated outermost stratum corneum. Keratinocytes undergoing terminal
differentiation are marked by tissue-specific concomitant expression of genes encoded in the
Epidermal Differentiation Complex (EDC) locus. The EDC genes are organized into four gene
families - S100, Sprr, Lce, and Flg-like, which are coordinately expressed upon activation of the
terminal differentiation program in keratinocytes. The molecular mechanisms that govern the
activation of the EDC during epidermal differentiation are poorly understood. The synteny and
colinearity of the locus across multiple mammalian species and the coordinate expression of
EDC genes upon keratinocyte differentiation suggest molecular mechanisms operating at the
chromatin level. I hypothesize coordinate activation of the EDC by an enhancer regulatory
element. Enhancers are non-coding regulatory DNA sequences that upon binding specific
transcription factors, are able to increase expression of a proximal or distal target gene. Previous
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work in our lab identified an epidermal-specific enhancer, CNE 923, that was active in in cellbased luciferase assays and transgenic mice. Here, I examine the function of the 923 enhancer
for epidermal differentiation. Using an independent transgenic mouse line, I identified
spatiotemporal sensitivity of the 923 enhancer that correlated with the patterning of epidermal
barrier formation during mouse embryonic development. To determine if 923 formed chromatin
interactions with the EDC gene promoters, I performed chromosome conformation capture (3C)
assays in proliferating and differentiated primary mouse keratinocytes. The 3C studies identified
physiologically sensitive chromatin interactions between 923 and EDC gene promoters. The data
supports a dynamic EDC chromatin topology during keratinocyte differentiation. A requirement
for c-Jun/AP-1 in relation to 923-mediated EDC chromatin remodeling for normal EDC gene
expression during keratinocyte differentiation was further determined by chromatin
immunoprecipitation, 3C, and RNA-seq upon pharmacological inhibition of AP-1 binding. To
further determine the function of 923 in vivo, I generated a series of mutation alleles using
CRISPR/Cas9 genome editing in mice. Cas9 nuclease activity targeted to the flanking ends of
the 923 enhancer in mouse zygotes by a pair of guide RNAs, coupled with homologous
recombination-mediated loxP insertions, generated 1 floxed (923flox), 2 independent deletions
(923delA, 923delB), and 1 partial deletion (923pdel) alleles for the 923 enhancer. My results from the
923 knockout mice identified decreased expression of nearby Smcp, Lce6a, and involucrin gene
expression, decreased distal Crnn and Lce gene family members, and a correlative increase in
expression of Sprr gene family members. To identify the chromatin interactions for the 923
enhancer on a genome-wide scale, I performed high-throughput circular chromosome
conformation capture (4C-seq) assays with respect to the 923 enhancer and an additional Flg
promoter viewpoint in proliferating and differentiated keratinocytes and P5424 T-cells. My
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results revealed 923 enhancer-mediated chromatin interactions indicative of a topologically
associated domain encompassing the EDC. However, an enrichment of 923 mediated chromatin
interactions within the EDC, were identified in keratinocytes relative to the T-cells, specifically
between the 923 enhancer and the Sprr and Lce gene families, and with non-coding regions in
the gene desert between the S100 and Sprr gene families. Of note was a 923 interaction with
another putative enhancer near Crct1, enriched specifically in proliferating keratinocytes, and
suggesting cross-talk between enhancers. Keratinocyte-specific trans-interactions identified by
MACS and GREAT algorithms included genes important for epidermal function including
Trp63, an important regulator of keratinocyte differentiation. Together, my 4C-seq identifies
unique chromatin architectures of the EDC in keratinocytes and T cells, including keratinocytespecific enhancer-enhancer crosstalk in cis and interactions between transcriptionally active loci
in trans. My studies identify, for the first time, a link between the 923 enhancer and proximal
(Ivl, Smcp, Lce6a) and distal genes (Crnn, distal Lce family), the loss of which coincides with
upregulation of other epidermal differentiation genes (Sprr family) to maintain skin barrier
function. Together, my work has identified 923 as an epidermal-specific enhancer that
participates in a chromatin looping network to co-regulate expression of genes important for
epidermal development, as a mechanism for maintaining skin barrier integrity.
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Chapter 1

Introduction
1.1 Overview
Transcriptional regulation plays a major role in the development of the epidermis. The
development and organization of the epidermis relies on the spatiotemporal-specific activation of
genes in order to direct the fate of each cell. With each somatic cell containing an identical
genome, how does the keratinocyte interpret the genome in a way that activates a transcriptional
program specific to epidermal differentiation? Early studies of gene regulation focused on single
gene promoters and their transcription factor binding sites (Visel et al. 2007). However, not all
transcriptional activation is attributable to biochemical activity at the gene promoter, thus
suggesting the contribution of other loci. The notion of a non-promoter regulatory element that
could modulate the expression of a target gene located some distance away arose with the
discovery of the SV40 tandem repeat sequence (Banerji et al. 1981; Benoist and Chambon 1981;
Gruss et al. 1981; Moreau et al. 1981; Fromm and Berg 1983). The SV40 sequence “enhanced”
transcription from distal genes in a position and independent manner, leading to coinage of the
term, “enhancer”. The complete genomes of humans and other model organisms in conjunction
with Next-Generation sequencing and high-throughput methods have allowed us to identify,
define, and ascertain the function, of regulatory elements such as enhancers on a genome-wide
scale (Visel et al. 2007; Levo and Segal 2014; Shlyueva et al. 2014). In this introductory
1

chapter, I discuss a history of the conceptual advances in our understanding of the enhancer in
epidermal development, specifically with regards to EDC gene expression.

1.2 What is an Enhancer?
The concept of an “enhancer” emerged in 1981. In that year, Pierre Chambon and George
Khoury independently discovered a non-coding 72 bp tandem repeat sequence upstream of the
SV40 early gene promoters that was required for transcription (Benoist and Chambon 1981;
Gruss et al. 1981). A subsequent study from Walter Schaffner identified the ability of the SV40
DNA sequence to “enhance” the expression of rabbit β-globin in an expression vector even when
the SV40 sequence was placed thousands of base pairs away from the β-globin gene promoter
(Banerji et al. 1981). Chambon observed similar results using the gene for conalbumin (Moreau
et al. 1981). Further experiments performed by Paul Berg and Michael Fromm showed that the
SV40 sequence was able to “enhance” transcription independent of its location (upstream or
downstream of its target gene) and orientation (forward or reverse) (Fromm and Berg 1983).
This established the SV40 sequence as the prototype of a novel genetic element, an enhancer,
and established the definition of a classical enhancer as a non-coding sequence that can modulate
gene expression in a position- and orientation-independent manner.
The discovery of the SV40 enhancer paved the way for the identification of enhancers in
other tissue types (Shlyueva et al. 2014). Often, searches for enhancers were prioritized and
interrogated in the immediate vicinity of target genes, including upstream or downstream
sequences (including 5’ and 3’ untranslated regions (UTRs)), introns, and intergenic regions
(reviewed in (Kleinjan and van Heyningen 2005)).
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In vivo studies of these putative enhancers identified the spatiotemporal specificity of
these sequences to ensure biologically relevant cell- and tissue-specific gene expression
(reviewed in (Levine 2010; Williamson et al. 2011)). Biochemical studies further identified
clusters or arrays of transcription factor binding sites that act as “building blocks” of cisregulatory modules that also show enhancer activity (reviewed in (Hardison and Taylor 2012;
Levo and Segal 2014; Shlyueva et al. 2014)). The enrichment of multiple transcription factor
binding sites within an enhancer facilitates cell-specific expression largely attributable to
combinatorial and differential binding of transcription factor family members in the context of
different microenvironments. Based on these later studies, we more loosely define an enhancer
as a non-coding sequence containing clusters of transcription factor binding sites that drives cell, tissue-, or developmental stage-specific gene expression.
Following completion of the human genome sequence, the National Human Genome
Research Institute, recognizing the need to more fully understand the regulation of gene
expression, launched the Encyclopedia of Non-Coding Elements (ENCODE), a collaborative
public research project to identify and characterize the function of noncoding elements in the
genome, and develop the tools and technology to achieve this goal (The ENCODE Project
Consortium 2007). Next-generation sequencing was instrumental in generating these genome
datasets in a cost-effective manner. The ENCODE studies as well as work by others have greatly
facilitated our ability to identify enhancers on a genome-wide scale based on chromatin
modifications that are unique to these regulatory elements such as DNaseI hypersensitivity (open
chromatin) and histone modification epigenetic marks (H3K27Ac, H3K4me1), and transcription
factor binding (p300, activating TFs) associated with functional enhancers (reviewed in (Ong
and Corces 2011; Hardison and Taylor 2012; Shlyueva et al. 2014)). The high-throughput
3

chromatin immunoprecipitation of chromatin containing specific histone modifications enabled
the discovery of enhancers and future downstream functional analyses (reviewed in (Shlyueva et
al. 2014)).

1.3 Development of the Epidermis
The epidermis is located at the surface of the skin and whose architecture provides the
key structure for the physical barrier of the skin. As well, the epidermis provides a tractable and
spatially hierarchical model to investigate the development of committed cells. Epidermal cells
or keratinocytes within the multiple stratified layers of the epidermis must strike a critical
balance between self-renewal and differentiation in order to build a functional epidermal barrier
across the entire body (Hsu et al. 2014). Keratinocyte self-renewal is marked by parallel cell
division within the basal layer. Expression of Keratin 5 (K5) and Keratin 14 (K14) marks these
basal proliferating keratinocytes.
During differentiation, the basal keratinocyte asymmetrically divides giving rise to a
basal daughter keratinocyte and a suprabasal daughter keratinocyte that migrates outwards,
entering the spinous layer (Lechler and Fuchs 2005; Blanpain and Fuchs 2009; Hsu et al. 2014).
Here, the spinous and granular keratinocytes activate Keratin 1 (K1) and Keratin 10 (K10)
expression concomitant with K5/K14 downregulation. During late terminal differentiation, the
keratinocytes coordinately express many Epidermal Differentiation Complex (EDC) genes,
including the filaggrin (FLG) and FLG-like, late cornified envelope (LCE), small proline-rich
region (SPRR), and S100 genes (Mischke et al. 1996; Zhao and Elder 1997; Marshall et al. 2001;
de Guzman Strong et al. 2010). As the keratinocytes reach the outermost stratum corneum, they
enucleate and are surrounded by their own cornified envelope (the single most basic structural
4

unit of the skin barrier) formed by the cross-linking of scaffold proteins by transglutaminase-1,
and sealed together by keratinocyte-extruded lipids to form a semi-permeable barrier (Lechler
and Fuchs 2005). In mice, the pattern of functional barrier acquisition corresponds to maturation
of the cornified envelopes, and proceeds from specific dorsal initiation sites at embryonic day
(E)16, spreading to converge at the dorsal and ventral midline so that the whole embryo is
impermeable at E17 (Hardman et al. 1998).
Epidermal differentiation can be recapitulated in vitro by exposing keratinocytes
proliferating to high calcium concentrations (Yuspa et al. 1989; Pillai et al. 1990). This process,
called calcium switching, stimulates the calcium receptor (CaR) and downstream phosphokinase
C (PKC) signaling, thus activating the Fos/Jun family of transcription factors that play an
important role in keratinocyte differentiation (Reviewed in (Bikle et al. 2012)). Fos and Jun
proteins form homo- or heterodimers that comprise the AP-1 transcription factor complex
(Shaulian and Karin 2001). In normal epidermis as well as in organotypic epidermal cultures, the
expression pattern of AP-1 proteins is tightly regulated even within the differentiated layers
(Mehic et al. 2005). Fos proteins are found in the nuclei of both basal and suprabasal
keratinocytes. JunB and JunD are expressed in all layers of normal epidermis. Interestingly, cJun is expressed in the spinous layer, then disappears and reemerges in the outermost granular
layer directly at the transition zone to the stratum corneum. Many of the genes expressed in
keratinocytes, in either proliferative or differentiated layers of the epidermis have AP-1 binding
sites. Together, this suggests that the binding of different combinations of AP-1 protein
complexes to different enhancers drives the region-specific expression of the genes in the
epidermis.

5

1.4 Epidermal Differentiation Complex
The EDC locus, on human chromosome 1q21 and mouse chromosome 3q, contains a
dense cluster of genes which encode proteins that are the major molecular markers for terminal
differentiation in the mammalian stratified epidermis.
Loricrin and involucrin are major protein components of the cornified envelope (CE) - a
structural unit of the skin barrier (Rice and Green 1977; Simon and Green 1984). As early
scaffolds for the CE, loricrin and involucrin were the first EDC genes to be discovered (Eckert
and Green 1986; Mehrel et al. 1990; Hohl et al. 1991). The functional cloning of mRNAs in UVtreated and calcium-treated human keratinocytes led to the additional discovery of the SPRR and
S100 genes (Kartasova and van de Putte 1988; Marenholz et al. 2004). It was later determined
that these gene families are physically linked together on human chromosome 1q21 by the
hybridization of gene-specific probes on electrophoresed genome restriction fragments (Volz et
al. 1993). In 1996, the Epidermal Differentiation Complex name was proposed upon higher
resolution mapping (Mischke et al. 1996). Later, a search for molecular markers that coincided
spatio-temporally with skin barrier formation in mice identified a set of Expressed Sequence
Tags (ESTs) that shared sequence homology to SPRR1 but were expressed at a later stage of
epidermal differentiation, and therefore named late envelope proteins (LEPs) (Zhao and Elder
1997; Marshall et al. 2001; Wang et al. 2001). The nomenclature for LEPs was subsequently
changed to late cornified envelopes (LCEs) to more accurately reflect the shared genomic
organization, protein homology, and expression pattern (Jackson et al. 2005). Thus, with the
inclusion of the LCEs, the human EDC comprises a cluster of 64 coding genes and 4 gene
families: filaggrin and FLG-like, late cornified envelope (LCEs), small proline rich region
(SPRRs), and S100 genes (Volz et al. 1993; Rothnagel et al. 1994; Mischke et al. 1996; Song et
6

al. 1999; Jackson et al. 2005; de Guzman Strong et al. 2010). The FLG, LCE, and SPRR gene
families encode structural components of the epidermal skin barrier, while many of the S100
genes encode chemoattractant proteins that are expressed upon disruption of the barrier (Segre
2006). The FLG-like genes, including trichohyalin (TCHH), repetin (RPTN), hornerin (HRNR),
and filaggrin-2 (FLG-2), represent evolved paralogous genes given the fusion of the consensus
S100 domain (two Ca2+-binding EF domains) to gene-specific unique central repeat and Cterminal domains (Henry et al. 2012). The clustering and number of the EDC genes, the shared
homology at the N- and C-terminal domains, and the variability in the internal repeat sequences
underscore the evolution and divergence of the EDC from a common ancestor (Backendorf and
Hohl 1992; The Chimpanzee Sequencing and Analysis Consortium 2005).
Loricrin-deficient mice exhibited a delay in barrier formation suggesting the existence of
a compensatory mechanism for the skin barrier (Koch et al. 2000). Although no phenotype was
observed in the involucrin-deficient mice (Djian et al. 2000), triple knockout mice of involucrin,
and two non-EDC genes, periplakin and envoplakin, that contribute to the early protein scaffold
of the cornified envelope, led to defects in the epidermal barrier (Sevilla et al. 2007).
The role of filaggrin in the epidermis was gleaned from human genetic studies that
identified semi-dominant stop-gain FLG mutations in patients with ichthyosis vulgaris (IV)
resulting in a complete loss of profilaggrin (Smith et al. 2006). Moreover, the overlap between
IV and atopic dermatitis (AD) led to the discovery of common loss-of-function FLG variants for
AD in Europe (Palmer et al. 2006), and has been one of the most widely replicated genetic risk
factors for a common disease to date (Rodríguez et al. 2009). ‘Flaky tail’ mice with dry skin,
orthokeratosis, and acanthosis (Presland et al. 2000) also exhibited a predisposition to AD that
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was associated with a spontaneous frameshift deletion mutation in Flg resulting in loss-offunction and the ‘matted’ allele of Tmem79 (Fallon et al. 2009).
The shared biology of the EDC gene components led to the conceptual recognition of
the EDC genes as a cluster. This in turn has been pivotal in driving current studies to understand
the transcriptional regulation of this important locus in cutaneous biology.

1.5 Regulation of EDC gene expression
1.5.1 Understanding gene regulation: Pre-Human Genome Era
Pioneer studies to elucidate gene expression for epidermal differentiation focused on the
expressions of involucrin (IVL) and loricrin (LOR). These two important marker genes are
distinctively expressed in terminally differentiated keratinocytes, and encode structural proteins
that are cross-linked with many of the other proteins encoded by the EDC genes to form the
cornified envelope (Segre 2006). IVL is cross-linked early in the formation of the cornified
envelope (Eckert et al. 2004) and LOR is in turn cross-linked to the existing scaffolding
containing IVL (Nithya et al.). In the developing mouse embryo, Ivl and Lor transcripts are
upregulated as early as E15.5 (Oh et al. 2014), and protein expression can be observed by E16.5,
corresponding to the onset of skin barrier formation (Hardman et al. 1998; Marshall et al. 2001).
The tight correlation of IVL and LOR expression with keratinocyte terminal differentiation
renders these genes as ideal candidates for studying the mechanisms that underlie the switch
from a proliferating to a differentiating program in keratinocytes.
Involucrin

8

Transcriptional activation of involucrin (IVL) regulation using a β-galactosidase reporter
gene construct in transgenic mice identified keratinocyte-specific expression driven by a 3.7 kb
upstream sequence of IVL (Carroll and Taichman 1992). Using a series of deletion constructs of
the aforementioned reporter construct, optimal expression of IVL in transgenic mice was further
attributed to two discrete IVL upstream regions, the distal- and proximal-regulatory regions
(DRR and PRR) (Welter et al. 1995; Banks et al. 1998). Within the DRR, an AP-1 binding site
was required for IVL expression above basal levels, while a synergistic adjacent SP1 binding site
was necessary for optimal expression (Banks et al. 1999). The DRR AP-1 site was found to
interact with Fra-1, JunB, JunD, and p300, a histone acetyltransferase often associated with
enhancers (Ogryzko et al. 1996; The ENCODE Project Consortium 2007), while the DRR SP1
site was observed to interact with SP1, SP3, and KLF4 transcription factors (Welter et al. 1995;
Banks et al. 1998; Balasubramanian et al. 2005; Crish and Eckert 2008; Chew et al. 2013).
Because Fra-1 and KLF4 are known to interact with p300 (Kaczynski et al. 2003; Crish and
Eckert 2008), this observation and others suggest a complex of transcription factors that forms
on the DRR to drive IVL expression during keratinocyte differentiation.
Loricrin
Transcriptional activation of mouse loricrin expression was first localized to a 6.5 kb
region spanning the loricrin gene (DiSepio et al. 1995). Transgenic reporter mice in which the
LOR coding sequences were replaced by a β-galactosidase gene revealed that the remaining 1.5
kb of 5′-flanking sequence, a small noncoding exon, a 1.1 kb intron, a single coding exon, and
2.2 kb of 3′-flanking sequence from the mouse loricrin gene drove epidermal-specific, but not
differentiation-specific expression. Minimal promoter activity, dependent on an AP1 site
conserved between mouse and human, was mapped to a 60 bp upstream sequence of the
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transcription start site. In the case of the human LOR gene, enhancers located within 1.5 kb of 5′flanking sequence and 9 kb of 3′-sequence were responsible for the tissue- and differentiationspecific expression of the human LOR transgene in transgenic mice (Yoneda and Steinert 1993).
As few as 154 bp of 5′-upstream sequence from the cap site directed expression specifically in
cultured keratinocytes (NHEK and HaCaT), in a Sp1/c-Jun and p300/CREB-dependent manner
(Jang and Steinert 2002). Differential occupation of the keratinocyte-specific repressor-1 (KSR1) comprised Sp3, CREB-1/CREMα/ATF-1, Jun B, while an AP-2-like protein was lost upon
Sp1/c-Jun/p300/CBP recruitment during differentiation at this LOR site, thus enabling LOR
transcriptional resolution in stratified layers (Jang and Steinert 2002).

1.5.2 EDC loci in other mammals: Identifying Conserved Noncoding
Elements by Comparative Genomics in the Post-Human Genome Era
Many of the genes in the EDC are coordinately expressed at the onset of mouse
epidermal differentiation at embryonic (E)15.5 (de Guzman Strong et al., 2010). The dorsal-toventral patterning of skin barrier formation is conserved between 4 mammalian species (mouse,
rat, rabbit, and opossum) and is associated with concomitant EDC gene activation (Hardman et
al., 1998; de Guzman Strong et al., 2010). These observations raised an interesting question.
How are the EDC genes concomitantly activated? A likely explanation is the involvement of
regulatory DNA elements such as enhancers to direct spatiotemporal expression of the EDC in
the epidermis. The availability of complete genome sequences of the human, mouse, and other
mammalian species greatly facilitated the timely identification of regulatory elements (Visel et
al., 2007). Potential regulatory elements can be identified by sequence conservation in the
noncoding regions of phylogenetically distinct animal species. Comparative genomic sequence
alignments of 7 orthologous mammalian EDC loci across eutherian (placental) and metatherian
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(marsupial) highlighted the evolutionarily conserved colinearity (order of the genes) and synteny
(located on the same chromosome) of the EDC (de Guzman Strong et al., 2010). Moreover, 48
conserved noncoding elements (CNEs) from the 7-mammal alignment data set were identified in
the EDC. The regulatory activity for each CNE was tested in transfected keratinocytes using the
firefly luciferase reporter assays. Approximately 50% of the CNEs exhibited regulatory activity,
either enhancing or repressing luciferase activity in either or both proliferating or differentiated
keratinocytes. The results demonstrated the physiological plasticity of these CNEs relevant to
gene transcription.

1.5.3 Coordinate regulation of EDC gene expression
The discovery of enhancers in the EDC enabled hypothesis-driven research towards the
elucidation of a potential locus control region (LCR) in the EDC. An LCR is defined as a strong
enhancer that is capable of directing tissue-specific expression in a position independent manner
(Li et al., 2002). CNE 923, located 923 kb away from the most 5’ EDC gene, was hypothesized
to be a LCR of the EDC since it exhibited the highest reporter and hence enhancer activity in the
keratinocytes.

The enhancer activity for 923 was further validated based on DNaseI

hypersensitivity in primary human keratinocytes. Ectopic expression of β-galactosidase by 923
in transgenic mice further demonstrated the epidermal-specificity of the 923 enhancer (de
Guzman Strong et al., 2010) and recapitulated the spatio-temporal migration of epidermal barrier
formation (Oh et al., 2014).
While these studies supported an intriguing role for the 923 enhancer as an LCR in
epidermal-specific transcriptional activation, the mechanism was less clear. My work, described
in the following chapters, seeks to further elucidate the role of CNE 923 to regulate EDC
expression. Chapter 2 details my study that further characterized the enhancer activity 923 in an
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independent transgenic mouse line while also identifying the 923 enhancer/c-Jun/AP-1
transcription factor axis that linked chromatin state to gene expression of the EDC (Oh et al.,
2014). Chapter 3 discusses the function and necessity of the endogenous 923 using a mouse
model generated via CRISPR-Cas9 genome editing (Oh et al. 2016). Finally, Chapter 4 details
the genome-scale chromatin architectures of the EDC in keratinocytes and T cells.

1.6 The Role of Chromatin Architecture in the Control of
Gene Expression
Recent cell biology studies in epidermal development have highlighted the importance of
chromatin remodeling as a mechanism for efficient and coordinate regulation of gene clusters
(Fessing et al. 2011; Mardaryev et al. 2013; Oh et al. 2014; Sethi et al. 2014) During epidermal
development, the EDC locus relocates away from the nuclear periphery and towards the nuclear
interior prior to the activation of EDC gene expression (Gdula et al. 2013). Ablation of either
p63, a master regulator of epidermal development (Mills et al. 1999; Yang et al. 1999; Viganò
and Mantovani 2014), or Satb1, a higher-order genome organizer that binds to the EDC in
epidermal progenitor cells (Fessing et al. 2011), resulted in the loss of keratinocyte-specific and
EDC gene expression associated with alterations in the chromatin conformation of the EDC. The
observation that p63 directly regulates the expression of Satb1, designated Satb1 as an important
downstream target of p63 required for the proper establishment of higher-order EDC chromatin
structure and coordinated gene expression (Fessing et al. 2011). Similarly p63 and its direct
target Brg1 are essential in remodeling the higher-order chromatin structure of the EDC and
positioning the locus within the 3D chromatin landscape to allow efficient expression of EDC
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genes in epidermal progenitor cells during skin development (Mardaryev et al. 2013; Sethi et al.
2014).

1.6.1 The formation and biology of enhancer-promoter chromatin loops
The idea of the formation of enhancer-promoter chromatin loops to drive gene activation
has emerged as a major framework around which we can approach investigations of enhancerpromoter interactions. As mentioned before, the first and thus one of the most well-studied loci,
is the evolutionarily conserved β-globin locus important for hematopoiesis (reviewed in (Kiefer
et al. 2008)). The 5 globin genes (ε, Gγ, Aγ, δ and β) form a cluster and are expressed in a
developmental-stage- and tissue-specific manner controlled by a locus control region (LCR). The
functional relevance of enhancer-promoter chromatin interactions for gene activation at this
locus was recently demonstrated in an elegant series of studies (Deng et al. 2012). Previously, it
was demonstrated that the GATA-1 transcription factor and Ldb1 were required to form a
chromatin interaction between the β-globin locus control region and the β-globin promoter for
transcriptional activation in erythroid cells (Song et al. 2007; Tripic et al. 2009). The more
convincing experiment demonstrated a requirement for the formation of the chromatin loop for
gene transcription arose from the use of artificial zinc fingers (ZF) (Deng et al. 2012).
Introduction of the artificial targeted ZF forced chromatin loop formation by tethering Ldb1 to
the β-globin locus control region in GATA-1 null erythroblasts and was sufficient to activate βglobin gene expression. This work was the first to demonstrate the causality of chromatin spatial
interactions in promoting gene transcription.
My own work has also identified a role for such chromatin looping interactions in
epidermal development. As will be described in greater detail in Chapter 2, epidermal-specific
enhancer 923, whose optimal activity requires AP-1 transcription factor binding, was found to
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interact with several of the EDC gene promoters (Oh et al. 2014). The loss of AP-1 binding
resulted in changes in 923-mediated interactions, and correlating to the loss of EDC gene
expression during keratinocyte differentiation, demonstrating the importance of enhancerpromoter interactions in keratinocyte differentiation.
The identification of chromatin looping interactions
The distant arrangement between enhancers and their target genes in metazoans incited
debates on how the enhancers were regulating their distant target genes (Krivega and Dean
2012). Chromatin looping and tracking were proposed as models to explain this phenomenon
(Dean 2006). However, the first experimental confirmation of the close proximity between
enhancers and target genes came with the chromosome conformation capture (3C) technique
(Dekker et al. 2002). 3C was used to demonstrate that loop formation between the β-globin locus
control region (LCR) enhancer and gene accompanied transcriptional activation (Carter et al.
2002; Tolhuis et al. 2002; Palstra et al. 2003) and established a paradigm that was later validated
in numerous other loci, including the α-globin gene cluster, TH2, IFNG, MHC class II and IgH
loci (Kadauke and Blobel 2009). Transcription factor ChIP-chip studies also revealed that
enhancers could be located even further from their target genes than previously thought, as far as
10-20 kbs to several Mbs away (Hong et al. 2008). Often, these proximal and distal enhancers
interact to co-regulate a target gene.
Recent improvements to the chromatin conformation methods have allowed us to
examine the chromatin interactions of genomic regions at varying levels of depth and resolution.
4C (circular chromosome conformation capture) detects all interacting sequences with a
sequence of interest (bait such as an enhancer) (Zhao et al. 2006).
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5C (chromosome

conformation capture carbon-copy) is designed to detect many known interactions with
numerous baits and typically within a gene locus (Dostie et al. 2006) whereas Hi-C approach is
aimed to detect all chromatin interactions (Lieberman-Aiden et al. 2009). Methods such as
ChIA-PET (Chromatin interaction analysis with paired-end tag sequencing) combine the two to
simultaneously identify genome-wide chromatin interactions and the proteins that are binding
these interactions (Li et al. 2010). The evidence for epigenetic modifications, chromatin looping,
and the interplay between the two are relatively recent advancements that have provided new
insights to our understanding of the biochemical aspects of enhancer-mediated transcriptional
regulation.

1.6.2 Higher-level chromatin architecture: Topologically Associated Domains
(TAD) and Chromosome Territories (CT)
Topologically associated domains (TADs) were first identified by Hi-C (a variation of the
3C technique) (Dixon et al. 2012; Sexton et al. 2012). TADs represent distinct clusters of
enhancer-promoter interactions (Symmons et al. 2014; Lupiáñez et al. 2015). At the highest
order of chromosome organization, spatially proximal TADs compose a chromosome territory
(CT), which is a compartment within the nucleus that is often segregated in a chromosomespecific manner (reviewed in (Fraser et al. 2015)). It has been noted that actively transcribed
gene-rich loci that are in an open conformation are more likely to loop out of their CTs,
suggesting that the space between CTs is important for genomic loci to access the transcription
machinery (reviewed in (Fraser et al. 2015)).
The influence of CTs over long range enhancer-promoter interactions was demonstrated
for the developing limb bud (Amano et al. 2009). The differential expression of the Sonic
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hedgehog (Shh) gene across regions of the limb bud as shown in the developing mouse embryo
was mediated by specific interactions between the Shh promoter and a long-range enhancer
MFCS1. In the intermediate portion of the limb bud which lacked ectopic Shh expression, the
long-range enhancer was spatially and linearly distant from the Shh coding region. In the anterior
limb bud cells, the long-range enhancer interacted with the Shh coding region, thus representing
a poised state within their CT as Shh was not expressed. However, in the cells of the zone of
polarizing activity (ZPA) where Shh is actively expressed, the chromatin interactions between
the Shh promoter and MFCS1were observed in a 3D-FISH experiment to relocate outside the
CT. Thus, the gene regulatory effect of an enhancer-promoter interaction was shown to be
affected by the location of the interacting regions relative to their CT.

1.6.3 Involvement of cohesin and CTCF in forming active chromatin hubs
Enhancer activity is often modulated by a different class of regulatory elements called
insulators that function as physical barriers to the optimal enhancer-promoter formation for
transcriptional activation.

Here we discuss newly recognized attributes of enhancers and new

direct roles for CCCTC-binding factor (CTCF) insulators in enhancer–promoter interactions and
in broadly configuring the genome (Reviewed in (Krivega and Dean 2012)).
Cohesin is a complex of proteins that holds sister chromatids together during DNA
replication until the sister chromatids separate at anaphase (reviewed in (Hagstrom and Meyer
2003)). The Drosophila Nipped-B gene is similar to cohesin regulatory factor Scc2 (Rollins et al.
1999). Mutations in Nipped-B diminished the ability of an enhancer to overcome an intervening
insulator by interacting with a distal promoter, thereby identifying what was then considered a
non-canonical role for cohesin to regulate enhancer-promoter interactions and gene expression
(Rollins et al. 1999). Subsequently, it was discovered that mammalian cohesin complexes can be
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recruited to DNase I hypersensitive sites and regulatory elements by the CTCF DNA binding
protein (Parelho et al. 2008; Rubio et al. 2008; Wendt et al. 2008). CTCF binds at insulators and
at boundary elements to demarcate active chromatin hubs and limit the effect of enhancers
(Wallace and Felsenfeld 2007), and cohesin contributes to CTCF’s enhancer blocking activity
(Parelho et al. 2008; Rubio et al. 2008). Studies of the apolipoprotein gene cluster (Mishiro et al.
2009), the globin locus (Hou et al. 2010), and the T-cell receptor (Tcra) locus (Seitan et al.
2011) have since demonstrated the cooperation of CTCF and cohesin to mediate insulators
corresponding to TAD boundaries, thereby maintaining proper chromatin loop formation and
localization of transcriptional apparatus at the gene promoters to control gene expression.
A powerful example of the biological function of CTCF is that of chromosomal
rearrangements of the conserved TAD-spanning WNT6/IHH/EPHA4/PAX3 locus that disrupt a
CTCF-associated boundary domain within a TAD and cause limb malformations in humans.
Mice harboring the equivalent disease-relevant rearrangements of the locus that interrupted a
CTCF-associated boundary domain were generated using CRISPR/Cas9 genome editing, and
displayed ectopic limb expression of an uninvolved gene in the locus due to misplacement of a
cluster of limb enhancers relative to TAD boundaries (Lupiáñez et al. 2015). This demonstrated
the functional importance of TADs for orchestrating gene expression via genome architecture
and suggests the potential for disease-associated large-scale chromosomal abnormalities to
pinpoint TAD boundaries.
A more recent study identified a functional role for the directionality of a CTCF insulator
to influence chromatin topology and enhancer-promoter function (Guo et al. 2015). Inversions of
CTCF boundary elements in the P-cadherin enhancer using CRISPR/Cas9-genome editing
altered the chromatin topology and gene expression. This study demonstrated a novel governing
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principle for chromatin architecture for gene expression by linear DNA, and holds great potential
for the more accurate prediction of enhancers in the skin and other tissues.

1.6.4 Super-enhancers and the role of Mediator
More recently, a new class of enhancers called “super-enhancers” was identified (Whyte
et al. 2013). Super-enhancers are marked by high levels of the Mediator coactivator complex
occupation as determined by ChIP-seq and span much larger distances than typical enhancers
(8.7 kb versus 703 bp). Mediator is a major component of the transcription pre-initiation
complex (PIC) machinery with RNA polymerase II (RNA pol II) and is required for activatordependent transcription in vitro and in vivo (reviewed in (Poss et al.)). Reduced levels of
Mediator specifically affected gene expression near the super-enhancers (Whyte et al. 2013).
This was convincingly demonstrated with the loss of enhancer-promoter loops of select genes
upon loss of Mediator (Sung et al. 2005; Wang et al. 2005). Mediator-occupied super-enhancers
also exhibited enriched binding of transcription factors that are master regulators involved in
cell-identity including ESCs, pro-B cells, T helper cells, myotubes, and macrophages.
The role of super-enhancers was recently identified in epidermal stem cells (Adam et al.
2015). The target genes associated with the epidermal stem cell-specific super-enhancers
identified by H3K27Ac and Mediator ChIP-seq methods contained a high frequency of
transcription factor binding motifs for Sox9, Lhx2, Nfatc1 and Nfib, previously reported to be
important for maintaining the hair follicle stem cell niche (Chang et al. 2013; Folgueras et al.
2013; Keyes et al. 2013; Kadaja et al. 2014). As further evidence of their importance, these
transcription factors were shown via ChIP-seq to bind at high frequency to super-enhancers
relative to typical enhancers, in particular Sox9, corroborating its known role as a master
transcription factor. Lineage tracing during epidermal development in the mouse, wound-healing
18

and in cell culture enabled the detection of the remodeling of super-enhancer regions and thereby
supporting the idea that enhancers are activated or silenced in lineage-specific fashion. The
ability of Mediator to identify key transcription factors and enhancer sequences in a variety of
cell types and its sensitivity to changing conditions highlights its potential as a tool to pinpoint
important regulatory sequences involved in cell and tissue homeostasis, even without prior
knowledge of the transcription factors or genes involved.
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2.1 Abstract
The Epidermal Differentiation Complex (EDC) locus comprises a syntenic and linear
cluster of genes whose concomitant expression is a hallmark feature of differentiation in the
developing skin epidermis. Many of the EDC proteins are cross-linked together to form the
cornified envelope, an essential and discrete unit of the mammalian skin barrier. The mechanism
underlying coordinate transcriptional activation of the EDC is unknown. Within the human
EDC, we identified an epidermal-specific regulatory enhancer, 923, that responded to the
developmental and spatio-temporal cues at the onset of epidermal differentiation in the mouse
embryo.

Comparative chromosomal conformation capture (3C) assays in proliferating and

differentiated primary mouse keratinocytes revealed multiple chromatin interactions that were
physiologically sensitive between the 923 enhancer and EDC gene promoters and thus depict the
dynamic, chromatin topology of the EDC. We elucidate a mechanistic link between c-Jun/AP-1
and 923, whereby AP-1 and 923-mediated EDC chromatin remodeling is required for functional
EDC gene activation. Thus, we identify a critical enhancer/transcription factor axis governing the
dynamic regulation of the EDC chromatin architecture and gene expression and provide a
framework for future studies towards understanding gene regulation in cutaneous diseases.

2.2 Introduction
The epidermis lies at the surface of the skin and provides the first line of defense against
the external environment (Koster and Roop 2007; Fuchs 2009; Kubo et al. 2012). Protecting
against infection and inflammation, the epidermis comprises stratified layers of epidermal cells
or keratinocytes that are individually surrounded by a cornified envelope and function as one of
the essential core units of the skin barrier. To build the epidermal barrier akin to a “bricks-and29

mortar” architecture, a basal keratinocyte in the innermost layer of the epidermis receives an
inductive cue to differentiate and orients its mitotic spindle perpendicularly to the basement
membrane (Lechler and Fuchs 2005). In doing so, an asymmetric cell division gives rise to a
basal cell and a suprabasal daughter cell that is committed to terminal differentiation. As the
keratinocyte completes the differentiation process, it is pushed upward and sequentially through
the spinous and granular layers and finally to the outermost stratum corneum.
A hallmark feature for the execution of the terminal epidermal differentiation program is
the expression of genes encoded by the Epidermal Differentiation Complex (EDC) locus
(Mischke et al. 1996; Zhao and Elder 1997; Marshall et al. 2001; de Guzman Strong et al. 2010).
The EDC (located on human 1q21 and mouse 3q) consists of 4 gene families that are associated
with skin barrier formation: Small Proline Rich Region (SPRR), Late Cornified Envelope (LCE),
filaggrin (FLG) and filaggrin-like (FLG-like), and S100 genes. Genes encoded in the EDC are
coordinately activated during embryonic epidermal differentiation (de Guzman Strong et al.
2010). Exciting and recent studies in mice have identified a role for epigenetics in the regulation
of the EDC during skin development (reviewed in (Botchkarev et al. 2012)). Epidermal-specific
loss of Ezh2, an essential component of the Polycomb repressor complex for histone
modification, resulted in early epidermal differentiation owing to precocious recruitment of AP-1
transcription factor to the EDC for gene expression (Ezhkova et al. 2009). Furthermore, Satb1, a
higher-order genome organizer, was recently identified as a p63 target and binds to the EDC
(Fessing et al. 2011). Satb1-/- mice exhibited alterations in the chromatin conformation of the
EDC resulting in defects in keratinocyte-specific and EDC gene expression and hence abnormal
epidermal morphology and further demonstrated a requirement for the proper establishment of
higher order EDC chromatin structure and coordinated gene expression.
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This was further

supported by confocal microscopy and computational modeling that identified distinct and active
remodeling of the nuclear architecture associated with gene expression specifically in the
terminally differentiated keratinocyte (Gdula et al. 2013). Comprehensive studies of the β-globin
locus control region and the X-inactivation center further support evidence for causality of
chromatin folding and 3D genome organization with respect to gene regulation (Deng et al.
2012; Nora et al. 2012). However, despite these studies, the molecular mechanism(s) that
underlie activation and coordinate regulation of the EDC genes at the nucleotide level are
unknown. The synteny and linearity of the EDC across a wide range of mammalian species
suggests a molecular mechanism originating at the proximal genomic level.
One plausible model is the activation of critical EDC expression by cis-regulatory
elements during skin barrier formation. Comparative genomics and the Encyclopedia of DNA
Elements (ENCODE) consortium that has annotated 80% of the genome attributed to function
have greatly facilitated identification of regulatory elements (Dunham et al. 2012).

We

previously identified many conserved non-coding elements (CNEs) within the human EDC that
could synergistically or independently coordinate EDC gene expression (de Guzman Strong et al.
2010). Approximately 50% of them exhibit regulatory activity. CNE 923 (approximately 923 kb
from the transcriptional start site of S100A10, the most 5’ EDC gene) displayed the strongest
enhancer activity in proliferating and differentiated keratinocytes in our functional screen. This
result corroborated with transgenic reporter mice that demonstrated epidermal-specific enhancer
activity for CNE 923 in vivo. This led us to hypothesize a role for 923 in the coordinate
transcriptional activation of the EDC.
Here, we tracked the activity of CNE 923 during development in transgenic mice and
identified spatio-temporal sensitivity for 923 that coincides with the onset and patterning of
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epidermal differentiation.

Chromatin conformation capture (3C) studies were employed to

determine the physical interactions between 923 and EDC gene promoters and revealed multiple
chromatin spatial interactions surrounding 923. Comparative 3C analyses between proliferating
and differentiated primary keratinocytes revealed a dynamic 923-centric EDC chromatin domain
associated with concomitant EDC gene expression. Comparative genomics and genetic studies
identified an AP-1 transcription factor binding site within 923 that was required for enhancer
activity.

We determine that the AP-1 binding site in 923 is functionally relevant, as

pharmacological inhibition of AP-1 in calcium-induced keratinocytes repressed EDC gene
expression and was associated with aberrant chromatin remodeling and loss of c-Jun/AP-1
binding to 923. Thus, our results provide a framework to examining molecular mechanisms that
link DNA sequence to chromatin architecture and biological functions relevant to development
and disease.

2.3 Results
2.3.1 923 is an epidermal-specific enhancer responsive to the spatial and
temporal cues in the developing mouse epidermis
We previously observed that human CNE 923 exhibited epidermal-specific enhancer
activity, driving lacZ expression in G0 transgenic mice (923-hsp68-lacZ) analyzed only at mouse
embryonic day (E)16.5 (de Guzman Strong et al. 2010). However, the onset and the spatial and
temporal patterning for 923 during mouse embryonic development were unclear. To address
this, we generated additional 923-hsp68-lacZ transgenic mice.

923 enhancer activity (as

measured by lacZ transcript levels) was detected as early as E15.5 in the developing mouse
epidermis (Figure 2.1e), and coincided with the onset of early epidermal differentiation as
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demonstrated by positive Keratin 1 (K1) expression (Figure 2.1d) and activation of involucrin
(Ivl), Flg, and loricrin (Lor) expression (Figure 2.1e). X-galactose reactivity (blue) was not
detectable at E15.5 in whole-mount or cross-sections of the epidermis (Figure 2.1a, 2.1b) owing
to the lack of β-galactosidase protein expression. At E16.5 and E17.5, we observed expression
of 923 enhancer activity correlating with the patterning of barrier acquisition (dorsal to ventral
migration pattern (Hardman et al. 1998) (Figure 2.1a). 923 β-galactosidase enhancer activity
was localized to the spinous to stratum corneum layers of the dorsal epidermis at E16.5 and
E17.5 (Figure 2.1b). Failure to detect β-galactosidase activity on the dorsal epidermis of E17.5
whole-mount embryos is consistent with barrier acquisition that precludes substrate penetration
to detect β-galactosidase activity.

Together, the data supports the responsiveness of 923

enhancer activity to the spatio-temporal cues of the developing mouse epidermis.

2.3.2 The dynamic chromatin architecture of the EDC
We previously identified DNaseI hypersensitivity for 923 (de Guzman Strong et al. 2010)
(de Guzman Strong et al., 2010) and note ENCODE-annotated H3K4me1 histone modification
mark in proliferating primary human keratinocytes that independently tags functional enhancers
(Ernst et al. 2011) (Figure 2.3a). Enhancers are known to form long-range physical interactions
with target gene promoters for activation (Tolhuis et al. 2002). Given these observations and the
spatio-temporal sensitivity in the developing mouse epidermis, we hypothesized a role for 923 in
mediating the chromatin conformation of the EDC.
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Figure 2.1. 923 is sensitive to spatio-temporal cues during mouse embryonic epidermal
development. (a) Whole mount lacZ staining of 923-hsp68-lacZ mice demonstrates 923 activity (βgalactosidase/X-gal blue reactivity) following spatio-temporal patterns of epidermal barrier formation in
the developing embryo by initial observation of activity at E16.5 (dorsal) that migrates ventrally by
E17.5. (b) 923 activity localizes to granular and spinous layers of embryonic dorsal epidermis with
corresponding (c) filaggrin (FLG) and (d) keratin1 (K1) immunofluorescent staining (green). Keratin14,
K14 (red) marks basal keratinocytes, 20X. Dotted lines, basement membrane. Experiments observed in
≥ 2 independent mice. (e) 923 activity (qPCR, lacZ transcript) is noted at E15.5, E16.5, and E17.5 dorsal
epidermis, concomitant with Flg, involucrin (Ivl), and loricrin (Lor) transcription relative to E14.5. Error
bars represent mean+/-SD.
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To test this hypothesis, 3C assays coupled with quantitative PCR (qPCR) (Hagège et al.
2007) were employed in proliferating and differentiated primary mouse keratinocytes to detect
physical chromatin interactions at the sub-megabase level between the endogenous mouse 923
ortholog and the EDC genes. 923 formed multiple interactions with EDC gene promoters (9 out
of 46 tested queries, Sprr2a1, Sprr2d, Sprr2f, Sprr1b, Sprr3, Ivl, Lce1b, Lce1a2, and Crct1
[cysteine-rich C-terminal 1]) in proliferating keratinocytes despite the lack of EDC gene
expression relative to the differentiated keratinocytes (Figure 2.2a, 2.2b).

In differentiated

keratinocytes, a reconfiguration of the EDC chromatin state was identified and was associated
with eleven 923-mediated chromatin spatial interactions between a HindIII fragment 5’ of Lce3b
and S100a6, Sprr2a1, Sprr2b, Sprr3, Sprr4, Ivl, Lce6a, Lce1b, Lce1e, and Crct1 gene promoters
that was relatively consistent with their expression during terminal differentiation (Figure 2.2a,
2.2b).

In comparison to the proliferating cells, the observed interactions in differentiated

keratinocytes that were lost included Sprr2d, Sprr2f, and Sprr1b, and Lce1a2 (within 250 kb of
923) as well as a gain with 5’ of Lce3b, S100a6, Sprr2b, Sprr4, Lce6a and Lce1e. Notably, the
gain of 923’s interaction with S100a6 was located 2Mb away across a gene desert and observed
higher frequencies of interactions with Sprr2a1 and Sprr2b (both >250kb away from 923). All
of the above genes with the exception of Sprr2f are expressed by E15.5 as previously described
in the newly differentiated dorsal epidermis of the developing mouse embryo (de Guzman Strong
et al. 2010). The genes for which there were gains of interactions in differentiated keratinocytes
had similar if not increased levels of expression at E16.5 relative to E15.5. These observations
further identify a longer range EDC chromatin topology in differentiated cells (Figure 2.2a) and
are underestimated given the modest coverage associated with 3C methodology and as not all
keratinocytes completely differentiated. In sum, our results support both shared and unique
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Figure 2.2. The Chromatin State of the Mouse EDC is Dynamic. (a) Semi-quantitative chromosomal
conformation capture (3C-qPCR) assays were performed on primary mouse keratinocytes (proliferating
and differentiated). Peaks = frequencies of physical interactions observed between HindIII restriction
fragments containing 923 (green bar) and queried restriction fragments containing/neighboring EDC gene
promoters (black bars + gray lines) or proximal sequences (gray lines) relative to a cell-ubiquitous Ercc3
control. HindIII fragment (5’ of Lce3b) represents a chromatin interaction that was not enhancer-promoter
specific. Peaks, average of at least 2 biological replicates. Error bars represent the mean+/-SEM. (b)
EDC gene expression heatmap (fold change) in differentiated vs. proliferating keratinocytes based on
analysis of 3 pairwise RNA-seq libraries, green/yellow = upregulated, blue = downregulated, black = no
change, (Table S3).
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chromatin spatial interactions between the 923 epidermal-specific enhancer and EDC gene
promoters in proliferating and differentiated primary mouse keratinocytes that represent the
dynamic chromatin architecture of the EDC.

2.3.3 AP-1 transcription factor binding is required for 923 enhancer activity
and EDC gene expression
To elucidate the molecular mechanism underlying 923 enhancer activity, we performed a
bioinformatics search to identify core transcription factor binding sequences within 923 that are
responsible for driving functional enhancer activity. Assessment of core enhancer functional
activity in 4 PhastCons blocks were prioritized and represent highly conserved sequences
between 28 vertebrate species and therefore likely to impart function (Siepel et al. 2005;
Alexander et al. 2010) (Figure 2.3b). Deletions of blocks 1 and 4 at the 5’ and 3’ ends of 923
significantly decreased luciferase activity (Figure 2.3c) thus demonstrating a functional role for
these blocks for 923 enhancer activity. As deletion of block 1 resulted in the greatest and more
significant decrease in enhancer activity, we prioritized a search for transcription factor binding
motifs within block 1. We identified an AP-1 transcription factor binding site (Figure 2.4a) and
hypothesized that AP-1 is required for 923 enhancer activity. Deletion of the AP-1 binding site
by site-directed mutagenesis led to a significant decrease in 923 enhancer activity under
proliferating and differentiated conditions (Figure 2.4b) thus demonstrating a functional role for
AP-1 to mediate 923 enhancer activity in both physiological states.
To examine a role for AP-1 activity with respect to 923 enhancer activity and EDC gene
activation, AP-1 binding was inhibited by Tanshinone IIA (TanIIA) treatment in primary mouse
keratinocytes induced to differentiate (calcium induction) (Ezhkova et al. 2009). Calcium-
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Figure 2.3. PhastCons (vertebrate conserved) blocks 1 and 4 are required for 923 enhancer
activity. (a) 923 correlates with ENCODE-annotated strong enhancer (H3K4me1) and DNaseI
hypersensitivity clusters in normal human epidermal keratinocytes (NHEK) and 4 PhastCons blocks
(UCSC, hg18, block 1 (23 bp): chr1:151145182-151145204; block 2 (34 bp): chr1:151145525151145558; block 3 (26 bp): chr1:151145572-151145597; block 4 (9 bp): chr1:151145661-151145669).
(b) Individual deletion (del) of each PhastCons block reveals that c) blocks 1 and 4 are required for
enhancer activity based on transient dual-luciferase reporter assays in proliferating and differentiating
keratinocytes (n=2). *, P = 2.05 x 10-4 , *’, 1.6 x 10-4, **, P = 31.02 x 10-3, **’, 3.51 x 10-3. P-values are
based on a two-tailed t-test. Error bars represent mean+/-SE.
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Figure 2.4. c-Jun/AP-1 transcription factor binding to PhastCons block 1 is required for 923
enhancer activity. (a) PhastCons block 1 contains a conserved AP-1 transcription factor binding
sequence (UCSC, hg18, chr1:151145183-151145189). (b) Deletion of the AP-1 binding site significantly
decreased luciferase and hence enhancer activity (n=3), * P=1.93 x 10-4 , ** P=4.76 x 10-4 (two-tailed ttest). (c) Chromatin immunoprecipitation on differentiated cells demonstrates 1.6-fold decrease in AP-1
binding to PhastCons block 1 in TanIIA-treated versus mock-treated cells (P=0.04). The positive control,
an ENCODE-annotated site within Keratin5 (Krt5), displayed 2.3-fold decrease in AP-1 binding in
TanIIA-treated versus mock-treated cells (P=0.06). A negative control (no AP-1 site) showed no
difference between mock-treated and TanIIA-treated cells (n=2). P-values based on a one-tailed t-test.
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induced keratinocytes treated with TanIIA exhibited repressed EDC gene expression (Figure
2.5b). Moreover, chromatin immunoprecipitation for AP-1 (c-Jun) revealed that the repression
was associated with the loss of AP-1 binding to block 1 in 923 in TanIIA-treated, calciuminduced keratinocytes compared to mock controls (Figure 2.4c). Together, the data demonstrates
a requirement for AP-1 in activating EDC gene expression, specifically associated with
functional AP-1 binding within the 923 enhancer in vivo.

2.3.4 The c-Jun/AP-1/923 axis regulates the EDC transcriptome by
modulating the chromatin architecture
To identify the mechanism by which AP-1 inhibition represses EDC gene expression, we
returned to 3C assays to examine the chromatin conformation of the EDC with respect to 923 in
the context of AP-1 pharmacological inhibition. The chromatin conformation was assessed at 48
hours post-TanIIA treatment to best ascertain the direct effects of AP-1 inhibition as opposed to
secondary effects beyond 48 hours. Although there was no significant differences in the number
of 923-mediated chromatin interactions in TanIIA-treated vs. mock-treated differentiated
keratinocytes (11 vs. 12), only 6 interactions were shared (Sprr2a1, Sprr3, Ivl, Lce1d, Lce1e, and
5’ of Lce3b) and are close by (within 325 kb) (Figure 2.5a).

Moreover, in TanIIA-treated

keratinocytes, there was a loss of 923 interactions with Sprr2b, Sprr2d, Sprr1b, Lce6a, and
2310050C09Rik and a gain of spatial interactions with Sprr1a, Lce1b, and Lce1c and at the
relatively extreme 5’ and 3’ ends of the EDC reaching as far away as >2 Mb and 866 kb in
S100a13 and Tchh (trichohyalin), respectively. Despite the gain of chromatin interactions, no
appreciable differences in gene expression for Sprr1a, Lce1b, Lce1c, S100a13 and Tchh were
observed. It appears that AP-1 pharmacological inhibition resulting in decreased c-Jun/AP-1
binding at 923 (Figure 2.4c) was not sufficient to completely abrogate all chromatin spatial
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Figure 2.5. c-Jun/AP-1 activity is required for 923-mediated chromatin state remodeling to activate
EDC gene expression. (a) Pharmacological inhibition of AP-1 binding using TanIIA (1.0 mg/L)
modulates the chromatin interactions between 923 (green bar) and EDC gene promoters (gray bars) (n=2)
in differentiated keratinocytes and (b) represses EDC gene expression based on heatmap depiction,
yellow = upregulated, blue = downregulated in TanIIA-treated relative to mock.

41

interactions within the EDC that could be maintained by other transcription factors. However,
our data supports a role for AP-1 in mediating proper 923-centric EDC chromatin conformation
for EDC gene activation.

2.4 Discussion
Although 3C assays and recent high-throughput genomic studies have enhanced our
understanding of chromatin architecture and gene regulatory modules (de Wit and de Laat,
2012), the mechanisms governing chromosomal spatial interactions are poorly understood. Our
studies identify a molecular mechanism describing transcription factor/enhancer modulation of a
cluster of genes, namely AP-1 in the EDC architecture required for epidermal differentiation.
We translate a “linear” interpretation (de Wit and de Laat 2012) of the keratinocyte genome from
our studies and ENCODE and prioritize functional studies on 923 to elucidate the 3D structure or
chromatin interactions within the EDC. Our study demonstrates that 923 displays epidermalspecific enhancer activity that tracks with spatial and temporal patterns of epidermal
differentiation and barrier formation during normal mouse development. We further elucidate an
association of 923 with the coordinate activation of EDC genes during epidermal differentiation
based on 3C assays that identified nearby chromatin spatial interactions between 923 and several
EDC genes located as far as 2Mb away. Specifically, we observe a chromatin state of the EDC
in proliferating keratinocytes that are marked by fewer cis-spatial interactions with 923 and do
not express EDC genes. By contrast, the chromatin state of the EDC remodels in differentiated
keratinocytes that express many EDC genes, as demonstrated by greater observed 923-mediated
interactions with EDC gene promoters. Although in vivo knockout studies for 923 are beyond
the scope of this study and would address the functional role of 923 as an intriguing locus control
region (LCR) for the EDC during mouse development, our data nevertheless support a functional
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role for 923 in mediating the chromatin spatial interactions of the EDC. In support of this model,
a recent study evaluating a ZF-mediated Ldb1/β-globin LCR physical tethering to the β-globin
promoter in GATA-1 deficient erythroid cells demonstrated causality of chromatin spatial
interactions to gene transcription (Deng et al. 2012). The requirement of the AP-1 binding site
for 923 enhancer activity in both proliferating and differentiated states and the repression of EDC
expression by pharmacological inhibition of AP-1, suggest that the AP-1/923 axis is an important
mechanism to coordinate the EDC transcriptome. A bioinformatic analysis of transcription
factor binding sites in 923 suggests additional putative transcription factor binding sites
including CREB within PhastCons Block 4 that could likely contribute to 923 enhancer function.
It is interesting to note that even in a proliferative state, the loss of the AP-1 binding site
in 923 led to a significant decrease in enhancer activity and chromatin interactions were observed
between EDC gene promoters and 923. A majority of AP-1 members are expressed in basal
keratinocytes with a more restricted expression of specific AP-1 members in the suprabasal
layers (Jochum et al. 2001). AP-1 is known to translate extracellular signals to a transcriptional
response (Schonthaler et al. 2011). Together, these observations and our data suggest a role for
AP-1 (c-Jun) in modulating 923 activity in basal keratinocytes by folding the EDC chromatin
state, and for which activation of EDC transcription in the terminally differentiated keratinocyte
is driven by the specificity of an AP-1 homo/heterodimeric partner. Although the epidermis with
targeted loss of c-Jun (Zenz et al. 2003) and c-Jun/JunB (Guinea-Viniegra et al. 2009) exhibited
normal skin morphology (that could be attributed to compensatory mechanisms to correct for
skin barrier (Koch et al. 2000; Huebner et al. 2012)), the epidermal-specific c-Jun/JunB and
JunB knockouts exhibited inflammatory defects owing to interleukin 6 (IL-6) and tumor necrosis
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factor α (TNFα) expression respectively. Together, these observations lay the groundwork for
investigations linking the role of chromatin architecture in skin barrier as well as inflammation.
A recent study revealed that chromatin architectural proteins may play a greater role than
transcription factors in mediating promoter-enhancer interactions (Phillips-Cremins et al. 2013).
Genome-wide analysis of chromatin interactions lost during the differentiation of embryonic
stem cells (ESCs) to neural progenitor cells (NPCs) unveiled a strong colocalization of the
architectural proteins Mediator and cohesin to the ESC-specific interactions, a partial
colocalization of the Oct4/Sox2/Nanog (OSN) transcription factors with Mediator and cohesin,
and far fewer interactions that were enriched for only transcription factors.

The roles of

Mediator and cohesin in mediating enhancer-promoter interactions were validated by the
abrogation of an interaction between Olig1 and a putative ESC-specific enhancer in Mediator
and cohesin knockdown cells. This data suggests that a proportion of AP-1-mediated 923
interactions may in fact be dependent on the presence of chromatin architectural proteins that are
able to maintain these interactions even when AP-1 activity is inhibited, while a smaller
proportion of interactions are mediated solely by AP-1.
A genomic study has recently elucidated the chromatin topologies of the human and
mouse genome that are marked by distinguishing structural topological domains (Dixon et al.
2012).

These domains are stable, highly conserved, and often demarcated by boundaries

enriched for CCCTC-binding factor (CTCF), housekeeping genes, tRNAs, and short interspersed
nuclear element (SINE) transposons. That the EDC is also syntenic and linear across a wide
range of metatherian genomes (de Guzman Strong et al. 2010) suggests a model for the EDC as a
single distinct topological domain. Of note, ENCODE-annotated CTCF elements flank the gene
families within and just outside the EDC, suggesting a role for CTCF as boundary elements for a
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putative EDC topology (Ernst et al. 2011).

More high-throughput and higher resolution

characterization of the EDC chromatin conformation using 4C or 5C methodology would
certainly address this hypothesis as well as to depict additional chromatin interactions in an
unbiased manner.
The EDC has been implicated in atopic dermatitis and psoriasis (Giardina et al. 2006;
Palmer et al. 2006; Sandilands et al. 2007; de Cid et al. 2009; Esparza-Gordillo et al. 2009;
Hirota et al. 2012; Paternoster et al. 2012). Specifically, discovery of FLG mutations initially in
ichthyosis vulgaris (Smith et al. 2006) and particularly in atopic dermatitis (AD) (Palmer et al.
2006) and other atopic diseases such as asthma and allergic rhinitis (Irvine et al. 2011),
highlights the importance of how even one of the EDC components broadly affects prevalent
allergic diseases. Even at the exclusion of common FLG mutations, genetic association to the
EDC continues to persist in atopic dermatitis suggesting additional genetic variants within the
EDC (Morar et al. 2007; Esparza-Gordillo et al. 2009). Our analysis provides a genomic
framework for which we can begin to interrogate regulatory element variants as causative in
these diseases. Although discovery of causative variants is prioritized in genomic regions in
linkage disequilibrium (LD) with genome-wide association study (GWAS)-identified SNPs, our
chromatin experiments suggest discovery of causative SNPs that are not in LD but are in
“physical proximity” and trans to GWAS-identified SNPs.

2.5 Materials and Methods
2.5.1 Mice
h923-hsp68-lacZ reporter FVB/N mice were housed in pathogen-free, barrier facilities at
NIH (Bethesda, MD) and Washington University School of Medicine (St. Louis, MO). All
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animal procedures were approved by the NHGRI Animal Care and Use Committee and
Washington University Division of Comparative Medicine Animal Studies Committee. All
animal work was conducted in accordance with the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. Morning observation of a vaginal plug was
designated as embryonic day (E) 0.5.

2.5.2 LacZ staining and Immunohistochemistry
Whole-mount embryos and frozen OCT sections were stained overnight for βgalactosidase activity as previously described (de Guzman Strong et al. 2010) and imaged on a
Nikon SMZ 1500 Stereomicroscope and a Nikon Eclipse 80i brightfield microscope (Nikon,
Tokyo, Japan), respectively. Primary antibodies used for immunofluorescence are rabbit K1
(17iKSCN, 1:500), rabbit FLG (5C-KSCN, 1:500) and chicken K14 (5560, 1:1000) (courtesy of
J. Segre). Secondary antibodies used were goat anti-rabbit (Alexa Fluor 488, 1:500) and goat
anti-chicken (Alexa Fluor 594, 1:1000) IgG antibodies (Life Technologies, Frederick, MD).
Sections were fixed in 4% paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA) prior
to permeabilization with 0.1% Triton X-100 and subsequent antibody incubation. Sections were
counterstained with SlowFade Gold antifade reagent with DAPI (Life Technologies, Frederick,
MD) prior to fluorescent imaging on a Zeiss AxioImager Z1 and captured with AxioCam MRc
and Axiovision software (Carl Zeiss, Stockholm, Sweden).

2.5.3 Chromosomal conformation capture (3C) assay
Primary keratinocytes were isolated from newborn mice as previously described (Lichti
et al., 2008) and plated under proliferating or differentiating (2.0 mM Ca2+) conditions in custom
keratinocyte media. 3C assays were performed as previously described (Hagège et al. 2007).
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Briefly, approximately 10 million cells were harvested at 72 hours post-calcium treatment and
cross-linked with 2% formaldehyde prior to overnight HindIII (New England Biolabs, Ipswich,
MA) digestion. Each 3C library was assessed for efficient digestion efficiency by qPCR, and
then further ligated with T4 DNA ligase (New England BioLabs, Ipswich, MA) overnight,
decrosslinked using Proteinase K (IBI Scientific, Peosta, IA), and purified by phenol/chloroform
(Life Technologies, Frederick, MD). Each putative physical interaction between 923 and an
EDC gene promoter (detected by head-to-head [same strand] primer pair within 50-150 bp of a
HindIII cut site and designed in NCBI37/mm9, Table S1) was detected by qPCR (Quantitect
SYBR Green, Qiagen, Chatsworth, CA, ViiA7, Applied Biosystems, Foster City, CA) in
triplicate in 3C libraries of equivalent concentrations. CT values for each measured interaction
were normalized against CT values across an uncut region and a pan-cell Ercc3 chromatin
interaction (Hagège et al. 2007). Positive 3C interactions represent a minimum average of at
least 1 replicate from 2 independent 3C libraries as a criterion to best exclude false positive and
random events.

2.5.4 RNA isolation and analysis
RNA-seq RNA isolation and analysis is described in supplementary methods (Appendix A).
RNA-seq data have been deposited in the NCBI SRA under accession number PRJNA210793.
qRT-PCR Real-time qPCR on cDNA (generated using SuperScript II reverse transcriptase (Life
Technologies)) using SYBR Green was performed in triplicate (ABI ViiA7, Foster City, CA)
and normalized to β2-microglobulin. Only CT values with single peaks on melt-curve analyses
were included. Primers are listed in Table S2.
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2.5.5 Luciferase assay
923 deletion constructs were cloned synthetically (IDT) or by PCR amplification. AP-1
site deletion was generated by site-directed mutagenesis (QuikChange Site-Directed Mutagenesis
Kit, Agilent, Palo Alto, CA). All clones were verified by Sanger sequencing. Dual luciferase
assays were performed in duplicate as previously described (de Guzman Strong et al. 2010).

2.5.6 Transcription factor binding prediction
Transcription factor binding sites were predicted by aligning each PhastCons block
sequence (with a relative profile score threshold of 80%) against the JASPAR CORE database of
transcription factor binding profiles (http://jaspar.genereg.net/) (Bryne et al. 2008).

2.5.7 AP-1 binding inhibition assay
Primary keratinocytes grown under differentiating conditions (2.0mM Ca2+) were treated
with either 1.0mg/L Tanshinone IIA (Biomol, Plymouth Meeting, PA) or DMSO (mock) during
calcium shifting 24 hours after plating. Cells were harvested at 2 days post-calcium treatment
for 3C assays and RNA isolation for gene expression analysis by real-time qPCR.

2.5.8 Chromatin Immunoprecipitation
Chromatin (approximately 5 x 106 cells) was sonicated (Bioruptor XL [Diagenode,
Denville, NJ]) prior to immunoprecipitation with rabbit antibodies: c-Jun (AP-1) (Abcam,
Cambridge, MA; Cat. # ab31419) and IgG (Millipore, Billerica, MA; Cat. # 12-370) antibodies
bound to Dynabeads Protein A (Life Technologies). ChIP Primers are listed in Table S4.

2.6 Supplementary Material
Supplementary material may be viewed in Appendix A.
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3.1 Abstract
Tissue-specific gene expression is driven largely by enhancers. Despite genome-wide discovery
of enhancers in the skin, their function in skin biology is not fully known. Here we address the
function of the epidermal-specific enhancer 923 in the Epidermal Differentiation Complex
(EDC) locus via CRISPR/Cas9 genome editing in mice. Targeting of the 923 enhancer in mouse
zygotes using a pair of flanking guide RNAs to direct Cas9 nuclease activity coupled with
homologous recombination-mediated loxP insertions generated 1 floxed (923flox), 2 independent
deletions (923delA, 923delB), and 1 partial deletion (923pdel) 923 enhancer alleles. Our results
identify a significant dose-dependent requirement of the 923 enhancer for nearby Ivl, Smcp, and
Lce6a gene expression, distal Lce3 and Crnn gene expression, and a compensatory increase in
members of the Sprr gene family (Sprr4, Sprr2i, Sprr2g, etc.) to reinforce the epidermal barrier.
The results demonstrate a requirement of the 923 enhancer for directing proximal and distal gene
expression.

3.2 Introduction
Enhancers are regulatory elements that drive tissue-specific gene expression and are often
critical for cell fate decision and function. Despite genome-wide discovery of enhancers across a
wide and diverse range of tissues and cell types using ChIP-seq studies, we know very little
about how the enhancer regulates gene expression in vivo. The concomitant activation of the
genes encoded by the Epidermal Differentiation Complex (EDC) specific to the stratified skin
epidermis and the discovery of enhancers within the EDC provides a unique opportunity to
investigate enhancer-driven events in EDC activation specific to the skin. We initially identified
several candidate enhancers within the EDC locus based on sequence conservation across a wide
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range of mammalian species (de Guzman Strong et al. 2010). Their enhancer activities were
confirmed in cell-based reporter assays and were dynamic and physiologically dependent. The
923 enhancer in the human EDC, named after its kb distance away from the most 5’EDC gene,
S100A10, demonstrated the highest activity in this assay as well as being DNaseI hypersensitive.
Moreover, 923 exhibited epidermal-specific activity and was sensitive to the spatiotemporal cues
during epidermal development (de Guzman Strong et al. 2010; Oh et al. 2014). Chromosome
conformation capture studies further revealed remodeling of the mouse EDC surrounding the
endogenous 923 enhancer upon epidermal differentiation and a requirement for the AP-1
transcription factor binding to 923 for inducing EDC expression.

Given these results, we

hypothesized that the 923 enhancer is required for EDC gene activation and the development of
the epidermis. To test this hypothesis, we generated mice with a deletion of the 923 enhancer
using the CRISPR/Cas9 genome editing tool. Loss of the 923 enhancer in two independent
mouse models for the 923 deletion exhibited a dose-dependent decrease in proximal gene
expression of Ivl, Smcp, and Lce6a, distal gene expression of Lce3e, Lce3f, and Crnn, and an
observed compensatory increase in the Sprr family members to reinforce the epidermal barrier.
Together, our data identifies a requirement for the 923 enhancer for proximal and distal gene
expression in the EDC.

3.3 Results
3.3.1 Generation of an Allelic Series of the EDC 923 enhancer in mice using
CRISPR/Cas9 Genome Editing
To generate a deletion for the 923 enhancer, we employed the CRISPR/Cas9 genome
editing strategy in mice. Two short guide (sg)RNA were designed to target the flanking ends of
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the orthologous mouse 923 sequence for cleavage by Cas9. Two single stranded
oligodeoxynucleotides (ssODNs), each containing a loxP site and a restriction enzyme
recognition site flanked by specific homology arms, were also introduced to generate a floxed
allele. The strategy leverages endogenous DNA repair mechanisms in response to Cas9-induced
double strand breaks, generating a floxed allele by homology-directed repair enabled by the
ssODNs, as well as a deletion allele by non-homologous end joining (Figure 3.1a). Targeting
specificity was verified using in vitro pilot studies prior to zygote injection. Of the 779
C57BL6/6XCBA hybrid zygotes injected, 80 F0 newborns were recovered, of which 75 survived
to weaning age. Our initial PCR screen identified 7 out of 80 mice whose 923 allele size
deviated from the wild type allele (partial or full deletions) demonstrating 8.75% targeting
efficiency. We also identified loxP insertion at either the 5’ or 3’ end at 13.75% efficiency
collectively (5’ only: 3/80; 3’ only: 5/80; 5’ and 3’: 3/80). From these mice, we confirmed
germline transmission for one floxed allele (923flox) with both loxP inserting in cis, two deletion
alleles (923delA, 923delB), and one partial deletion with 238 bp of 923 intact (923pdel) (Figure
3.1b). Additionally, the 923delA allele of 923 was flanked by both 5’ and 3’ loxP sites, while the
923delB allele also contained a 3’ loxP site.

3.3.2 923 deletion mice were viable and appeared normal
To directly identify the phenotype for the loss of the 923 enhancer, we first prioritized
our studies on the homozygous 923delA, 923delB, and 923pdel -/- mice. All 923delA, 923delB, and
923pdel -/- mice appeared normal throughout gestation and into adulthood and were viable (Figure
3.2, 3.5). This was further supported by no deviations of expected versus observed genotypes for
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Figure 3.1. CRISPR/Cas9 targeting strategy. a) 2 sgRNAs were used to target Cas9 nuclease to
specific sites flanking 923. 2 ssODNs were introduced to insert loxP sequences into the cleavage sites by
homology-directed repair. b) Generation of multiple 923 enhancer alleles by CRISPR/Cas9 genome
editing.
53-5 (923fl/fl): Successfully introduced loxP sites flanking (positions) 923 in the mouse genome to create a
floxed conditional deletion. Same strand 5’ and 3’ loxP sites confirmed by generation of F2s and cloning
and sequencing.
923delA: Global deletion of whole 923 sequence. Insertion of flanking loxP sites.
923delB: Global deletion of whole 923 sequence. Larger region deleted in 59-10.
923pdel: Global deletion of partial 923 sequence. Loss of blocks 2, 3, and 4. Block 1 intact.
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Figure 3.2. 923 deletion mice are viable and appear normal. Homozygous deletion mice do not appear
different under normal housing conditions, when compared to heterozygous and homozygous wildtype
littermates.
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all 3 heterozygous parental crosses even after several generations of backcrossing to control for
possible off-target effects (Χ2 test, α=0.05) (Table S1). Normal fecundity was also observed for
both 923delA and 923delB -/- mice (data not shown). Thus, the data demonstrate that the loss of the
923 enhancer does not affect overall viability under the conditions in which the mice were
housed.

3.3.3 Skin barrier appears normal in 923 deletion mice
We next investigated the function of the skin barrier in the 923delA and 923delB -/- mice.
No gross morphological differences in the skins of 923delA and 923delB +/- and -/- mice (both
newborn and 8-week) compared to the respective wildtype littermates were observed (Figure
3.3).
We subsequently examined the morphology of the cornified envelopes from 923delA,
923delB, and 923pdel -/- mice that contribute to the structural integrity of the skin barrier. Equal
quantities of angular and balloon shaped cornified envelopes from newborn 923delA, 923delB, and
923pdel -/- mice were observed compared to their wild type littermates (Figure 3.4). Similarly, the
edges of the cornified envelopes appeared smooth for all 923 homozygous knockout mice,
indicating no observable structural differences of the cornified envelopes as well.
As both 923delA and 923delB -/- mice appeared normal, we sought to determine if the
development of skin barrier formation in the mouse embryo was delayed due to the loss of 923.
Delayed skin barrier formation has been observed in several mouse models that revealed a
compensatory mechanism to correct the skin barrier during development (Koch et al. 2000;
Strong et al. 2006). No apparent differences in the patterning and temporal development of skin
barrier formation were observed in the homozygous 923delA and 923delB -/- embryos compared to
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Figure 3.3. Normal histology of 923 deletion mouse epidermis. 923 deletion mice appear to have
normal epidermal structure based on H&E staining of epidermal sections from a) newborn mice, and b) 8
week old mice.
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Figure 3.4. Normal cornified envelope morphology in 923 deletion and partial deletion mice. Similar
quantities of angular and balloon shaped cornified envelopes with smooth edges were isolated from
newborn skin of homozygous deletion, heterozygous and wildtype littermates of 923delA, 923delB, and
923pdel lines.
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wild type and heterozygous littermates assessed by blue X-gal reactivity as a proxy for outside-in
barrier formation (Fig. 3.5). Together, our results indicate normal skin barrier function with
respect to skin morphology, cornified envelope formation, and skin barrier development with the
loss of the 923 enhancer in mice.

3.3.4 The 923 enhancer is required for dose-dependent expression of proximal
gene Ivl, Smcp, Lce6a, and distal Crnn and Lce3 genes
To determine the effect of the loss of the 923 enhancer on the skin transcriptome, we
performed RNA-seq on newborn skin. We treated the independent deletion lines, 923delA and
923delB, as biological replicates to account for stochastic changes in gene expression not due to
the loss of 923. Our results identified a significant decrease (adjusted p-value <0.05) in the
expression of the proximal gene Ivl, and the distal gene Crnn in 923del -/- mice in comparison to
heterozygous and wildtype newborn littermates (Figure 3.6a). Additionally, while statistical
significance was not achieved, a decrease was noted in the expression of proximal genes Smcp
and Lce6a, and distal genes Lce3a, Lce3b, Lce3e and Lce3f. Moreover, we determined that the
decrease in Ivl, Smcp and Crnn expression was dose-dependent with 923del +/- mice exhibiting
approximately 50% less Ivl and Crnn expression compared to wild-type littermates. The
magnitude of the difference in expression was greatest for Ivl, which displayed a 30-fold
decrease in 923del -/- relative to wild-type littermates. The dose-dependent decrease in Ivl was
also observed by qPCR in cultured primary keratinocytes isolated from 923delB -/- newborn mice
in comparison to wild-type and heterozygous littermates, confirming a cell-intrinsic effect
(Figure 3.6d). The observed decrease in Ivl gene expression appeared to thus lead to reduced
involucrin protein expression in the epidermis (Figure 3.6a, c). By contrast, 923pdel-/- newborn
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Figure 3.5. Normal patterning of skin barrier development in 923 deletion mice. The extent of skin
barrier formation was assessed by an outside-in X-gal dye penetration assay. Blue stain indicates X-gal
reactivity with endogenous β-galactosidase where the X-gal solution has penetrated the epidermis where
the skin barrier has not formed.
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Figure 3.6. Deletion of 923 results in loss of proximal and distal gene expression. a) RNA-seq to
assess gene expression in the skin of newborn mice revealed a dose-dependent decrease in neighbouring
genes, Ivl, and Smcp, and Lce6a, and a compensatory increase in the expression of the Sprr gene family in
both independent full deletion lines, 923delA and 923delB. b) In 923pdel mice, no significant changes in gene
expression were observed as assessed by qPCR, indicating sufficiency of the remaining 238bp of the 3’
end of 923 for regulation of proximal gene expression. c) Immunofluorescent staining of 923 KO
epidermal sections confirms decreased protein expression of IVL assessed by RNA-seq. d) Allele dosedependent decrease in Ivl expression was observed in cultured primary keratinocytes isolated from
923delB wildtype, heterozygous, and homozygous deletion littermates, upon differentiation. Asterisk
indicates statistical significance (p < 0.05).
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mice displayed no significant changes in EDC gene expression, thus demonstrating that 238 bp
of the 923 locus is sufficient for cis-regulatory gene expression (Figure 3.6b, 3.1b). In our
previous study, we demonstrated a requirement for a PhastCons block (highly conserved
sequence [mouse: 20 bp, human: 23 bp]) for enhancer activity and AP-1 transcription factor
binding (Figure 3.1b) (Oh et al. 2014). As block 1 is intact in the 923pdel-/- mice, the lack of
gene expression differences in these mice further validates our previous findings, indicating that
238 bp of the 923 locus that includes block 1 is sufficient for 923’s enhancer activity both in
vitro and in vivo.

3.3.5 Loss of 923-driven proximal gene expression results in a compensatory
increase in the expression of Sprr gene family members
Gene expression analysis also revealed a compensatory upregulation of Sprr gene family
members (Sprr2a2, Sprr2e, Sprr2g, Sprr2i, Sprr2j, Sprr1b) in 923delA and 923delB -/- mice in
comparison to wild-type littermates (Figure 3.6a). The Sprr gene family which also contains Ivl
(de Guzman Strong et al. 2010), encodes proteins that are precursors for cornified envelope
formation (Hohl et al. 1995). Together, our data identifies a requirement for the 923 enhancer to
regulate proximal and distal gene expression in the EDC, the loss of which induces coordinated
upregulation of Sprr family members to reinforce the skin barrier.

3.4 Discussion
Despite large, publically available datasets by the ENCODE Consortium and others that
have identified many putative enhancers on a genome-wide scale (Kellis et al. 2014), the
functions of these enhancers in the context of relevant tissue types remain poorly understood.
However, while techniques exist for high-throughput screens of enhancer activity and for the
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validation of enhancer function, these methods have relied on exogenous introduction of the
putative enhancer to in vitro or transgenic models, and might not truly reflect the function of the
endogenous enhancer. The advent of CRISPR-Cas9 genome editing technology has greatly
facilitated the functional analyses of enhancers in vivo and in a more efficient and cost-effective
manner (Guo et al. 2015; Han et al. 2015; Lupiáñez et al. 2015; Yang et al. 2016) by way of the
relative ease of designing gRNAs to target loci. Recent studies have successfully used CRISPRCas9 to introduce mutations of enhancers ranging from specific nucleotide substitutions to
deletions over 10 Kb in a variety of human and mouse cell lines, as well as mouse models in
order to study the roles of these enhancers (Li et al. 2014; Han et al. 2015; Zhang et al. 2016).
Furthermore, a study employing CRISPR-Cas9 to invert CTCF binding sites within distal
enhancers resulted in aberrant chromatin topology and gene expression (Guo et al. 2015). From
investigating the effects of enhancers on nearby gene expression, to understanding their roles in
maintaining the broader genomic architecture, these studies highlight the ability of the CRISPRCas9 system to enable investigators to dissect the functions of non-coding elements within their
native loci.
Here, we apply the CRISPR/Cas9 strategy that enabled us to generate multiple alleles of
the 923 enhancer. Mice harboring either of the two independent deletions of 923 (923delA,
923delB) demonstrated in nearby genes, Smcp, Lce6a, distally located Lce3 family genes (Lce3a,
Lce3b, Lce3e and Lce3f) and Crnn, and to the greatest extent, an allele dose-dependent decrease
in Ivl, the gene most proximal to 923. Coincident with this, we observed an upregulation of Sprr
gene family members, Sprr2a2, Sprr2e, Sprr2g, Sprr2i, Sprr2j, and Sprr1b. However, mice with
only a partial deletion of 923 did not display any significant alterations in gene expression,
indicating that the remaining 923 sequence is sufficient for 923 enhancer activity.
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The deletion of 923 resulting in the loss of proximal (Ivl, Smcp, and Lce6a) and distal
(Lce3-family and Crnn) gene expression, while intervening Lce genes remain unaffected, is
supported by previous studies demonstrating that subgroups of the Lce genes have distinct
expression patterns, indicating independent modes of regulation (Marshall et al. 2001; Jackson et
al. 2005, 2011; Niehues et al. 2016). The positions of the affected genes relative to 923, also
suggests that 923 mediates a non-linear mechanism such as chromatin looping, to bring the
affected genes into spatial proximity in order to regulate their expression. Our previous study
which identified 923, also identified additional conserved non-coding elements (CNEs) with
enhancer activity located in the vicinity of Crnn and the distal Lce3 genes (de Guzman Strong et
al. 2010). CNE 531 located within the Lce3 gene family most distal from 923, as well as CNEs
461 and 409 which cluster around Crnn in the Flg-like gene family, displayed significant
enhancer activity in differentiating keratinocytes. CNEs 531, 461, and 409 all flank the boundary
between the Lce and Flg-like gene families. A previous study observed an enrichment of
chromatin interactions between conserved non-coding sequences, thought to be a result of their
occupation of the same transcription factories to drive the expression of co-regulated genes
(Robyr et al. 2011). The regulation of many EDC genes by a common core of transcription
factors (p63, AP1, Sp1, CREB, Ezh2, C/EBP, Klf) suggest similar behavior within the EDC,
where co-regulated genes are organized into transcription factories by regulatory elements for
efficient gene activation. Another study observed spatial compression of the EDC locus during
terminal differentiation of keratinocytes, proposed to represent the looping of chromatin into an
active chromatin structure (Fessing et al. 2011). The loss of 923 resulting in loss of expression
from proximal genes and distal genes flanking the Lce-Flg boundary could therefore indicate the
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loss of a chromatin interaction between 923 and enhancers in the Lce-Flg boundary region that
normally co-regulates the genes near the two regions.
The upregulation of the Sprr gene family in response to loss of 923/Ivl indicates a
compensatory response to maintain the skin barrier. Ivl and the other Sprr genes form the initial
scaffold of the cornified envelope (CE), which is the basic structural unit of the epidermal barrier
(Kalinin et al. 2002). Previous studies have demonstrated that the Sprr genes are coordinately
upregulated during stress, including a model of epidermal barrier deficiency resulting from the
ablation of the Klf4 transcription factor (Patel et al. 2003). The observation that Sprr genes are
upregulated upon the loss of 923/Ivl suggests that the normal appearance and function of the
epidermal barrier in the 923 knockout mice is a result of a deficiency that has been compensated
by increased quantities of other Sprr proteins. The redundancy of individual components of the
cornified envelopes has been well demonstrated. For example, loricrin deficient mice display
mild erythema at birth that resolves within 5 days, and fragile CEs that contain increased
amounts of other CE proteins such as Sprr2 and repetin that compensate for the loss of loricrin
(Koch et al. 2000).

Also, a previous study demonstrated a delayed barrier formation and

abnormal CE ultrastructure in Ivl-Evpl-Ppl triple KO mice (Sevilla et al. 2007) compared to
single Ivl, Evpl, and Ppl knockouts in mice that exhibited normal skin barrier formation (Djian
et al. 2000; Määttä et al. 2001; Aho et al. 2004), suggesting that these three genes are able to
compensate for each other’s loss. Although the mechanism underlying the compensatory
response is unclear, activation of Sprr genes in barrier-deficient epidermis was shown to
correlate with an increased prevalence of DNaseI-hypersensitive sites within the locus,
suggesting the activity of enhancers to coordinate this response (Martin et al. 2004). The
upregulation of Sprr genes in 923 knockout mice could represent a shift from the use of a
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preferred enhancer (923) to other nearby enhancer(s) that drive the expression of genes with
related functions.
Together, these studies suggest a mechanism where resident enhancers within each gene
family mediate looping of the EDC chromatin into an active chromatin hub for easy access to a
common pool of transcription factors. Interactions between multiple enhancers across the EDC
would exist as a “backup system” to allow rapid activation of genes of related function to
compensate for each other’s loss, in an organ such as the skin which is essential to survival. The
existence of CTCF sites at the boundaries between gene families further supports the plausibility
of this model, as CTCF has been observed to mediate the formation of chromatin loops in
relation to gene expression (Tang et al. 2015).
The availability of CRISPR-Cas9 genome editing has never been timelier, as it will
enable future functional analyses of additional enhancers that may be driving gene expression in
the skin, and allow us to elucidate the mechanisms underlying the proposed network of
enhancers that cooperate to maintain a functional skin barrier.

3.5 Materials and Methods
3.5.1 Mice
All mice were housed in pathogen-free, barrier facilities at NIH (Bethesda, MD) and Washington
University School of Medicine (St Louis, MO). All animal procedures were approved by the
Division of Comparative Medicine Animal Studies Committee at Washington University. All
animal work was conducted in accordance with the Guide for the Care and Use of Laboratory
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Animals of the National Institutes of Health. Morning observation of a vaginal plug was
designated as embryonic day (E) 0.5.

3.5.2 Generation of 923 alleles in mice by CRISPR/Cas9 genome editing
To target the orthologous mouse 923 enhancer, two small guide RNAs and two ssODNs
containing loxP sites with 80bp homology arms flanking loxP and restriction enzyme sites were
designed to target insertion of loxP to Cas9 cut sites by homologous recombination (Integrated
DNA Technologies, Coralville, IA). Three rounds of injection in 779 zygotes were performed.
Founders were initially screened for large deletions via PCR using flanking X primers
(m923Cas9delF and m923Cas9delR) and 5’ and 3’ loxP-specific primers that were resolved on
1% agarose gel electrophoresis. Positive candidates for loxP insertion and <1407 bp were
subsequently cloned and Sanger sequenced. 923delA, 923delB, 923pdel and 923flox were backcrossed
on to C57B6 mice at least 4 times and selected for the black coat phenotype to exclude potential
off-target effects. Sequences of sgRNAs, ssODNs, and genotyping primers are listed in
Supplementary Material.
923delAand 923delB: Primers flank entire region. Larger region deleted in 923delB. Same primers
identified 923pdel due to partial deletion.
5’ loxP: Left primer on upstream sequence, right primer on junction of 5’ loxP and 923.
3’ loxP; Left primer on junction of 923 and 3’ loxP, right primer on downstream sequence.

3.5.3 Histology and Immunohistochemistry
Dorsal skin was excised from newborn mice and frozen in OCT compound prior to
cryosectioning. Dorsal skin was excised from 8 week old mice and preserved in 4%
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paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA) prior to paraffin sectioning.
Sections were stained with hematoxylin and eosin (H&E) by the Washington University
Developmental Biology Histology Core. H&E stained sections were imaged on a Nikon Eclipse
80i brightfield microscope (Nikon, Tokyo, Japan).
Primary antibodies used for immunofluorescence are rabbit IVL (4b-KSCN, 1:200) and chicken
K14 (5560, 1:500) (courtesy of J. Segre). Secondary antibodies used were goat anti-rabbit (Alexa
Fluor 488, 1:500) and goat anti-chicken (Alexa Fluor 594, 1:500) IgG antibodies (Life
Technologies, Frederick, MD). Sections were fixed in 4% paraformaldehyde (Electron
Microscopy Sciences, Hatfield, PA) prior to permeabilization with 0.1% Triton X-100 and
subsequent antibody incubation. Sections were counterstained with SlowFade Gold antifade
reagent with DAPI (Life Technologies, Frederick, MD) prior to fluorescent imaging.

3.5.4 RNA analyses
Total RNA was isolated by TriZol extraction (Life Technologies, Frederick, MD) from
epidermal isolates preserved in RNALater (Thermo Fisher Scientific, Waltham, MA).
Real-time qPCR on cDNA (generated using SuperScript II reverse transcriptase (Thermo Fisher
Scientific)) using SYBR Green was performed in triplicate (Fast SYBR Green Master Mix ABI
ViiA7, Thermo Fisher Scientific) and normalized to β2-microglobulin. Only CT values with
single peaks on melt-curve analyses were included. Primers are listed in the supplementary
material. RT-qPCR was performed on at least 2 individuals per genotype.
RNA-seq was performed on ribosome-depleted RNA libraries that were single-read sequenced
on Illumina HiSeq3000 and analyzed by the Washington University Genome Technology Access
Center (GTAC). Differential expression was determined based on normalization to the E14.5
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developmental time point, with one individual from each independent deletion line (923delA,
923delB) representing biological replicates. Differential expression values corresponding to Figure
3.6a are listed in the Supplementary Material.

3.5.5 Dye penetration barrier assays
Mouse embryos were incubated in an X-gal solution for at least 4 hours at 37°C. The embryos
were imaged on a CanoScan 5600F scanner (Canon, Melville, NY) to determine the extent and
location of skin barrier formation.

3.5.6 Cornified envelope preparations
Skin was taken from newborn and postnatal day 1 mice and floated on 0.25% Trypsin to allow
dissociation of the epidermis from the dermis. An approximately 1cm2 piece of epidermis was
incubated at 95°C in a solution of 2% SDS to obtain cornified envelopes in a single-cell
suspension. The suspension was placed on a slide and examined using phase contrast light
microscopy on a Zeiss Axiovert 40 CFL (Carl Zeiss, Stockholm, Sweden). Images were captured
with Zeiss AxioCam ERc 5s using Zeiss ZEN software (Carl Zeiss, Stockholm, Sweden).

3.6 Supplementary Material
Supplementary material can be viewed in Appendix B.
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Chapter 4

Genome-wide Chromatin Architecture of the
EDC
4.1 Abstract
Enhancers are known to drive tissue-specific gene expression by forming physical interactions
by chromatin looping with the gene promoters. Epidermal enhancer 923 was previously shown to
interact with several EDC gene promoters selectively assayed in the context of epidermal
development. However, we do not fully understand the extent to which 923 is involved in the
chromatin architecture underlying expression of EDC and other genes essential for epidermal
development. Here, I sought to determine the chromatin architecture within and surrounding the
EDC, pertaining to keratinocyte differentiation. I approached this by using large-scale highthroughput chromosome conformation capture assays (4C-seq) to identify the keratinocytespecific chromatin interactions with respect to 2 viewpoints in the EDC, the 923 enhancer and
Flg promoter. A marked decrease in interaction frequencies beyond the EDC in all EDCviewpoint libraries supports the notion of a topologically associated domain encompassing the
EDC. Within the EDC, I identified an enrichment of interactions for the 923 enhancer with the
Sprr and Lce gene families in the keratinocytes compared to the P5424 T-cell line that does not
express EDC genes. Keratinocyte-specific enrichment of interactions was observed between each
of the 923 enhancer and Flg promoter with the gene desert located between the S100 and Sprr
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families. Of note was a proliferating keratinocyte-specific interaction between 923 and a
previously identified enhancer (CNE 531) near the Crct1 gene. In addition, the Flg viewpoint
displayed a differentiated keratinocyte-specific enrichment of interactions with the region
between Hrnr and Rptn containing previously identified enhancer CNE 184. Trans-interactions
enriched in keratinocytes were identified with non-EDC genes that are important for epidermal
function including Trp63, an important regulator of keratinocyte differentiation. Together, my
results identify a network of biologically relevant chromatin loops to the EDC to include
enhancer-gene interactions in cis and in trans as well as enhancer-enhancer interactions. The
evidence for chromatin architecture involving the EDC and other loci important for epidermal
function further supports the notion of a “form follows function” principle for keratinocytespecific gene expression.

4.2 Introduction
As described in Chapter 1, epidermal development involves the coordinated expression of
many genes including the EDC genes, the keratins, desmogleins, and plakins. The regulation of
these genes requires the binding of many of the same transcription factors (TFs) such as AP-1,
KLF, and CEBP, to proximal and distal enhancers to drive their tissue-specific gene expression.
While the importance of these individual components is known, the precise mechanisms by
which they cooperate to drive such coordinate expression are not well understood. Investigations
into the chromatin architecture surrounding an active gene or enhancer will provide insights
about the molecular mechanisms that drive gene expression in a cell or tissue-specific manner. A
recent analysis leveraged a focused high-resolution 3C variant known as chromosome
conformation capture carbon-copy (5C) to investigate the relationship between the chromatin
architecture and expression of the CFTR locus in a variety of cell types (Smith et al. 2016).
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Based on the 5C interactions, they identified a region spanning the locus known as a
topologically associated domain (TAD), where there was a high frequency of chromatin
interactions within the TAD, and lower interaction frequencies with regions outside the TAD.
The TADs and their boundaries were consistent across different cell-types. However, cellspecific gene expression coincided with cell-type-specific enhancer-promoter interactions within
TADs, as well as cell-type-specific interactions between TADs that tended to involve loci
clustered around TAD boundaries. This suggested that the key to elucidating the molecular
mechanisms driving cell-specific expression lies in the analysis of cell-specific chromatin
interactions. Additional studies have also definitively established a role for CTCF to maintain the
boundaries of these TADs, thereby allowing genes that are close on the linear genome, but
residents of neighboring TADs, to have different gene expression patterns (Guo et al. 2015;
Lupiáñez et al. 2015; Yang et al. 2016).
Within the β-globin locus, temporal control of gene expression is a result of the
organization of active chromatin hubs (ACH) by CTCF-mediated loops (TADs) and enhancergene interactions (Palstra et al. 2003). These studies in conjunction with ENCODE-annotated
CTCF binding sites led me to hypothesize the existence of one or more TADs within the EDC.
These TADs and the enhancer-promoter interactions within would thus form an ACH to mediate
the concomitant activation of EDC genes brought into proximity with the enhancers during
keratinocyte differentiation. Furthermore, intra-chromosomal (cis) and inter-chromosomal (trans)
interactions revealed spatial association of the active globin genes with other co-regulated genes
at “transcription factories”, and found that the transcription factor KLF1 was necessary for
mediating the associations of KLF1 co-regulated genes (Schoenfelder et al. 2010). Given that the
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same transcription factors regulate many of the co-expressed genes essential for epidermal
differentiation, it seems likely that the EDC participates in such a transcription factory.
In Chapter 2, the characterization of 923’s enhancer function revealed physical chromatin
interactions between 923 and several of the EDC gene promoters. This was determined using
low-throughput chromosome conformation capture assays (3C) that depend on PCR-based
identification of individual ligation junctions. 3C is a very targeted approach that provides a
limited view of all possible interactions in which a single genomic region might be a participant.
It requires prior knowledge, or a strong suspicion, of the existence of an interaction in order for
primers to be designed for the amplification of specific targets. The evidence of 923’s enhancer
activity described in Chapters 2 and 3 suggests a pivotal role for 923 in mediating the chromatin
architecture of the EDC. Further interrogation of 923 will provide a more detailed view of its
interactions within the EDC as well as a unique viewpoint for enhancer-centric EDC contacts
with other loci. Given my previous work and the prior studies, I hypothesized that 923 formed
both cis-interactions representing enhancer-promoter contacts within an EDC TAD or ACH and
trans-interactions representing an epidermal differentiation transcription factory, in a
keratinocyte-specific manner.
To capture genome-wide chromatin interactions with the EDC, I performed the circular
chromosomal conformation capture assay coupled with next-generation sequencing (4C-seq)
(Splinter et al. 2012), with respect to the 923 enhancer and the Flg promoter in proliferating
keratinocytes, differentiating keratinocytes, and P5424 T-cells. The T-cells do not express EDC
genes and thus provide background interaction frequencies for an inactive EDC locus. I aimed to
discover chromatin interactions with the Flg promoter as coding mutations have been identified
in ichthyosis vulgaris and atopic dermatitis, diseases with a component of skin barrier deficiency
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component (Irvine and McLean 2006; Palmer et al. 2006; Smith et al. 2006; Nomura et al. 2009),
but little is known about the enhancers that regulate FLG. 4C-seq is a variation of 3C that in
theory detects “all” chromatin looping events for a specific “viewpoint” or “bait” sequence of
interest. Thus, I sought to identify 923 enhancer- and Flg promoter-mediated chromatin
interactions specific to keratinocytes that define both “within-TAD” cis-interactions and
“between-TAD” trans-interactions.
The 4C strategy will enable me to 1) gain a genome-wide view of the native chromatin
architecture mediated by 923 and the Flg promoter underlying normal keratinocyte
differentiation, and 2) potentially identify cis- or trans-acting regulatory elements for Flg gene
expression

4.3 Results
4.3.1 Generation and sequencing of 4C-seq libraries
4C-seq libraries were generated from proliferating and differentiated mouse primary
keratinocytes with 3 biological replicates per condition/cell-type.

Specifically, the 4C-seq

libraries were derived from the same cells used in my previously cross-linked 3C experiments
described in Chapter 2. To establish a background frequency of non-keratinocyte-specific
interactions, I also generated libraries from the P5424 RAG1−/−, p53−/− pro-T-cell line. In
addition to the 923 and Flg gene promoter viewpoints, I included the Eβ enhancer with known
interactions within the Tcrb locus in the P5424 T-cells as a technical control for the 4C-seq
technique (Oestreich et al. 2006).
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The 4C-seq libraries were created as previously described (Splinter et al. 2012, see also
Methods). However, I wanted to ensure enough unique reads to maximize mappability of the
interacting sequences. Thus, I devised a unique strategy to increase the number of informative
bases in the sequencing reads (interacting sequences) in my 4C-seq libraries. Instead of adding
standard Illumina sequencing adaptor tails to the 4C amplicons, I designed custom nested index
PCR primers to bind within the viewpoint or bait (923 or Flg) as close as possible to the
restriction site junction with the interacting sequence (Fig. 4.1). This also necessitated the use of
custom sequencing primers (Table S1). I successfully generated 4C-seq libraries from
proliferating and differentiated mouse primary keratinocytes based on optimal digestion using
HindIII (first digest) and NlaIII (second digest) restriction enzymes (>80% digestion assessed by
qPCR across the restriction sites flanking the viewpoint fragment). I determined both efficient
ligation (formation of high molecular weight products), and successful synthesis of nested PCR
amplicons, by agarose gel electrophoresis (Fig. S1). The 21 4C-seq libraries were pooled and
then sequenced on two lanes of an Illumina Hi-Seq 2500 to obtain 50 bp single-end reads. The
use of two lanes represent technical replicates to account for batch effects.

4.3.2 Quality assessment of 4C sequencing data
The raw sequencing reads were initially demultiplexed by allowing for 1 mismatch for
each of the index sequences and subsequently binned into the corresponding library, with a range
of 47,000 reads – 6.2 million reads per library in one lane (lane 6), and 43,000 reads – 6.9
million reads per library in the second lane (lane 7) (Fig. S2). Many of the reads, 62 million
(52%) from lane 6 and 58 million (46%) from lane 7, could not be assigned to any of the
libraries. The demultiplexed reads were mapped to a “fragment end library” consisting of a
reduced genome containing only genomic sequences flanking the recognition sites of the
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restriction enzymes used in the experiment (HindIII and NlaIII), and limited only to fragments
flanked by one HindIII and one NlaIII site (Splinter et al. 2012). Visual inspection of the
demultiplexed RPM normalized reads in the UCSC genome browser revealed unexpectedly that

!

Figure 4.1. Custom primers for 4C-seq library preparation. Custom nested and indexed primers were
designed to amplify off the inverse PCR product, as close as possible to the bait-interactor ligation
junctions as possible. Primers for all libraries utilizing the same viewpoint are identical, except the index
sequences on the reverse primer which are unique for each library. Libraries were submitted for
sequencing with custom sequencing and index read primers.
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in one of the Flg promoter viewpoint P5424 T-cell libraries, the region surrounding 923
contained the highest frequency of reads (Fig. S3). Since 4C experiments characteristically
display the highest interaction frequencies close to the viewpoint fragment and decrease with
increasing distance (Splinter et al. 2012), this unusual distribution of interactions suggested
contamination of reads between the libraries. I hypothesized that this was due to the
misassignment of reads during the demultiplexing process, and meant that any attempt at
identification of significant interactions would most likely produce many false positives.
In order to increase stringency, I repeated the demultiplexing of the 4C-seq data to allow
exact matches (0 mismatches) for each of the index sequences. As a result, the number of reads
mapped to each library decreased to 5315 reads - 4.4 million reads/library (lane 6) and 6535
reads - 4.8 million reads/library (lane 7), with an increase in the number of unassignable reads to
81 million (68%) and 82 million (65%) respectively (Fig. S2). Again, the demultiplexed reads
were mapped to the reduced genome as before. Visual inspection of the 0 mismatch
demultiplexed RPM normalized reads in the UCSC genome browser revealed that the unusual
peak previously observed near 923 in the Flg viewpoint P5424 T-cell libraries was no longer
present (Fig. S3). Instead, each library now displayed the expected interaction pattern where the
greatest number of reads mapped to the region close to its respective viewpoint (Fig. S3, S4, S5).
This finding confirmed that the increased reads mapping to the 923 viewpoint in a library for the
Flg viewpoint stemmed from reads obtained from an improper assignment of reads belonging to
a 923 viewpoint library. The 1.4 – 10-fold loss in the number of reads resulting from the more
stringent demultiplexing meant that the sparse coverage achieved in most of the libraries was
prohibitive to the method of analyzing 4C that relies on identifying regions that are significantly
over-represented relative to the neighboring regions (Splinter et al. 2012). Nevertheless, using
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the 0 mismatch demultiplexed libraries, each of the two lanes produced 11 out of 21 libraries
with sufficient 4C library quality (>40% cis-interactions, >1 million reads) for further analysis
for the identification of keratinocyte specific cis- and trans-interactions (Fig. S6, Table S2) (van
de Werken et al. 2012). From each lane, one out of three biological replicates of the 923
viewpoint differentiating keratinocyte libraries (923 KerD), Flg viewpoint proliferating
keratinocyte libraries (Flg KerP), and Flg viewpoint differentiating keratinocyte libraries (Flg
KerD), two out of three biological replicates of the 923 viewpoint P5424 T-cell libraries (923
Tcells) and Flg viewpoint P5424 T-cell libraries (Flg Tcells), and all three biological replicates
of the Eβ enhancer viewpoint P5424 T-cell libraries (Eβ Tcells) had passed the quality threshold
defined earlier. None of the 923 viewpoint proliferating keratinocyte libraries (923 KerP)
surpassed the quality threshold, but one replicate that fell just short of the threshold was included
in the downstream analyses for the purpose of completeness.

4.3.3 4C-seq identifies the EDC as a topologically associated domain
4C-seq libraries that passed the quality threshold as defined above were visualized on the
UCSC Genome Browser using RPM-normalized reads, and represent chromatin interaction
profiles in proliferating keratinocytes, differentiating keratinocytes and P5424 T-cells. In each of
these libraries, the peak height at each mapped position corresponds to the number of reads per
million (RPM) at that position, and represents the frequency of chromatin interactions between
the viewpoint in question and the fragment to which the read belongs. The interaction profiles
demonstrate the characteristic interaction frequencies that are highest in the regions closest to the
respective viewpoints, and decline with increasing distance from the viewpoint (Fig. 4.2). The
923 and Flg promoter viewpoint in keratinocyte libraries showed a marked decline in the
frequencies of interactions that occur within a 5Mb domain surrounding the EDC (S100a1 –
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Figure 4.2. 4C-seq reveals an EDC TAD and an enrichment of EDC reads in keratinocyte libraries.
After RPM normalization, peaks remain visible in the keratinocyte 4C libraries after subtracting T-cell
reads, indicating an enrichment of interactions within the EDC in keratinocytes with both the a) 923 and
b) Flg viewpoints.
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S100a10) and demarcated by neighboring genes Rps27 and Gabp2 (Fig. 4.2). There also
appeared to be localized peaks within the EDC indicating an overrepresentation of interactions in
specific regions of the EDC. While interactions existed beyond the EDC, these were rare and
sparse. These observed chromatin interactions in keratinocytes suggest a compact chromatin
structure within the bounds of Rps27 and Gabp2, specific interactions within this structure, and
obstacles to interactions with regions outside this 5Mb domain. On the other hand, the T-cell
libraries representing an inactive EDC showed a more gradual decrease in interaction frequencies
that appeared to decline as a function of distance. Beyond the boundaries of the locus marked by
Rps27 and Gabp2, there was a low, albeit evenly distributed frequency of interactions (Fig. 4.2).
This suggested a chromatin conformation of the EDC locus in T-cells that is absent of the
specific interactions within the chromatin structure that were observed in the keratinocytes.
Together, these observations indicate an EDC TAD that appear to exhibit similar
boundaries where interactions are more frequent within the TAD and less frequent outside the
TAD, regardless of cell-type. Within the TAD in keratinocytes, however, there appear to be cellspecific interactions.

4.3.4 Keratinocyte-specific cis-interactions with the 923 enhancer and Flg
promoter were observed within the EDC
The distribution of 4C-seq reads revealed distinct regions for which there were
observable increased interactions frequencies that were specific to either keratinocytes compared
to T cells (Fig 4.2). Thus, to identify chromatin interactions for the 923 enhancer and the Flg
promoter within the EDC that were enriched specifically in keratinocytes, I subtracted 4C-seq
reads obtained from the T-cells that represent the “background”. This approach to identify
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keratinocyte-specific chromatin interactions with either the 923 enhancer or the Flg promoter
enables a more focused investigation on key chromatin interactions but does not completely
exclude the importance of genomic regions associated with fewer reads for interactions. I also
used the MACS peak caller to identify regions where 4C-seq reads for the 923 enhancer and Flg
promoter were enriched in the keratinocytes compared to the P5424 T-cells (Feng et al. 2012).
The numbers of regions containing keratinocyte-enriched 4C-seq reads based on
subtracting the background T-cell reads within the EDC are listed in Table 4.1. As shown in
Table 4.2, which lists a subset of the reads accounted for in Table 4.1, only a small number of the
keratinocyte-enriched 4C-seq reads overlap annotated regulatory elements. Interestingly, several
of the keratinocyte-enriched 4C-seq reads correspond to annotated Cdx1 transcription factor
binding sites (Lesurf et al. 2016) (Table 4.2). Cdx1 does not have a known role in keratinocyte
differentiation, but is important for regulating the differentiation of gastrointestinal epithelia
(Chan et al. 2009). The identification of an annotated binding site for Jarid2, Suz12, EZH2, Mtf2
within exon 2 of the Tchh gene (Table 4.2, UCSC mm10: chr3: 93443451-93443501) was
particularly interesting since Jarid2, Suz12, and EZH2 are Polycomb group proteins that are
important for epigenetic regulation of keratinocyte function (Eckert et al. 2011; Botchkarev et al.
2012), and Mtf2 has been known to complex with Polycomb Repressive Complex 2 (Li et al.
2010). Another region (Table 4.2, chr3:93,015,655-93,015,705), containing 4C-seq reads
enriched specifically in the 923 viewpoint proliferating keratinocytes, overlaps the Crct gene.
This region is orthologous to a previously identified CNE in the human genome, 531, that
demonstrated enhancer activity in an in vitro reporter assay (de Guzman Strong et al. 2010).
A keratinocyte-specific enrichment of 4C-seq reads was also identified in both
proliferating and differentiating keratinocytes within the 1.3 Mb gene desert that separates the
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Table 4.1. Numbers of enriched 4C-seq reads in keratinocyte libraries based on
subtraction of T-cell reads.
Gene!family!
S100!5'!
Gene!desert!
Pglyrp3!
Sprr!
Between!Sprr!and!Lce!
Lce!
Between!Lce!and!Flg!
Flg!
Between!Flg!and!S100!3'!
S100!3'!

Enriched!in!library!
923!KerD! 923!KerP! Flg!KerD!
Flg!KerP!
3!
5!
13!
11!
38!
21!
70!
102!
2!
0!
6!
7!
15!
5!
36!
42!
2!
0!
1!
5!
11!
12!
18!
24!
5!
4!
10!
2!
17!
14!
30!
3!
0!
1!
2!
1!
1!
2!
2!
0!

Table 4.2. Regulatory element annotations of enriched 4C-seq reads in keratinocyte
libraries based on subtraction of T-cell reads.
Genomic!position!
Chr!

Enriched!in!
library!
Annotated!Function!(Lesurf!et!al.!2016)!

chr3

Start!
End!
92303052! 92303102! 923!KerD!
923!KerP,!
93443451! 93443501! Flg!KerD!
Flg!KerD,!
91203067! 91203117! Flg!KerP!
Flg!KerD,!
91262658! 91262708! Flg!KerP!

chr3

93015655! 93015705! 923!KerP!

chr3
chr3
chr3

Cdx1!binding!site!upstream!of!Sprr2b!
Jarid2,!Suz12,!EZH2,!Mtf2!binding!site!
overlapping!Tchh)exon!2!
Cdx1!binding!site!in!gene!desert!
Cdx1!binding!site!in!gene!desert!
Functional!conserved!regulatory!element!
CNE!531!(de!Guzman!Strong!et!al.!2010)!
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S100 and Sprr gene families (Fig. 4.2a). In the 923 viewpoint proliferating keratinocyte library,
one enriched region was located approximately 520 kb downstream from the S100a9 gene (~800
kb upstream from Pglyrp3) (UCSC mm10: chr3:91,216,458-91,216,507), while one was
observed in the differentiating keratinocytes approximately 780 kb downstream from S100a9
(~540 kb upstream from Pglyrp3) (chr3: 91,471,110-91,471,159). With the Flg promoter
viewpoint (Fig. 4.2b), the proliferating keratinocytes, showed an enriched region approximately
370 kb downstream from the S100a9 gene (~950 kb upstream from Pglyrp3) (chr3: 9106572891065777), while several were observed in the differentiating keratinocytes at approximately 185
kb, 540 kb, 760 kb, and 700 kb from S100a9 (1135 kb, 780 kb, 560 kb, and 520 kb from
Pglyrp3) (chr3:90880868-90880917, chr3: 91138413-91138462, chr3: 91230604-91230653,
chr3: 91272119-91272168). The enrichment of reads within the gene desert might indicate as yet
unannotated regulatory elements, or might be an artifact of the chromatin architecture of the rest
of the EDC locus. The differentiated keratinocytes also showed specific enrichment of
interactions between the Flg promoter and regions across the Flg, Lce, and Sprr gene families
(Fig. 4.2b). One of these interaction peaks in particular lies between Hrnr and Rptn, in a region
orthologous to a human EDC region harboring a cluster of previously identified CNEs (180, 184,
and 189) with demonstrated regulatory activity in vitro (de Guzman Strong et al. 2010). Thus, I
identified chromatin interactions between the 923 enhancer and the Flg promoter that correlate to
functional regulatory elements in keratinocytes and suggests a potential role in these specific
looping events for functional gene activation.
To determine the biological relevance of the chromatin interactions, I subsequently
interrogated the MACS peaks using the Genomic Regions Enrichment of Annotations Tool
(GREAT).

Specifically, GREAT assigned potential biological functions to the regions where
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4C-seq reads were enriched in keratinocytes relative to T-cells (McLean et al. 2010). Tables S3 –
S6 list all Gene Ontology (GO) associations that achieve a significance threshold of binomial
FDR <0.05, ranked in decreasing order of significance (smallest binomial FDR to largest
binomial FDR). EDC genes are listed in bold.
This analysis identified an enrichment of 4C-seq reads in close proximity to genes
associated with epidermal development-related GO terms (Table 4.3, Table 4.4). Keratinization,
cornified envelope, and keratinocyte differentiation were the top three GO terms (based on FDR)
for the 923 KerD (Table 4.3, Table S3). Cornified envelope was the top GO term associated with
interactions enriched in Flg KerD, with keratinization, keratinocyte differentiation, epidermal
cell differentiation, epidermis development, skin development, and structural constituent of
epidermis achieving significance as well (Table 4.4, Table S4). This was consistent with the
established role of Flg as an important keratinocyte differentiation gene, as well as 923’s role in
regulating key structural genes such as Ivl. In the Flg KerD library. Enriched reads were found in
the Flg, Sprr (including Ivl), Lce, and S100 gene families (Table 4.4, Table S5), placing the Flg
promoter within a network of chromatin interactions extending all across the EDC. In the 923
KerD library, most of the enriched reads were found within the Sprr gene family (Table 4.3,
Table S3), indicating that within the EDC, the 923 enhancer mediates chromatin interactions
mainly localized to the Sprr gene family to which it belongs. Considering the proximity of 923 to
the Ivl gene, the absence of reciprocity between the 923 viewpoint and Flg was surprising, but
could be due to the smaller number of reads obtained from the 923 KerD library.
The GREAT analysis also identified an enrichment of 4C-seq reads in both the 923 KerD
(Table S3) and Flg KerD (Table S5) libraries near genes associated with detection and defense
responses to bacteria, including GO terms such as peptidoglycan receptor activity and detection
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Table 4.3. GREAT-predicted cis-regulatory targets of 4C-seq reads enriched in 923 enhancer viewpoint differentiating
keratinocytes (923 KerD) relative to T-cells.
ID#

Desc#

GO:0031424)

keratinization)

2.60E614) Ivl,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2i,Sprr3,Sprr4#

GO:0001533)

cornified)envelope)
keratinocyte)
differentiation)

2.67E614) Ivl,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2i#

GO:0030216)

BinomFdrQ# Genes#

3.35E605) Ivl,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2i,Sprr3,Sprr4,Yap1#

Table 4.4. GREAT-predicted cis-regulatory targets of 4C-seq reads enriched in Flg promoter viewpoint differentiating
keratinocytes (Flg KerD) relative to T-cells.
ID#

Desc#

GO:0001533)

cornified)envelope)

4.89E618) Anxa1,Flg,Hrnr,Ivl,Lor,Rptn,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i#

GO:0031424)

GO:0009913)

keratinization)
keratinocyte)
differentiation))
epidermal)cell)
differentiation)

GO:0008544)

epidermis)
development)

3.83E613) Abca12,Hrnr,Ivl,Lor,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i,Sprr3,Sprr4)
Abca12,Anxa1,Ctnnd1,Hrnr,Ivl,Lor,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i,Sprr3,Spr
2.29E605) r4,Trp63)
Abca12,Anxa1,Atoh1,Clic5,Clrn1,Ctnnd1,Ercc3,Gli2,Grxcr1,Hdac2,Hrnr,Ivl,Lor,Myo7a,Pcdh15,Slitrk6,Sprr1
2.45E603) b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i,Sprr3,Sprr4,Trp63)
Abca12,Anxa1,Atoh1,Barx2,Clic5,Clrn1,Ctnnd1,Ercc3,Flg,Foxq1,Gli2,Grxcr1,Hdac2,Hrnr,Igf1r,Inhba,Ivl,Lce
1g,Lce1i,Lce1l,Lce1m,Lce3a,Lce3c,Lce3f,Lor,Myo7a,Pcdh15,Pdgfa,Pou3f2,Slitrk6,Sprr1b,Sprr2a1,Sprr2a2,
1.68E602) Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i,Sprr3,Sprr4,Tgfb2,Trp63)
Abca12,Anxa1,Arrdc3,Atoh1,Barx2,Clic5,Clrn1,Col1a1,Col1a2,Ctnnd1,Ercc3,Flg,Foxq1,Gli2,Grxcr1,Hdac2,H
rnr,Igf1r,Inhba,Ivl,Lce1g,Lce1i,Lce1l,Lce1m,Lce3a,Lce3c,Lce3f,Lor,Myo7a,Pcdh15,Pdgfa,Pou3f2,Slitrk5,Slit
2.18E602) rk6,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i,Sprr3,Sprr4,Tcf7l2,Tgfb2,Trp63)

GO:0030216)

GO:0043588)

GO:0030280)

skin)development)
structural)
constituent)of)
epidermis)

BinomFdrQ# Genes#

3.82E602) Lor#
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of bacterium. A closer look revealed that this was the result of an enrichment of 4C-seq reads
within the gene desert which are associated with flanking genes Pglyrp3 and Pglyrp4, and
correspond to the enriched reads that had been identified in the gene desert by subtracting the
background T-cell reads.

4.3.5 Keratinocyte-specific trans-interactions with the 923 enhancer and Flg
promoter were observed near epidermal differentiation genes
The results of the MACS peak calling and subsequent GREAT analysis were also used to
predict the functional significance of trans-interactions for the EDC in keratinocytes.
Interestingly, within both 923 KerP and Flg KerP libraries, there were shared enrichments of 4Cseq reads relative to T-cells near Vmn1r family genes related to pheromone receptor activity
(Tables S4 and S6). The Flg KerP libraries also displayed an enrichment of 4C-seq reads near
genes belonging to the Olfr family (Table S6). Although the expression of the Olfr genes was
originally thought to be limited to sensory neurons in the olfactory nasal epithelium, studies have
indicated roles for the Olfr genes in other epithelial tissues (Gu et al. 2014). Therefore, the
identification of 4C-seq reads near Olfr aside from the Vmn1r genes with respect to the EDC,
could represent spatial proximity of these loci within a nuclear compartment for gene regulatory
crosstalk.
I decided to focus on trans-interactions that would be most relevant to understanding the
genome-wide interactions mediated by 923 and the Flg promoter in the context of keratinocyte
differentiation by only considering MACS peaks that were associated with significantly enriched
GO terms keratinocyte differentiation, keratinization, and cornified envelope, as determined by
GREAT (Tables 4.3 and 4.4). These included an interaction between the 923 enhancer and
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genomic fragments neighboring Yap1 in differentiating keratinocytes, associated with the GO
annotation of keratinocyte differentiation (Table 4.3, Table 4.5, Fig. 4.3). As well, MACS
identified trans interactions between the Flg promoter with genomic regions near Abca12,
Anxa1, Ctnnd1, and Trp63 (Table 4.4, Table 4.6). Interestingly, Trp63, encodes p63, which is an
important regulator of epidermal differentiation (Fig. 4.4). The identification of interactions with
important epidermal differentiation genes on other chromosomes suggests possible co-regulation
of Flg and 923-regulated genes by a wider network of chromatin interactions that extends
beyond the EDC. However, additional experiments will need to be performed in the future to
validate these findings.

4.4 Discussion
In summary, my results identify similar EDC TADs in proliferating versus differentiated
keratinocytes and P5424 T-cells, consistent with the earlier studies that noted invariant TAD
boundaries regardless of cell-type (Smith et al. 2016). However, within the boundaries of the
EDC TAD, the keratinocyte libraries appeared to also contain distinctive peaks in interactions
compared to the T-cells, likely representing interactions specific to an active EDC locus. Using
3D-FISH, a previous study demonstrated keratinocyte-specific compression of the EDC locus
mediated by chromatin remodeler, Satb1, and predicted that Satb1 regulates EDC gene
expression by forming a densely looped chromatin structure (Fessing et al. 2011). A related
study further demonstrated that low EDC gene expression was correlated with distal positioning
of the EDC from the neighboring genes Rps27 and Gabp2, while high EDC expression
correlated with proximity between the EDC and Rps27 and Gabp2 (Mardaryev et al. 2013).
Using 923- and Flg-centric 4C-seq as independent functional assays for the chromatin
architecture of the EDC, I identified a similar topology within the EDC that is unique to
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Table 4.5. 4C-identified trans-interactions.
Bait

Target

Function

923

Yap1

Modulator of epidermal stem cell proliferation

Abca12

Keratinocyte lipid transporter, important for maintaining epidermal
lipid barrier

Anxa1

Interacts with S100A11 in epidermal growth factor-triggered
growth signal pathway

Ctnnd1

Important for cell adhesion

Trp63

Master regulator of keratinocyte differentiation

Flg
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Figure 4.3. Keratinocyte-specific chromatin interactions identified between the 923 enhancer and
Yap1. Example of a MACS-called significant interaction in 923 viewpoint differentiating keratinocyte
library relative to T-cells. A 4C interaction with 923 mapped to a genomic region near Yap1 and was
identified by MACS as significantly enriched in a differentiating keratinocyte library relative to a T-cell
library.
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Figure 4.4. Keratinocyte-specific chromatin interactions identified between the Flg promoter and
Trp63. Example of a MACS-called significant interaction in the Flg promoter viewpoint differentiating
keratinocyte library relative to T-cells. A 4C interaction with the Flg promoter mapped to a genomic
region near Trp63 and was identified by MACS as significantly enriched in a differentiating keratinocyte
library relative to a T-cell library.

Table 4.6. Numbers of enriched 4C-seq reads in keratinocyte libraries relative to T-cells based on
MACS peak calls.
Gene$family$

Enriched$in$library$
923$KerD$

923$KerP$

Flg$KerD$

Flg$KerP$

S100$5'$

0$

0$

2$

0$

Gene$desert$

6$

1$

13$

1$

Pglyrp3$

0$

0$

3$

0$

21$

1$

10$

2$

Between$Sprr$and$Lce$

0$

0$

1$

0$

Lce$

3$

3$

7$

0$

Between$Lce$and$Flg$

0$

0$

8$

0$

Flg$

0$

0$

22$

3$

Between$Flg$and$S100$3'$

0$

0$

1$

0$

S100$3'$

0$

0$

2$

0$

Sprr$
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keratinocytes compared to T-cells that do not express the EDC genes. The EDC cis-interactions
identified by subtraction of T-cell reads indicated that both 923 and the Flg promoter were
capable of forming interactions throughout the EDC (Table 4.1). This method identified cisinteraction profiles that encompass similar regions with respect to both 923 and Flg baits,
providing further evidence for the EDC chromatin domain identified in the previous studies
(Fessing et al. 2011; Mardaryev et al. 2013). However, the more stringent MACS peak caller
indicated that 923, formed more localized interactions mainly within the Sprr gene family and
the nearby Lce family, while the Flg promoter displayed a more far-reaching interactions,
extending throughout the EDC (Table 4.6).
The identification of chromatin looping events within the gene desert for both 923 and
Flg loci suggests the co-opting of a regulatory element by both a gene and an enhancer. The
chromatin looping events between 923 and CNE 531 enhancer support the tendency for
regulatory elements to interact with each other, as previously noted (Robyr et al. 2011). The
interactions between the Flg promoter and the gene desert, as well as the region harboring CNE
enhancers 180, 184, and 189, also illustrate the use of 4C-seq data to discover putative functional
regulatory elements for chromatin remodeling.
Recent studies have identified specific roles for CTCF to mediate chromatin architecture
and gene expression. Depletion of the structural proteins CTCF and cohesin and the deletion of
CTCF binding sites and a cis-regulatory element identified that while CTCF binding was
necessary for maintaining a normal interaction profile, the regulatory element was required for
normal gene expression (Yang et al. 2016). Additional studies definitively demonstrated that the
deletion of a CTCF site, can alter the TAD structure caused aberrant enhancer-promoter
interactions and thus aberrant gene expression (Guo et al. 2015; Lupiáñez et al. 2015). Consistent
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with these findings, ENCODE-annotated clusters of CTCF binding sites are found between each
of the 4 EDC gene families and suggest that up to 4 TADs may exist within the EDC (Fig. 4.5).
The locations of the CTCF sites are largely conserved across a variety of tissues and cell-types,
indicating a conservation of TADs.
Interestingly, the human orthologous region (UCSC hg38 chr1:152,162,963-152,173,456)
for the approximate 12 kb region (UCSC mm10 chr3: 93,376,723-93,389,039) that interacts with
the Flg promoter also encompasses a long noncoding RNA, FLG-AS1 (Flg anti-sense). FLGAS1 has 9 isoforms. The overlap between the CNE 184 enhancer and exon 1 of FLG-AS1-005
(ENST00000593011.5) suggests the existence of an enhancer RNA for this particular splice
variant of FLG-AS. Recent studies have demonstrated that enhancer RNAs (eRNAs) contribute
to regulating gene expression, that include stabilization of chromatin loops and targeting mRNAs
for degradation (Kim et al. 2010). The interaction between the Flg promoter and the proximal
region of the CNE 184 enhancer could indicate co-regulation of Flg and FLG-AS transcription
during keratinocyte differentiation. The resulting FLG-AS transcript could likely participate in a
positive feedback loop by stabilizing the chromatin interaction.
As demonstrated in this chapter, chromatin conformation studies can help us elucidate
mechanisms of gene activation by the discovery of putative regulatory elements. Often the
regulatory elements that affect the expression of a gene expression might be distally located,
making their target effects difficult to elucidate. Many common diseases cannot be completely
explained by coding variants with an alternative hypothesis for regulatory variants for disease
risks. Therefore, by identifying specific enhancer-promoter interactions and TADs within which
genes and enhancers are likely to interact, chromatin conformation studies have the potential to
pinpoint candidate regions for the identification of disease causing variants.
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Figure 4.5. Distribution of CTCF binding sites across the EDC. ENCODE CTCF ChIP-seq reveals
binding across a variety of cell lines that corresponds to the approximate boundaries of each of the EDC
gene families. Binding intensities correspond to the darkness of the lines, and indicate varying intensities
in different cell lines and tissues (UCSC Genome Browser build mm9).
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4.5 Materials and Methods
4.5.1 Circular chromosome conformation capture library preparation
Primary keratinocytes were isolated from newborn mice as previously described
(Lichti et al., 2008) and plated under proliferating or differentiating (2.0!mM Ca2+) conditions in
custom keratinocyte media. The 4C assay was performed as previously described (Splinter et al.,
2012). Approximately 10 million cells were harvested at 72 hours post-calcium treatment and
cross-linked while in single-cell suspension with 2% formaldehyde. The cross-linking reaction
was quenched with 0.125M glycine followed by cell lysis to recover the nuclei. The cross-linked
nuclei were incubated at 37ºC for 4 hours with 200U HindIII (New England BioLabs, Ipswich,
MA). An additional 200U of HindIII was supplemented before the nuclei were incubated
overnight, and again before another 4h incubation the following day. Each 4C library was
assessed for efficient digestion by qPCR, using primers to amplify across a HindIII site and
comparing the Ct values to amplification within a restriction fragment (primers listed in Table
S1). The libraries were then ligated with T4 DNA ligase (New England BioLabs) overnight at
16ºC. An aliquot from each library was electrophoresed on a 1.5% agarose gel and assessed for
efficient ligation as determined by the presence of large molecular weight fragments. Libraries
with satisfactory ligation efficiencies were then de-cross-linked using Proteinase K (IBI
Scientific, Peosta, IA), and purified by phenol/chloroform (Life Technologies). A second
digestion was performed at 37ºC overnight using 50U of NlaIII (New England BioLabs, Ipswich,
MA). Again, each library was assessed for efficient digestion by qPCR (primers listed in Table
S1) before proceeding to a second round of ligation. After efficient ligation was confirmed,
libraries were purified using the QIAquick PCR purification kit (Qiagen). The 4C libraries were
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amplified by inverse PCR followed by a nested PCR using primers containing Illumina adaptor
tails to generate 4C amplicon libraries (Table S1). Both rounds of PCR used the Expand Long
Template Polymerase (Roche) and the following PCR conditions: 94ºC for 2 min followed by 29
cycles of 94ºC for 10 s, 55ºC for 1 min and 68ºC for 3min (Fig. S1). 4C amplicon libraries were
sequenced using custom sequencing primers on an Illumina HiSeq 2500 (Illumina, Hayward,
CA) (Fig. 4.1). See Table S1 for inverse primer sequences and nested sequences.

4.5.2 Data Analysis
Mapping of 4C-seq reads
The raw sequencing reads were first demultiplexed by allowing either 0, 1, or 2 mismatches in
the index sequences. The successfully demultiplexed reads were then mapped to the mouse
genome (UCSC mm10) using the Burrows-Wheeler Aligner (BWA). Using the Basic4Cseq
software (Walter et al. 2014), the mapped reads were limited to a reduced genome containing
only valid restriction fragments based on the restriction enzyme strategy used in the experiment
and represent valid interactions.
Determination of 4C-seq library quality
Each 4C-seq library was assessed for quality using the Basic4Cseq software (Walter et al. 2014)
prior to further analysis. The criteria for a good quality library was previously empirically
determined as having at least 40% of cis-interactions and > 1 million reads (van de Werken et
al., 2012) (Figure S6, Table S2).
Identification of keratinocyte-specific 4C interactions
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Libraries that passed the quality control criteria were used for the identification of keratinocytespecific interactions. Enrichment of interactions in keratinocytes versus P5424 T-cells was
identified using the MACS peak caller (v1.4.2) (Zhang, et al., 2008). The default parameters
were used for running MACS. For each bait, keratinocyte libraries (proliferating or
differentiating) were used as “treatment” files, while T-cell libraries were used as “control” files.
Identification of trans-interactions
Peaks called by MACS were used as input for the Genomic Regulatory Enrichment of
Annotations Tool (GREAT v3.0) (McLean, C., et al., 2010). The UCSC mm10 build was used,
and GREAT hits that were significant by the binomial test (false discovery rate <0.05) were
further considered.

4.6 Supplementary Material
Supplementary material may be viewed in Appendix C.
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Chapter 5

Conclusions
5.1 Summary
Early studies towards understanding transcriptional regulation initially focused on the
proximal sequences for a gene of interest. For epidermal development, genetic approaches to
elucidate the mechanisms underlying the keratinocyte-specific gene expression identified a
shared core of p63, AP1, SP1, and C/EBP transcription factors in the activation of K5, K14, K1,
K10, LOR, and IVL. These early studies approached gene regulation from a proximal and genecentric level. As seen in the regulation of EDC gene expression within the developing epidermis,
proper control of gene expression is an intricate hierarchy of events. Due to the shared biology of
the EDC genes, the EDC locus was eventually recognized as a gene cluster. The availability of
whole genomes further identified sequence conservation of the EDC locus throughout
mammalian evolution, and together with the conservation of expression patterns between
mammalian species, indicated a selective pressure to maintain the locus as a regulatory module.
Bioinformatics tools and high-throughput experimental techniques have subsequently allowed us
to analyze the regulatory landscapes of the EDC locus as a whole.
My work sought to identify the link between concomitant EDC gene expression pattern
with respect to the 923 epidermal-specific enhancer during keratinocyte differentiation. Based on
the assumption that sequence conservation in noncoding regions likely implies function
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(Lindblad-Toh et al. 2011), 923 was identified as one of the 48 conserved non-coding elements
within the EDC locus that could serve as potential modulators (enhancers or repressors) of the
gene cluster (de Guzman Strong et al. 2010). This study demonstrated enhancer function for the
human 923 sequence as it was sufficient to increase reporter gene expression in keratinocytes as
well as direct epidermal specificity in transgenic reporter mice.
In Chapter 2, I further demonstrated that the enhancer activity for 923 correlated with the
dorsal to ventral patterning of skin barrier formation and the activation of marker genes of
epidermal differentiation , K1, Lor, Flg, and Ivl (Oh et al. 2014). Using a tiling 3C assay to
interrogate physical chromatin interactions between the 923 enhancer and EDC gene promoters,
I discovered a 923-centric chromatin architecture of the EDC that was dynamic with respect to
keratinocyte differentiation. I further identified a requirement for AP-1 transcription factor
binding to the 923 enhancer for EDC gene activation and chromatin remodeling based on
bioinformatics and genetics studies that mapped the functional relevance of the AP-1 binding site
and 3C assays on differentiated keratinocytes treated with the pharmacological AP-1 binding
inhibitor Tanshinone IIA. As distal enhancers have been known to regulate gene expression via
chromatin looping interactions (Ong and Corces 2011), my findings demonstrated this paradigm
for keratinocyte biology as mediated by 923. Furthermore, my identification of a role for AP-1
to affect EDC gene expression and chromatin looping provided a link between studies that
highlighted AP-1 as an important regulator of epidermal differentiation (Mehic et al. 2005;
Rorke et al. 2010), with cell biology studies that identified remodeling of the EDC and proper
nuclear spatial organization as requirements for EDC gene expression (Fessing et al. 2011;
Mardaryev et al. 2013).
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In Chapter 3, my goal was to determine if the 923 enhancer is necessary for EDC gene
expression. I addressed the function of 923 by deleting the orthologous 923 sequence in mice
using CRISPR/Cas9 genome editing. Targeted deletion of the 923 enhancer in vivo as a
functional assay in mice is more feasible given the ease of design, cost, and specificity of the
CRISPR/Cas9 genome editing technology. Using two designed sgRNAs to target Cas9 nuclease
activity to the flanking ends of 923 and two loxP ssODNs with specific homology arms to enable
the insertion of flanking loxP sequences by homology-directed repair, I recovered at least four
923 mutation alleles. They included one floxed 923 (923flox) with both loxP inserting in cis, two
independent deletion alleles (923delA, 923delB), and one partial deletion with a remaining 238 bp
of 923 (923pdel). Although 923delA and 923delB mice demonstrated normal viability and normal
epidermal barrier structure and function, gene expression analysis of both deletion lines indicated
an allele-dose dependent decrease in the expression of 923’s immediate neighbor, Ivl, and to a
lesser extent, proximal genes Smcp and Lce6a, and distal genes Crnn and several of the Lce gene
family members (Lce3a, Lce3b, Lce3e and Lce3f). Correlating with this observation was a
compensatory upregulation of several members of the Sprr gene family (Sprr2a2, Sprr2e,
Sprr2g, Sprr2i, Sprr2j, and Sprr1b) that are important to the integrity of the epidermal skin
barrier as well. Thus, based on these initial studies, I identified a requirement for the 923
enhancer for proximal and distal gene activation in the epidermis.
In Chapter 4, I sought to identify the chromatin architecture of the EDC on a genome-wide
scale with respect to the 923 enhancer and Flg promoter in keratinocytes compared to non-EDC
expressing T cells. My previous approach towards understanding the chromatin interactions of
923 using the 3C assays described in Chapter 2, provided a selective view on 923-mediated
interactions that were limited to EDC promoter regions. With increasing evidence that chromatin
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architecture is meditated by interactions between regulatory elements aside from enhancepromoter interactions (Robyr et al. 2011), I was compelled to expand my view of 923-mediated
chromatin architecture by using an unbiased 4C-seq approach. This would not only allow me to
interrogate interactions across the EDC at a higher resolution, but also allow me to identify
genome-wide interactions that would help me place the role of 923 and the EDC within a broader
context of the many other genes involved in epidermal differentiation. I also included a second
viewpoint at the Flg gene promoter in order to elucidate the underlying chromatin architecture
that affects its expression. I was interested in Flg as it encodes a major structural protein of the
skin barrier. As mentioned previously, FLG mutations in humans are associated with atopic
dermatitis (AD), but only account for about 40% of the disease incidence (Palmer et al. 2006).
However, the persistent linkage of AD to the EDC even after excluding known FLG mutations
suggests that additional causal variants reside within the EDC that could include regulatory
elements. The use of the Flg gene promoter as a viewpoint for a 4C-seq experiment would
therefore allow me to identify candidate enhancers that could be modulators of Flg expression,
while also providing an alternate view of the EDC chromatin landscape. From these experiments,
both the 923 and Flg promoter viewpoints revealed a topology domain in the EDC that was
specific to keratinocytes compared to T cells. Moreover, there also existed distinct chromatin
interactions in keratinocytes, and even specifically in proliferative versus differentiated states.
Interaction between the 923 enhancer and non-coding regions within the gene desert between the
S100 and Sprr gene families were strongly enriched in keratinocytes and suggests the presence of
as yet unannotated regulatory elements within the gene desert. Also, enhancer-enhancer
chromatin interactions were observed in keratinocytes, suggesting a role for chromatin looping
between enhancers to mediate keratinocyte-specific chromatin architecture of the EDC. These
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studies emphasize the need to more closely examine these regions and their roles in shaping the
EDC chromatin topology. Furthermore, the interaction identified between the Flg promoter and
enhancer 184 in the EDC demonstrate the potential of 4C-seq and other chromosome
conformation capture techniques for pinpointing target regions for elucidating causal variants for
diseases such as AD.
Together, the results of my work establish a paradigm for enhancer-promoter chromatin
interactions for gene activation specific to epidermal development. I characterized the AP-1dependent enhancer 923, demonstrating its role in mediating spatial interactions with numerous
EDC gene promoters to establish a poised conformation for coordinating EDC gene activation
upon the induction of epidermal differentiation (Oh et al. 2014). In Chapter 3, I further
discovered that the loss of the 923 enhancer results in a dose-dependent decrease in proximal
genes (Ivl, Smcp, and Lce6a) and distally located genes (Crnn and distal Lce family genes), along
with an increased expression of Sprr genes, to maintain the integrity of the skin barrier. The
exact nature of these mechanisms have yet to be explored. However, interactions between 923
and other enhancer elements within the EDC (detailed in Chapter 4) suggest an intriguing model
of chromatin looping mediated by enhancers in the Sprr, Lce, and Flg gene families to
coordinate gene expression, and to rapidly activate functionally related genes as a “back-up”
mechanism for overcoming the loss of functionally related proteins to maintain barrier integrity.
These findings contributed to the field’s understanding of the regulatory landscapes,
chromosome territories and topologically associated domains (TADs) that bring regulatory
enhancers and promoters into close proximity for the purpose of transcriptional regulation in the
context of keratinocyte differentiation.
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5.2 Future Directions
We have still much to learn about the regulatory principles that govern gene activation at
the chromatin level and specifically in epidermal development. Elucidation of the molecular
biology and biochemistry of enhancer-promoter interactions has opened up a new era to further
investigate the paradigm of transcriptional regulation. Armed with new methodologies for
genome sequencing and editing and protein engineering to both discover enhancers and to
rapidly test their function, we approach a comprehensive understanding of the principles of
genome architecture that modulate cellular transcriptomes at a faster rate than ever.
Large amounts of genomics data have been generated due to the availability of whole
genome sequences from increasing numbers of species (Lindblad-Toh et al. 2011), highthroughput techniques such as ChIP-seq, RNA-seq, and DNase-seq. The accompanying
development of bioinformatics tools to allow the integration of the genomic and epigenetic data
(Hoffman et al. 2013), have made it possible to analyze gene regulation on a large-scale. These
advances have enabled the field to identify enhancers across the genome based on correlative
epigenetic marks. However, we are at a critical point in deciphering the function of these
enhancers in skin biology and understanding the role that enhancers play in transcriptional
regulation and genome organization.
Previous evidence has shown that cohesin and CTCF play a role in maintaining enhancerpromoter interactions in a multitude of cell-types and tissues (Hadjur et al. 2009; Mishiro et al.
2009; Hou et al. 2010; Seitan et al. 2011). Specifically, CTCF has been shown to bind at the
boundaries of TADs in a directional manner, creating insulator boundary elements that allow
neighboring genes to be regulated in different ways (Dixon et al. 2012; Phillips-Cremins et al.
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2013; Guo et al. 2015; Tang et al. 2015). My own results from the 4C-seq experiments described
in Chapter 4 hint at the involvement of both 923 and Flg in a network of chromatin interactions
involving genes and regulatory elements throughout the genome to act cooperatively in order to
drive proper gene expression for epidermal differentiation. Within the EDC, the boundaries of
the gene families correspond approximately with clusters of CTCF binding sites (UCSC mm10).
Further, the discrete temporal activation of each EDC gene family during epidermal
differentiation (de Guzman Strong et al. 2010) indicates independent regulation of each gene
family. Taken together this suggests that CTCF is likely to be a major player in mediating the
formation of chromatin loops by defining TADs within the EDC. An intriguing hypothesis to test
is a functional role for CTCF to maintain normal EDC gene expression during epidermal
development.
Drawing from the expertise of the evolutionary biology field, we are now able to identify
candidate regions with regulatory potential faster than ever (Siepel et al. 2005; Pennacchio et al.
2006; Hemberg et al. 2012). Techniques such as the massively parallel reporter assay (MPRA)
that allow high-throughput assessment of enhancer activity have also made the task of in vitro
testing of multiple putative enhancers far less laborious (Kwasnieski et al. 2014). In Chapter 1,
the loss of AP-1 binding to 923 significantly diminished, but did not entirely ablate the ability of
923 to drive reporter gene expression or form chromatin interactions (Oh et al. 2014). This
indicated a contribution of other unknown protein factors for 923’s enhancer activity. Our lab
performed targeted sequencing of the 923 enhancer in a cohort of atopic dermatitis patients and
identified atopic dermatitis (AD) patient-specific variants that are predicted to disrupt the binding
of transcription factors with key roles in epidermal development, including Klf4 and Smad2:3:4
(Quiggle, et al. unpublished data). These suggest targets for further dissection of the molecular
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mechanisms governing 923’s enhancer activity. Additionally, the observed 4C-seq interactions
between enhancers 923 and 531 in proliferating keratinocytes, as well as between the Flg
promoter and enhancer 184 in differentiating keratinocytes, suggest that enhancers in the EDC
are important for physiologically sensitive chromatin looping. The MPRA technique would
allow us to perform mutation saturation of 923 and other enhancers of interest in order to gain a
high-resolution view of how variants within these elements could modulate EDC gene
expression and even in complex diseases such as AD.
Advances in genome editing (CRISPR/Cas9, TALENs) available today have also made it
easier than ever to functionally test the endogenous functions of enhancers (Fanucchi et al. 2013;
Sander and Joung 2014; Lupiáñez et al. 2015). They are also an advancement over transgenic in
vivo studies that lack the ability to address the function of enhancers in the appropriate genomic
context. The precision of these genome editing methods enables us to more directly test our
hypotheses in specific locus/loci within the regulatory landscape. Our CRISPR/Cas9 generated
923 knockout mice provide us with a unique opportunity to examine the importance and the
necessity of 923 for mediating chromatin looping in the EDC by performing 3C or 4C assays on
keratinocytes derived from the mice. By comparing the interactions observed in the homozygous
mutants to wild-type littermates, we will be able to determine if the chromatin interactions
observed previously using 923 as a bait are directly mediated by the 923 sequence, or if they
were merely an artifact of a 923-independent chromatin architecture that brought 923 into
proximity with the interacting regions. Furthermore, by overlaying the interaction data with
RNA-seq data from these mice, we can draw conclusions about which interactions affect gene
expression. We could also assess the allele-bias of 923 activity by using a heterozygous
background to investigate the ability of the intact 923 to drive expression of the target genes on
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the other allele harboring the deletion of 923. To test this, we would cross the 923 knockout
mutants (C57BL/6xCBA) (backcrossed to select for the C57BL/6 background), to Balb/C mice
and perform RNA-seq and 4C-seq on isolated epidermis from the heterozygous mice. The
Balb/C line is one of the most phylogenetically distant strains from C57BL/6, for which over
3,300 SNPs across the EDC locus have been identified between the strains, including 39 within
EDC genes (Eppig et al. 2015). The informative SNPs will allow us to phase the haplotypes, thus
identifying allele-specific interactions and transcription from the 4C-seq and RNA-seq,
respectively. The proof-of-principle for this approach has been demonstrated in human cell-lines
(Tang et al. 2015), and holds great potential for elucidating the role of chromatin architecture in
human disease, an area still largely unexplored.
The regulation of the Flg-like gene family is also as an interesting line of further
investigation. As discussed earlier, human EDC enhancer 184 overlaps with an annotated splice
variant of non-coding RNA, FLG-AS1-005 (Ensembl release 84) (Yates et al. 2016), as well as
ENCODE annotated H3K27Ac active enhancer marks (Hoffman et al. 2013). Further, there is
evidence that 184 forms chromatin interactions with a number of EDC genes which are
aberrantly expressed in AD-patients (Quiggle, et al. unpublished data). This suggests the
possibility that 184/FLG-AS1-005 is an eRNA that stabilizes the loop with Flg to drive
expression. Future experiments such as RNA-ChIP can be employed to test the hypothesis that
the FLG-AS1-005 transcript interacts with the chromatin loop involving 184 and Flg.
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Appendix A
Supplementary Material for Chapter 2
Table S1. List of Mouse 3C Primers
Forward primers
923 (anchor)
AGAAGGCAAGGGGAGGATAA
2310050C09Rik GACACGGGTCCAACTACCTC
Crct1

GTTGGTATAAGGGGCACAGG

Crnn

AGGACTCCTTCCTTCCCTCA

Flg2

ATTAAAATAAGACCTGCTGGTAAACT

Hrnr

CCAGATGATCCAGACACCGTA

Kprp

CACCCCTCCTGCACATAAAT

Lce1a1

TGATTTTTGTGTCCGTCTTCC

Lce1a2

ATGTACCCAAATGCCCAGAG

Lce1c

GGACCCTGTCCTGAAATTCG

Lce1d

GAGACTCTGCTATCTACAGGTGACA

Lce1e

TAAGCCCTCTGACGAGCATC

Lce1f

TCATGATGAATTCTTTAACCTTTCT

Lce3b

CATGTCAATAGCTCTGTCATGTGT

Lce3b_5’

CTGGGCATGGTCACTCCTAT

Lor

TGGAAGAGATTTAGGGAAGGAA

Lor_5’

CCTCCCAGGAGACCCATTTA

Pglyrp3

TTTTCTGAAGTACACCCTTTTGA

Pglyrp4

AAGCAATTGGTTGCAGCTCT

Rptn

GACCACAGGGACTCAACGAT

S100a1

GTGGGCTACGATCTCCTCTG

S100a1_5'

TGTGGTCTTTGCTGCTTTTG
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S100a10

TTGTCTGGAGCTACCCCATC

S100a13

CTCTTCACCTCCCGTTCAAA

S100a14

GCAGGAAGATCTGGAAGTGC

S100a16

CTGTGCTCTGCTCCGTGTT

S100a2

CCAAGTTGTTAACATACCCAGCTA

S100a4

GAGGCAGAGGCTGTCAGTTT

S100a6

GGGCGTGTCAAGAAGGAGT

S100a7a

CAAAACAGTGCCTTGCTTCA

S100a8

TGTATCATTTGGTGCTGGGTA

S100a9

CACAGGTTGTTGGCTCTTTTT

Sprr1a

TCCTTTGACTCTGTCCCAAAA

Sprr1b

GGGGTGTGTACTCCGTGTTC

Sprr2a1

CGTTCCCTTGCTATACTCCATC

Sprr2b

CAGGGGTGAACTACCAGGAG

Sprr2e

CACATGAACTAACTCAAGGTAGAGG

Sprr2f

CCTCAGTGTTCAGATCTGGGTAA

Sprr3

AAGGGTGAAATCCAGGATGA

Sprr4

CACACCTTTATGAAGAACCAGGA

Tchh

TGTTTTAATCTTTTCATAGAGACCACA

Tchhl1_3’

TGGCCAATCTTGAACTCTGA

Reverse primers
923 (anchor)

AATGGAAAGCACACCCAGAA

Flg

TGAGTTAGAAGTTGTGATCACTAGGAA

Ivl

GTCTGAGGTTCCTGCAATCC

Lce1b

GGAGGCATAAGCAGTCAGGA

Lce6a

TTGGGGATTGAGGAAAACAG
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S100a11

GCCCAGTGCTAGGTTCAAA

Sprr2d

GAACCTAATGGCTCAGGCTCT

Sprr2g

AAGAATGGAATGAGGAATAGGAAAC

Tchhl1

TTTTTCGGAAAGGTCACAACT

Control primers
cutF

CACACCTTTATGAAGAACCAGGA

cutR

GGCTTCAGAAAACCTCCAGA

uncutF

GGGTTGCCATTCAATACCAC

uncutR

TCTGGGCTCCTCCTCTGTAA

ERCC3-1

GCCCTCCCTGAAAATAAGGA

ERCC3-2

GACTTCTCACCTGGGCCTACA

Table S2. Mouse RT-PCR Primers
Gene

Forward

Reverse

2310050C09
Rik

CCTGCCAGGAAAGAAGATTT

ACAGTTTGAGGCTGGTAGGG

Crct1

TTCTGCCTAGCAGGTGTCAA

AGCAAGAGGAGGAGGAGGAC

Crnn

AACAGAAACTTGTCCCATCCTG

TGACGTCAGCAAACTCATGTT

Flg

CTCCTTCAGCTGCATTCGAT

TGCCTGTAGTTGTCCTTCCA

Flg2

TGCGTCAGGCCTTATCCTAC

TCCTTCTCCAGCAGTTCCTT

Hrnr

GCAAGCAACATCAGTCTCCA

CAGAATTTGGTGAAACTCTGTTA
CC

Ivl

GCCTTCTCCCTCCTGTGAGT

ATGTTTGGGAAAGCCCTTCT

Kprp

GCTCAGGTCCCAATCCAGTA

CCTTGGTCTCCACAACCACT

Lce1a1

CTCACCTTCCGAGGTATCCA

AAGACACAGGGGGACACTTG

115

Lce1a2

GCCCAAGGATCTTGTACTGC

CCAGGCTACAGCAGGAAGAC

Lce1b

TCCTCCTGAAGTGGCTACAGA

CCAGGCTACAGCAGGAAGAC

Lce1c

ACTGGCTGAGAAACCCACAG

CCAGGCTACAGCAGGAAGAC

Lce1d

ACTTCTCCTGAGGCGTCCAC

CCAGGCTACAGCAGGAAGAC

Lce1e

CCACTCACTGGGTGAGATACC

AACCCAAGCTACAGCAGGAA

Lce1f

ATCCACGCCATTAACACTGA

CCAGGCTACAGCAGGAAGAC

Lce3b

AGCATCCTCAGACACGGACT

TGTAGCACAGCAGGAAGAGG

Lce3c

TCTTCTCCTGCCTTTGCTGT

TGCTGATTCCTCCAGACTGT

Lce6a

ATTTCTGGCCCCATAAAACC

GCCTGCTGAACAAGAAGTCC

Lor

GGTCACCGGGTTGCAACGGA

GAGACACTAGAATTGGGAGG

Pglyrp3

TTGGCTTCTTGGCTCTCAGT

CAATGTCACACCAGCCTTTG

Pglyrp4

ATGCTGTCCTGGCTTCTTGT

TCAGCTTAGAGCTGCAACCA

Rptn

CCTGCCTCTTCTGCTCATTC

CCGAAGGATGTCTCCAAACT

S100a1

CAGTGGCCACATTTGCAG

TTCAGTTCTTTCTTGCTCAGCTT

S100a10

CTGAGAGTGCTCATGGAACG

TCCCCTTCTGCTTCATGTTT

S100a11

CCACCGTCAGCCACAGTC

ATCTAGCTGCCCGTCACAGT

S100a13

CCTTGCCTGGTGCTTATAAACTT

CCCTGCAAAGGTGAAGAAAG

S100a14

GGCAGGCTATAGGACAGACG

CCTCAGCTCCGAGTAACAGG

S100a16a

GAGGAGGTGGACTCACAGGA

TCCAGGTTCTGGATGAGCTT

S100a2

CGAGAGGCTCAAACACAACA

GGGACCCCTCAAGGAAGTTA

S100a4

CCCAAACCTCTCTATTCAGCA

CTTTTCCCCAGGAAGCTAGG

S100a6

ATCCCCTCGACCACTCCTT

AGATCATCCATCAGCCTTGC

S100a7a

GGATAGTGTGCCTCGCTTCA

AGACTGCCTGTCCTCCCTCT

CTGAGTGTCCTCAGTTTGTGC

GACCTGAGATATGATGACTTTAT
TCTG

S100a8
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S100a9

GAAGGAAGGACACCCTGACA

TCAACTTTGCCATCAGCATC

Sprr1a

GAGAACCTGCTCTTCTCTGAGTA
T

GCAGGGCTCAGGAACAGG

Sprr1b

GCGACCACACTACCTGTCCT

GGTGTCACAGGGTGTCTTGA

Sprr2a1

TTCCTGGTACTCAAGCATTGG

CAAGGCTCAAAGCACATGAC

Sprr2b

TTCCTGGTACTCAAGCATTGG

CTTGGGTGGACACTTCTGCT

Sprr2d

CAAGGCCGAGACTACTTTGG

ATGGCTCAGGACAAGGCTCT

Sprr2e

TCAGGTCCTAGGCTACTTTGG

TATGAGGGAGGAGGACATGG

Sprr2f

CTGGTACACACGTCCTGGAA

GCATTTCTGCTGGAATGAGG

Sprr2g

CAGGTCCTACACTACGTTGGAG

CTGGCATGGAGAAGGAAGAC

Sprr3

CCAAGAACCCAGTGATCTTCA

TGTTTCCTGGTTGTGGAACA

Sprr4

TCCCATCAGCATCAGAATCA

TGCTGTGCAGGACACTTCTC

Tchh

TGATGGAGCATCACTTAGCAA

GGCCTGATCGAGAGCATAAT

Tchhl1

CACATTGCCCCACATTCC

CCCTCAAGGAGCTGTCTCAG

Krt1

GACACCACAACCCGGACCCAAA
ACTTA

ATACTGGGCCTTGACTTCCGAGA
TGATG

Krt14

GGCCACCTACCTGGACAAG

GTCGATCTGCAGGAGGACAT

B2m

TGGTGCTTGTCTCACTGACC

CCGTTCTTCAGCATTTGGAT

Table S3. RNA-seq results
Gene Name

log2(Diff/Prolif)

P-Value

FDR (False Discovery Rate)

2310050C09Rik

5.96

2.81E-27

1.59E-25

Crct1

4.77

1.15E-71

6.30E-69

Crnn

3.58

2.63E-05

1.48E-04

Flg

2.61

5.27E-05

2.77E-04
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Flg2

8.65

8.08E-17

2.11E-15

Hrnr

5.64

9.03E-19

2.81E-17

Ivl

1.79

2.25E-10

2.95E-09

Kprp

3.21

7.22E-21

2.77E-19

Lce1a1

5.80

2.14E-27

1.23E-25

Lce1a2

6.77

6.86E-24

3.16E-22

Lce1b

5.24

2.34E-28

1.45E-26

Lce1c

7.24

9.99E-40

1.17E-37

Lce1d

6.09

1.64E-32

1.34E-30

Lce1e

4.76

3.90E-23

1.73E-21

Lce1f

6.89

1.42E-44

2.08E-42

Lce3b

0.74

3.05E-01

4.44E-01

Lce3c

2.58

2.49E-11

3.70E-10

Lce6a

6.48

5.34E-14

1.06E-12

Lor

6.25

1.70E-63

6.56E-61

Pglyrp3

0.63

5.00E-03

1.52E-02

Pglyrp4

3.93

5.18E-17

1.38E-15

Rptn

3.67

1.31E-12

2.23E-11

S100a1

1.05

6.87E-03

1.98E-02

S100a10

0.92

2.14E-05

1.22E-04

S100a11

1.40

7.85E-16

1.84E-14

S100a13

0.94

7.09E-02

1.41E-01

S100a14

1.82

2.15E-25

1.10E-23

S100a16

1.75

2.20E-19

7.32E-18

S100a2

-0.82

2.19E-01

3.47E-01

S100a4

2.77

5.09E-11

7.25E-10
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S100a6

1.67

4.93E-15

1.08E-13

S100a7a

2.19

3.36E-12

5.48E-11

S100a8

3.54

3.04E-18

9.03E-17

S100a9

3.36

8.02E-36

7.89E-34

Sprr1a

3.54

1.41E-26

7.69E-25

Sprr1b

2.59

3.50E-28

2.15E-26

Sprr2a1c

4.16

1.70E-04

7.95E-04

Sprr2b

4.27

2.53E-25

1.28E-23

Sprr2d

0.70

1.40E-02

3.66E-02

Sprr2e

-1.50

4.50E-05

2.41E-04

Sprr2f

0.32

6.18E-01

7.46E-01

Sprr2g

1.72

1.04E-09

1.26E-08

Sprr3

1.12

3.27E-03

1.05E-02

Sprr4

6.54

4.88E-18

1.42E-16

Tchh

2.22

2.08E-18

6.27E-17

Tchhl1

4.34

4.04E-16

9.77E-15

Table S4. ChIP Primers
Name

Forward
Coordinates
(NCBI37/mm
9)

Reverse

Block 1

Chr3:
92,380,67692380831

CCTTGTGATGAATCCAA
GAAA

TCTGGTCATATTCATCC
CTTCA

Chr15:

AGACGTGTGTCTGCATC

TTTGATGCGGTGAGCAA

(923 block 1)

Krt5

119

(ENCODE
annotated site
within keratin 5
[Krt5])

Neg

101,540,819101,540975

TGG

TTA

Chr3:
92,382,01992,382,161

TGCTTGCTACTGGGTCT
CAA

CCCTCCAAGTCCTATCA
TGC

(No ENCODE
annotated site)

Supplemental Materials and Methods
RNA-seq. Total RNA was isolated by TriZol extraction (Life Technologies, Frederick, MD)
from a parallel set of cells corresponding to cells used for the 3C libraries. Poly-A mRNA was
enriched (Dynabeads mRNA purification kit) and fragmented prior to SuperScript III 1st-strand
synthesis system (Life Technologies, Frederick, MD) and subsequently the NEBNext mRNA
Second Strand Synthesis Module (New England Biolabs, Ipswich, MA). RNA-seq libraries were
generated according to the manufacturer’s instructions (Illumina, Hayward, CA) and sequenced
using the Illumina HiSeq 2000.
A transcriptome index of the UCSC mm10 (GRCm38, Dec. 2011) mouse genome assembly was
constructed using TopHat v2.0.5 (Trapnell et al. 2009). Short, 50 bp single-end RNA-seq
(Mortazavi et al. 2008) reads were aligned to the mouse genome with TopHat (parameter set: -bowtie1 -a 5 -m 1 -i 10 -I 500000 -x 20 -n 2), allowing only one splice mismatch, two
mismatches within a read, an average intron length of 500,000 bp, a minimum anchor length of 5
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bp and a minimum exon length of 10 bp. Reads that aligned to the transcriptome more than 20
times were discarded. Alignments were converted to SAM format using the samtools package
(Li et al. 2009). Aligned transcripts in the SAM file were counted using the htseq-count program
(parameter set: --stranded=no –quiet).

Differential gene expression was calculated on the

transcript counts using the Bioconductor edgeR package version 3.2.3 (Robinson et al. 2010).
Significance cutoffs for differentially expressed genes were at FDR<0.001 and p<0.05.
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Appendix B
Supplementary Material for Chapter 3
Table S1. Χ2 test for deviation from expected Mendelian ratio reveals normal viability of 923
KO mice (α=0.05, df=2).
923delA F2
Genotype

Observed

Ratio

Expected

Χ2 test

Het

43

0.597222222

36

1.361111111

WT (-)

14

0.194444444

18

0.888888889

Mut (+)

15

0.208333333

18

0.5
2.75

Χ2 statistic

923delA F5
Genotype

Observed

Ratio

Expected

Χ2 test

Het

71

0.489655172

72.5

0.031034483

WT (-)

32

0.220689655

36.25

0.498275862

Mut (+)

42

0.289655172

36.25

0.912068966
1.44137931

Χ2 statistic

923delB F2
Genotype

Observed

Ratio

Expected

Χ2 test

Het

84

0.482758621

87

0.103448276

WT (-)

42

0.24137931

43.5

0.051724138

Mut (+)

48

0.275862069

43.5

0.465517241
0.620689655

923delB F4
122

Χ2 statistic

Genotype

Observed

Ratio

Expected

Χ2 test

Het

79

0.512987013

77

0.051948052

WT (-)

28

0.181818182

38.5

2.863636364

Mut (+)

47

0.305194805

38.5

1.876623377
4.792207792

Χ2 statistic

923pdel F6
Genotype

Observed

Ratio

Expected

Χ2 test

Het

8

0.216216216

18.5

5.959459459

WT (-)

11

0.297297297

9.25

0.331081081

Mut (+)

18

0.486486486

9.25

8.277027027
14.56756757

Χ2 statistic

Small Guide RNA (sgRNA) targeting sequences
Upstream 5’ sgRNA
5’- GAATACATCCCAGGAACAT -3’
Downstream 3’ sgRNA
5’- CAGTAAGCTAGCGCTAGAC -3’

ssODN sequences
Upstream 5’ ssODN
5’AGAAGTTTTTCAGTTCCCCATAGTTGTCCTGAGGAGCATATAATCTTTGTCTTAAGCAGATTTG
TTTACAATAATTCCCTATAACTTCGTATAGCATACATTATACGAAGTTATGCATGCTTTAAAGA
GATAGAGGACTGACATGACCCTCTGTCCTCTAAAACAAGTTTGCCAGGATTTCTCCATTCCCAG
AGCCATGA-3’
Downstream 3’ ssODN
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5’TCTCTGTTGTTAGAGTCCATCTCCTACACCGATAGAGACTGATTCTGAAAAAAAAGGAAGCTCC
CACTGTCCAAGTTCTAAAGCTTATAACTTCGTATAGCATACATTATACGAAGTTATTGGAAACC
AGACACCCTGGCTGCTGCTCTGAAGGCAACTCTTCCCTATCAGGCTCCTTAATAGGATTTGATC
AGTGTGAC-3’
SphI restriction site
HindIII restriction site
Homology arms
LoxP site

Genotyping primers
Mutant line

F primer

R primer

923delA
923delB

Mutant
allele

Wildtype
allele

317
CAGTTCCCCATAGTTGTCCTG

GGAAGAGTTGCCTTCAGAGC

923pdel

164

1407

579

5' loxP

TCTTTAGTGCTCAGTTAACAGC
T

AGTCCTCTATCTCTTTAAAGCAT
GCATAAC

259

-

3' loxP

GTTCTAAAGCTTATAACTTCGT
ATAGCA

TGCCTCACCAAATTCTCACA

195

-

923fl
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qPCR primers
Gene

Forward

Reverse

Crnn

AACAGAAACTTGTCCCATCCT TGACGTCAGCAAACTCATGTT
G

Flg

CTCCTTCAGCTGCATTCGAT

TGCCTGTAGTTGTCCTTCCA

Flg2

TGCGTCAGGCCTTATCCTAC

TCCTTCTCCAGCAGTTCCTT

Hrnr

GCAAGCAACATCAGTCTCCA

CAGAATTTGGTGAAACTCTGTTACC

Ivl

GCCTTCTCCCTCCTGTGAGT

ATGTTTGGGAAAGCCCTTCT

Lor

GGTCACCGGGTTGCAACGGA GAGACACTAGAATTGGGAGG

Rptn

CCTGCCTCTTCTGCTCATTC

CCGAAGGATGTCTCCAAACT

Sprr2d

CAAGGCCGAGACTACTTTGG

ATGGCTCAGGACAAGGCTCT

Sprr3

CCAAGAACCCAGTGATCTTCA TGTTTCCTGGTTGTGGAACA

Evpl

TCAAGGGGCTGAGCAAAG

AGCTTCTTCTGCGTCTCCAA

Ppl

ATACAGCCCAACGGTGCAG

CAGCACGTACAGCAGCTTTT

B2m

TGGTGCTTGTCTCACTGACC

CCGTTCTTCAGCATTTGGAT

RNA-seq results: Differential Expression relative to wildtype
Gene
S100a1
S100a13
S100a14
S100a16
S100a2
S100a3
S100a4
S100a5
S100a6
S100a7a
S100a8
S100a9

logFC het logFC mut
2.01E-01
5.78E-01
5.79E-01 -6.02E-02
1.26E-01 -8.39E-02
-7.12E-02
4.08E-02
-1.31E+00 -2.26E+00
2.01E+00 -1.14E-02
5.92E-01
1.76E-02
1.09E-01 -6.38E-02
5.35E-01 -5.49E-02
1.49E+00
7.49E-01
1.52E+00
4.86E-01
4.16E-01 1.05E+00

adj.P.Val
adj.P.Val
het
mut
9.66E-01
9.84E-01
9.66E-01
9.84E-01
9.66E-01
9.84E-01
9.66E-01
9.84E-01
9.66E-01
7.67E-01
1.60E-01
9.92E-01
9.66E-01
9.89E-01
9.66E-01
9.84E-01
9.66E-01
9.84E-01
9.66E-01
9.84E-01
9.66E-01
9.84E-01
9.66E-01
9.84E-01
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Pglyrp4
Pglyrp3
Lor
Prr9
Lelp1
Sprr2a1
Sprr2a1
Sprr2a2
Sprr2a2
Sprr2a3
Sprr2b
Sprr2d
Sprr2e
Sprr2f
Sprr2g
Sprr2h
Sprr2i
Sprr2j-ps
Sprr2k
Sprr1b
Sprr3
Sprr1a
Sprr4
Ivl
Smcp
Lce6a
Lce1a1
Lce1b
Lce1a2
Lce1c
Lce1e
Lce1f
Lce1g
Lce1h
Lce1i
Lce1j
Lce1k
Kprp
Lce1l
Lce3a
Lce3b

-2.24E-01
7.35E-02
-2.42E-01
6.85E-01
6.74E-01
1.09E-01
1.09E-01
1.09E-01
1.09E-01
-6.55E-01
-7.32E-01
-7.78E-01
-2.66E-01
-1.39E+00
1.24E-01
-5.80E-01
2.64E-01
-1.09E-01
-5.84E-01
-5.04E-01
-3.22E+00
-1.53E-01
9.98E-01
-8.40E-01
-9.23E-01
-3.07E-01
-2.33E-01
-6.27E-02
-1.15E-01
-1.70E-01
-2.34E-01
-4.11E-01
-1.88E-01
-8.97E-02
-8.13E-03
-3.16E-02
1.59E-01
-6.75E-01
-1.59E-01
-2.08E+00
-2.33E+00

3.47E-01
2.41E-01
-2.75E-02
-8.96E-01
-7.17E-01
-6.38E-02
-6.38E-02
8.27E-01
8.27E-01
3.02E-01
1.43E+00
1.17E+00
1.21E+00
-1.55E-02
1.71E+00
1.57E-01
1.20E+00
1.03E+00
1.81E-01
1.06E+00
-1.23E+00
4.58E-01
6.94E-01
-4.93E+00
-2.95E+00
-1.71E+00
-8.65E-02
-9.21E-03
4.03E-02
-4.23E-02
8.44E-02
3.62E-02
1.98E-01
4.04E-01
2.59E-01
6.84E-01
3.93E-01
-1.56E-01
4.21E-01
-1.59E+00
-5.95E-01
126

9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.68E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.04E-01
9.66E-01
9.66E-01
5.75E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.94E-01
9.82E-01
9.66E-01
6.63E-01
9.66E-01
9.66E-01
8.92E-01

9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
8.44E-01
8.44E-01
9.84E-01
9.10E-01
7.17E-01
9.84E-01
9.95E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
4.58E-04
2.80E-01
9.84E-01
9.84E-01
9.90E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01

Lce3c
Lce3d
Lce3e
Lce3f
Crct1
Lce1m
Crnn
Flg2
Hrnr
Rptn
Tchh
Tchhl1
S100a11
S100a10

-4.84E-01
-5.77E-01
-8.12E-01
-2.19E+00
5.15E-02
3.96E-02
-6.76E-01
3.03E-01
-8.69E-02
-3.00E-01
2.66E-01
8.49E-01
-2.21E-01
-6.16E-02

-9.96E-02
5.65E-01
-1.51E+00
-2.48E+00
-4.66E-02
-1.16E-01
-1.73E+00
4.76E-01
1.45E-01
1.35E+00
-9.53E-02
-4.92E-01
-3.22E-01
-1.47E-01

9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.67E-01
8.45E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01
9.66E-01

9.84E-01
9.84E-01
6.78E-01
9.84E-01
9.84E-01
9.84E-01
3.07E-02
9.11E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01
9.84E-01

Evpl
Ppl

-1.48E+00
2.66E-01

-1.33E-01
-9.53E-02

-4.90E-02
1.16E-01

9.84E-01
9.84E-01
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Appendix C
Supplementary Material for Chapter 4
Table S1. Custom Primers for 4C-seq
Nested$Inverse$PCR$
Guide$Primers$
$
Name$
AATGATACGGCGACCACCGAGATCTGTCAGATCTCAACATTCCTG
$
TCAAA
923$Read$HindIII$
CAAGCAGAAGACGGCATACGAGATAACCTCAACAACTTCCTAATA
923$Index$1$NlaIII$
TTTTAATGTCAAACAA
CAAGCAGAAGACGGCATACGAGATTCTAAGCACAACTTCCTAATA
TTTTAATGTCAAACAA
923$Index$2$NlaIII$
CAAGCAGAAGACGGCATACGAGATCTGTCATACAACTTCCTAATA
TTTTAATGTCAAACAA
923$Index$3$NlaIII$
CAAGCAGAAGACGGCATACGAGATGGAGGTGACAACTTCCTAATA
TTTTAATGTCAAACAA
923$Index$4$NlaIII$
CAAGCAGAAGACGGCATACGAGATGCTCGATACAACTTCCTAATA
TTTTAATGTCAAACAA
923$Index$5$NlaIII$
CAAGCAGAAGACGGCATACGAGATTAGAGTAACAACTTCCTAATA
TTTTAATGTCAAACAA
923$Index$6$NlaIII$
CAAGCAGAAGACGGCATACGAGATTCAGTCTACAACTTCCTAATA
TTTTAATGTCAAACAA
923$Index$7$NlaIII$
CAAGCAGAAGACGGCATACGAGATTTCCAAGACAACTTCCTAATA
923$Index$8$NlaIII$
TTTTAATGTCAAACAA
CAAGCAGAAGACGGCATACGAGATTAATCGGACAACTTCCTAATA
TTTTAATGTCAAACAA
923$Index$9$NlaIII$
AATGATACGGCGACCACCGAGATCTTGAGTTAGAAGTTGTGATCA
Flg$Read$HindIII$
CTAGGAA
CAAGCAGAAGACGGCATACGAGATCGCTGCCAAATTGGAAGCTAC
AAAAACATAGGTA
Flg$Index$10$NlaIII$
CAAGCAGAAGACGGCATACGAGATATGATGGAAATTGGAAGCTAC
Flg$Index$11$NlaIII$
AAAAACATAGGTA
CAAGCAGAAGACGGCATACGAGATCTTGTTAAAATTGGAAGCTAC
AAAAACATAGGTA
Flg$Index$12$NlaIII$
CAAGCAGAAGACGGCATACGAGATACGCCTCAAATTGGAAGCTAC
Flg$Index$13$NlaIII$
AAAAACATAGGTA
CAAGCAGAAGACGGCATACGAGATAGTTAAAAAATTGGAAGCTAC
AAAAACATAGGTA
Flg$Index$14$NlaIII$
CAAGCAGAAGACGGCATACGAGATGAGGACCAAATTGGAAGCTAC
Flg$Index$15$NlaIII$
AAAAACATAGGTA
CAAGCAGAAGACGGCATACGAGATGCCACCGAAATTGGAAGCTAC
AAAAACATAGGTA
Flg$Index$16$NlaIII$
CAAGCAGAAGACGGCATACGAGATCGACAGTAAATTGGAAGCTAC
Flg$Index$17$NlaIII$
AAAAACATAGGTA
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Eβ$Index$21$NlaIII$

CAAGCAGAAGACGGCATACGAGATCAAATACAAATTGGAAGCTAC
AAAAACATAGGTA
AATGATACGGCGACCACCGAGATCTAGTGGTAGGAATTGTTAGGA
AAAGAAG
CAAGCAGAAGACGGCATACGAGATCGTACTCATTTCAGCTCTCAT
CTATGAATGTAAGAGT
CAAGCAGAAGACGGCATACGAGATTATCTGTATTTCAGCTCTCAT
CTATGAATGTAAGAGT
CAAGCAGAAGACGGCATACGAGATCATTGAGATTTCAGCTCTCAT
CTATGAATGTAAGAGT

$
Sequencing)Primers)
Name$
923$Read$
923$Index$Read$
Flg$Read$
Flg$Index$Read$
Eβ$Read$
Eβ$Index$Read$

$
$
$
GTCAGATCTCAACATTCCTGTCAAAGCTT
TTGTTTGACATTAAAATATTAGGAAGTTGT
AGAAGTTGTGATCACTAGGAATACAAGCTT
TACCTATGTTTTTGTAGCTTCCAATTT
AGTGGTAGGAATTGTTAGGAAAAGAAGCTT
ACTCTTACATTCATAGATGAGAGCTGAAAT

Flg$Index$18$NlaIII$
Eβ$Read$HindIII$
Eβ$Index$19$NlaIII$
Eβ$Index$20$NlaIII$
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Figure S1. 4C-seq nested PCR products. The nested products were separated on a 1.5%
agarose gel. The leftmost lane contains a 1 Kb Plus DNA Ladder (Invitrogen). The smears and
discrete bands indicate that the 4C library contains amplicons of various sizes and quantities,
representing a variety of interacting sequences and interaction frequencies. PCR products larger
than ~120bp were cut out and submitted for sequencing to exclude primer dimers.
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Demultiplexing Distribution !
Lane 6, 1 mismatch!

Lane 7, 1 mismatch!

Lane 6, 0 mismatch!

Lane 7, 0 mismatch!

80!

# of reads (millions)!

70!
60!
50!
40!
30!
20!
10!
0!

Library!

Figure S2. Demultiplexing distribution allowing for 1 or 0 mismatches in the index.
Allowing for 1 mismatch in the index sequences resulted in a range of 47,000 reads – 6.2 million
reads per library in lane 6, and 43,000 reads – 6.9 million reads per library in lane 7. When
mismatches were not allowed, only 5315 reads - 4.4 million reads were obtained per library in
lane 6, 6535 reads - 4.8 million reads per library in lane 7. Approximately 60 million reads were
unassignable even allowing for 1 mismatch, while approximately 80 million reads were
unassigned when no mismatches were allowed.

131

Flg viewpoint 1 mismatch - EDC
view
Scale
chr3:
2659.75 -

923 viewpoint

1 Mb

91,000,000

Differentiated Ker

91,500,000

Flg viewpoint

92,500,000

93,000,000

Flg viewpoint 0 mismatch - EDC
view
Scale
chr3:
3036.46 -

mm10

92,000,000

93,500,000

Flg viewpoint

mm10

92,000,000

92,500,000

93,000,000

93,500,000

0_
24738.7 -

0_
21200.5 -

Flg_D2_norm_lane7_0mm

Flg_D2_lane7_norm

0_
13572.5 -

0_
11775.9 -

Flg_D3_norm_lane7_0mm

Flg_D3_lane7_norm

0_
17363.3 -

0_
15222.7 -

Proliferating Ker

Proliferating Ker

Flg_P1_norm_lane7_0mm

0_
33642.3 -

0_
29675.2 -

Flg_P2_norm_lane7_0mm

Flg_P2_lane7_norm

0_
16970.3 -

0_
14328.7 -

Flg_P3_norm_lane7_0mm

Flg_P3_lane7_norm

0_
8209.78 -

0_
7214.31 -

P5424 T-cells

P5424 T-cells

Flg_P5424_1_norm_lane7_0mm

Flg_P5424_1_lane7_norm

0_
5422.99 -

0_
5753.44 -

Contaminating “viewpoint” peaks in the wrong region

Flg_P5424_2_lane7_norm

Flg_P5424_2_norm_lane7_0mm

0_
7725.5 -

0_
7161.61 -

Flg_P5424_3_norm_lane7_0mm

Flg_P5424_3_lane7_norm

0_
S100a1
S100a13
S100a14
S100a14
S100a14
S100a16
S100a16

Differentiated Ker

91,500,000

Flg_D1_norm_lane7_0mm

Flg_D1_lane7_norm

Flg_P1_lane7_norm

923 viewpoint

1 Mb

91,000,000

S100a3 S100a9
S100a6
Pglyrp4
S100a7a
S100a8
S100a9
Pglyrp4
Pglyrp4

S100a2
S100a4
S100a5

4930529C04Rik
9130204L05Rik

Pglyrp3
DQ564077
DQ688935

Lor
Lor

Prr9
Sprr2a2
Sprr2e
Sprr3
Prr9
Sprr2a1
Sprr2e
Sprr3
Lelp1
Sprr2a1
Sprr2h
Sprr1a
Sprr2a2
Sprr2b
Sprr2i
Sprr4
Sprr2a1
Sprr2b
Sprr2i
Lelp1
Sprr2d
Sprr2k
AK137696
Sprr2d
Sprr2k
Sprr2f
Sprr3
Sprr2f
Sprr1a
Sprr2g
Sprr2h
Sprr2h
Sprr2h
Sprr2j-ps
Sprr1b
Sprr1b

Ivl
Lce1b
Lce1g
Kprp
Lce3a
Crct1
Ivl
Lce1b
Lce1g
Kprp
Lce3a
Crct1
Smcp
Lce1c
Lce1h
Lce1l
Lce3b
Lce1m
Lce6a
Lce1e
Lce1j
Lce3b
Lce1m
Lce6a
Lce1e
Lce1j
Lce3c
Gm4858
Lce1a1
Lce1h
Lce1l
Lce3c
Gm4858
Lce1a1
Lce1i
Lce3d
Lce1a2
Lce1i
Lce3d
Lce1a2
Lce1k
Lce3e
Lce1c
Lce1k
Lce3e
Lce1d
2310050C09Rik
Lce3f
Lce1d
2310050C09Rik
Lce3f
Lce1f
Lce1m
Lce1f

Crnn

Flg2

Flg

Hrnr

Rptn

S100a11
Tchh
S100a10
Mir5124
Tchhl1

0_
S100a1
S100a13
S100a14
S100a14
S100a14
S100a16
S100a16

S100a3 S100a9
S100a6
Pglyrp4
S100a7a
S100a8
S100a9
Pglyrp4
Pglyrp4

S100a2
S100a4
S100a5

4930529C04Rik
9130204L05Rik

Pglyrp3
DQ564077
DQ688935

Lor
Lor

Prr9
Sprr2a2
Sprr2e
Sprr3
Prr9
Sprr2a1
Sprr2e
Sprr3
Lelp1
Sprr2a1
Sprr2h
Sprr1a
Sprr2a2
Sprr2b
Sprr2i
Sprr4
Sprr2a1
Sprr2b
Sprr2i
Lelp1
Sprr2d
Sprr2k
AK137696
Sprr2d
Sprr2k
Sprr2f
Sprr3
Sprr2f
Sprr1a
Sprr2g
Sprr2h
Sprr2h
Sprr2h
Sprr2j-ps
Sprr1b
Sprr1b

Ivl
Lce1b
Lce1g
Kprp
Lce3a
Crct1
Ivl
Lce1b
Lce1g
Kprp
Lce3a
Crct1
Smcp
Lce1c
Lce1h
Lce1l
Lce3b
Lce1m
Lce6a
Lce1e
Lce1j
Lce3b
Lce1m
Lce6a
Lce1e
Lce1j
Lce3c
Gm4858
Lce1a1
Lce1h
Lce1l
Lce3c
Gm4858
Lce1a1
Lce1i
Lce3d
Lce1a2
Lce1i
Lce3d
Lce1a2
Lce1k
Lce3e
Lce1c
Lce1k
Lce3e
Lce1d
2310050C09Rik
Lce3f
Lce1d
2310050C09Rik
Lce3f
Lce1f
Lce1m
Lce1f

Crnn

Flg2

Flg

Hrnr

Rptn

S100a11
Tchh
S100a10
Mir5124
Tchhl1

Figure S3. View of the EDC in Flg 4C-seq libraries demultiplexed by allowing 1 mismatch (left) and 0 mismatches (right) in
index sequences. Different colored tracks indicate different cell types or conditions (green: differentiated keratinocytes, blue:
proliferating keratinocytes, black: P5424 T-cells). A viewpoint-like peak is observed at 923 in one of the P5424 Flg libraries
generated by allowing 1 mismatch in the index. This peak is not present in the same library generated by allowing 0 mismatch in the
index, indicating that contamination between libraries was a result of mismatches allowed during demultiplexing.
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Figure S4. View of the EDC in 923 4C-seq libraries demultiplexed by allowing 0
mismatches in index sequences. Different colored tracks indicate different cell types or
conditions (green: differentiated keratinocytes, blue: proliferating keratinocytes, black: P5424 Tcells).
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Figure S5. View of the EDC in Eβ 4C-seq libraries demultiplexed by allowing 0 mismatches
(bottom) in index sequences. Different colored tracks indicate different cell types or conditions
(green: differentiated keratinocytes, blue: proliferating keratinocytes, black: P5424 T-cells).
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Figure S6. 4C-seq library quality. Libraries were assessed based on the criteria of having at
least 1 million total reads mapping to fragments (blue), between 300,000 – 1 million reads
(grey), or less that 300,000 reads (black), and the number of reads mapping in cis and near the
viewpoint/bait. Good quality libraries have over 1 million reads (blue), over 40% of reads
mapping in cis, and over 40% of the fragments near the viewpoint having reads mapping to them
(upper right quadrant).
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Table S2. 4C-seq library quality.
Lane 6 Library quality

Lane 7 Library quality

Good

Poor

Good

Poor

923 D1

923 D2

923 D1

923 D2

923 P5424 2

923 D3

923 P5424 2

923 D3

923 P5424 3

923 P1

923 P5424 3

923 P1

Eβ P5424 1

923 P2

Eβ P5424 1

923 P2

Eβ P5424 2

923 P3

Eβ P5424 2

923 P3

Eβ P5424 3

923 P5424 1

Eβ P5424 3

923 P5424 1

Flg D3

Flg D1

Flg D3

Flg D1

Flg P5424 1

Flg D2

Flg P5424 1

Flg D2

Flg P5424 3

Flg P1

Flg P5424 3

Flg P1

Flg P2

Flg P2

Flg P3

Flg P3

Flg P5424 2

Flg P5424 2
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Table S3. GREAT-predicted cis-regulatory targets of 4C-seq reads enriched in 923 enhancer viewpoint differentiating
keratinocytes (923 KerD) relative to T-cells.
ID#

Desc#

GO:0031424)

keratinization)

BinomFdrQ#

2.60E614) Ivl,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2i,Sprr3,Sprr4#

Genes#

GO:0001533)

cornified)envelope)

2.67E614) Ivl,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2i#

GO:0030216)

keratinocyte)differentiation)

3.35E605) Ivl,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2i,Sprr3,Sprr4,Yap1#

GO:0042834)

peptidoglycan)binding)

2.14E603) Pglyrp3,Tlr2)

GO:0016019)

peptidoglycan)receptor)activity)

4.07E603) Pglyrp3#

GO:0008745)

N6acetylmuramoyl6L6alanine)amidase)activity)

4.07E603) Pglyrp3#

GO:0016045)

detection)of)bacterium)

4.16E603) Naip6,Pglyrp3,Tlr2)

GO:0006027)

glycosaminoglycan)catabolic)process)

4.93E603) Hyal4,Pglyrp3)

GO:0009253)

peptidoglycan)catabolic)process)

5.26E603) Pglyrp3#

GO:0044117)

5.87E603) Pglyrp3#

GO:0032827)

growth)of)symbiont)in)host)
negative)regulation)of)natural)killer)cell)differentiation)
involved)in)immune)response)

GO:0009595)

detection)of)biotic)stimulus)

2.93E602) Naip6,Pglyrp3,Tlr2,Tlr4)

GO:0006026)

aminoglycan)catabolic)process)

3.25E602) Hyal4,Pglyrp3)

GO:0008329)

signaling)pattern)recognition)receptor)activity)

3.30E602) Pglyrp3,Tlr2,Tlr4)

5.87E603) Pglyrp3#

Table S4. GREAT-predicted cis-regulatory targets of 4C-seq reads enriched in 923 enhancer viewpoint proliferating
keratinocytes (923 KerP) relative to T-cells.
ID#

Desc#

GO:0016503) pheromone)receptor)activity)

BinomFdrQ#

Genes#

Gm4133,Gm4187,V1ra8,Vmn1r119,Vmn1r13,Vmn1r14,Vmn1r15,Vmn1r16,Vmn1r165,Vmn1r17,Vmn1r1
8,Vmn1r185,Vmn1r2,Vmn1r234,Vmn1r235,Vmn1r238,Vmn1r26,Vmn1r27,Vmn1r29,Vmn1r3,Vmn1r30,V
1.35E603)mn1r39,Vmn1r41,Vmn1r42,Vmn1r53,Vmn1r57,Vmn1r71,Vmn1r77,Vmn1r78,Vmn1r88,Vmn1r89)
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Table S5. GREAT-predicted cis-regulatory targets of 4C-seq reads enriched in Flg promoter viewpoint differentiating
keratinocytes (Flg KerD) relative to T-cells.
ID#

Desc#

GO:0001533)

cornified)envelope)
peptidoglycan)receptor)
activity)
N6acetylmuramoyl6L6alanine)
amidase)activity)

4.89E618)

Anxa1,Flg,Hrnr,Ivl,Lor,Rptn,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i#

2.87E614)

Pglyrp3,Pglyrp4#

2.87E614)

Pglyrp3,Pglyrp4#

8.29E614)

Pglyrp3,Pglyrp4#

8.29E614)

Pglyrp3,Pglyrp4#

GO:0009253)

growth)of)symbiont)in)host)
negative)regulation)of)
natural)killer)cell)
differentiation)involved)in)
immune)response)
peptidoglycan)catabolic)
process)

9.35E614)

Pglyrp3,Pglyrp4#

GO:0031424)

keratinization)

3.83E613)

Abca12,Hrnr,Ivl,Lor,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i,Sprr3,Sprr4)

GO:0042834)

peptidoglycan)binding)
aminoglycan)catabolic)
process)
glycosaminoglycan)catabolic)
process)

4.20E613)

Pglyrp3,Pglyrp4#

1.90E612)

BC051070,Chi3l3,Chi3l4,Chi3l7,Chia,Pglyrp3,Pglyrp4)

2.28E611)

Pglyrp3,Pglyrp4#

detection)of)bacterium)
regulation)of)natural)killer)
cell)differentiation)
signaling)pattern)recognition)
receptor)activity)
negative)regulation)of)
interferon6gamma)
production)
regulation)of)natural)killer)
cell)activation)

6.80E610)

Pglyrp3,Pglyrp4#

1.83E608)

Pglyrp3,Pglyrp4#

4.90E608)

Colec12,Pglyrp3,Pglyrp4)

4.72E606)

Gata3,Pglyrp3,Pglyrp4)

5.76E606)

Il12b,Lyst,Pglyrp3,Pglyrp4)

8.61E606)

Pglyrp3,Pglyrp4#

GO:0016811)

detection)of)biotic)stimulus)
hydrolase)activity,)acting)on)
carbon6nitrogen)(but)not)
peptide))bonds,)in)linear)
amides)

1.48E605)

GO:0030216)

keratinocyte)differentiation))

2.29E605)

Acer2,Acy1,Aga,Gls,Hdac2,Hdac9,Ngly1,Pglyrp3,Pglyrp4)
Abca12,Anxa1,Ctnnd1,Hrnr,Ivl,Lor,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i,Sprr3,Sprr4,Trp6
3)

GO:0016019)
GO:0008745)
GO:0044117)

GO:0032827)

GO:0006026)
GO:0006027)
GO:0016045)
GO:0032823)
GO:0008329)

GO:0032689)
GO:0032814)
GO:0009595)

BinomFdrQ#

Genes#
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GO:0002698)

negative)regulation)of)
immune)effector)process)
negative)regulation)of)
lymphocyte)differentiation)
epidermal)cell)
differentiation)
negative)regulation)of)
cytokine)production)
negative)regulation)of)cell)
activation)
hydrolase)activity,)acting)on)
carbon6nitrogen)(but)not)
peptide))bonds)
defense)response)to)Gram6
positive)bacterium)

1.64E604)

Bcl6,Irak3,Itch,Pglyrp3,Pglyrp4,Tgfb2)

3.37E604)
2.45E603)

Bcl6,Gli3,Pglyrp3,Pglyrp4)
Abca12,Anxa1,Atoh1,Clic5,Clrn1,Ctnnd1,Ercc3,Gli2,Grxcr1,Hdac2,Hrnr,Ivl,Lor,Myo7a,Pcdh15,Slitrk6,Sprr1b,Sprr2a
1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i,Sprr3,Sprr4,Trp63)

3.41E603)

Bcl6,Chrna7,Gata3,Gata6,Ido1,Ifng,Il12b,Il6ra,Irak3,Irg1,Pglyrp3,Pglyrp4,Tgfb2,Trim27,Vsig4)

3.91E603)

Bcl6,Cnr1,Gli3,Ido1,Itch,Pawr,Pde5a,Pdgfa,Pdgfb,Pglyrp3,Pglyrp4,Prdm1,Serpine2,Socs6,Sox11,Vsig4,Vtcn1)

3.93E603)

Acer2,Acy1,Adar,Aga,Apobec4,Atic,Gls,Hdac2,Hdac9,Ngly1,Pglyrp3,Pglyrp4)

4.46E603)

Il6ra,Pglyrp3,Pglyrp4)

cellular)response)to)acid)
sodium:potassium6
exchanging)ATPase)activity)
negative)regulation)of)
lymphocyte)activation)
potassium6transporting)
ATPase)activity)

5.37E603)

Col1a1,Col1a2,Col4a6,Ipo5,Pdgfc,Pdgfd,S100a10,Sh3bp4)

5.39E603)

Atp1a1,Atp1a2,Atp1a4,Atp1b1)

6.60E603)

Bcl6,Gli3,Ido1,Itch,Pawr,Pde5a,Pglyrp3,Pglyrp4,Prdm1,Socs6,Sox11,Vsig4,Vtcn1)

1.17E602)

1.68E602)

GO:0002695)

epidermis)development)
negative)regulation)of)
leukocyte)activation)

Atp1a1,Atp1a2,Atp1a4,Atp1b1)
Abca12,Anxa1,Atoh1,Barx2,Clic5,Clrn1,Ctnnd1,Ercc3,Flg,Foxq1,Gli2,Grxcr1,Hdac2,Hrnr,Igf1r,Inhba,Ivl,Lce1g,Lce1i,
Lce1l,Lce1m,Lce3a,Lce3c,Lce3f,Lor,Myo7a,Pcdh15,Pdgfa,Pou3f2,Slitrk6,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2f,S
prr2g,Sprr2h,Sprr2i,Sprr3,Sprr4,Tgfb2,Trp63)

1.73E602)

Bcl6,Cnr1,Gli3,Ido1,Itch,Pawr,Pde5a,Pglyrp3,Pglyrp4,Prdm1,Socs6,Sox11,Vsig4,Vtcn1)

GO:0009408)

response)to)heat)

2.12E602)

GO:0043588)

skin)development)
adenosylhomocysteinase)
activity)

2.18E602)

Casq1,Cetn1,Crnn,Psip1,Xylt1)
Abca12,Anxa1,Arrdc3,Atoh1,Barx2,Clic5,Clrn1,Col1a1,Col1a2,Ctnnd1,Ercc3,Flg,Foxq1,Gli2,Grxcr1,Hdac2,Hrnr,Igf1r
,Inhba,Ivl,Lce1g,Lce1i,Lce1l,Lce1m,Lce3a,Lce3c,Lce3f,Lor,Myo7a,Pcdh15,Pdgfa,Pou3f2,Slitrk5,Slitrk6,Sprr1b,Sprr2
a1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i,Sprr3,Sprr4,Tcf7l2,Tgfb2,Trp63)

calcium)ion)binding)
structural)constituent)of)
epidermis)

3.77E602)

Ahcy,Ahcyl1,Gm4737)
9130204L05Rik,Adam8,Amy2a5,Anxa1,Bglap,Calb1,Casq1,Cdh10,Cdh12,Cdh18,Cdh19,Cdh2,Cdh20,Cdh6,Cdh7,Cd
h9,Cetn1,Clstn3,Crnn,Dmd,Dnahc7b,Dsc3,Edem1,Edil3,Efemp1,Egfem1,Egfl6,Eltd1,Epdr1,Fat4,Fbln5,Fbn2,Flg,Flg2
,Fscb,Fstl5,Gm5849,Gpd2,Grm7,Hrnr,Kcnip4,Lrp1b,Man1a,Man1a2,Mctp2,Notch2,Pcdh10,Pcdh15,Pcdh17,Pcdh18
,Pcdh19,Pcdh20,Pcdhb22,Pclo,Plcl2,Pls3,Rptn,S100a10,S100a11,S100a3,Slc25a13,Slc25a24,Slit2,Sulf1,Syt1,Tchhl1
,Wdr49)

3.82E602)

Lor#

GO:0045620)
GO:0009913)
GO:0001818)
GO:0050866)

GO:0016810)
GO:0050830)
GO:0071229)
GO:0005391)
GO:0051250)
GO:0008556)

GO:0008544)

GO:0004013)

GO:0005509)
GO:0030280)

2.29E602)
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GO:0016160)

amylase)activity)

3.97E602)

Amy2a5,Mgam)

Table S6. GREAT-predicted cis-regulatory targets of 4C-seq reads enriched in Flg promoter viewpoint proliferating
keratinocytes (Flg KerP) relative to T-cells.
ID)

Desc)

BinomFdrQ)

GO:0009593)

detection)of)chemical)
stimulus)

6.73E604)

GO:0050906)

detection)of)stimulus)
involved)in)sensory)
perception)

9.36E604)

GO:0051606)

detection)of)stimulus)

1.57E603)

GO:0050907)

detection)of)chemical)
stimulus)involved)in)sensory)
perception)

2.09E603)

GO:0050911)

detection)of)chemical)
stimulus)involved)in)sensory)
perception)of)smell)

2.32E603)

GO:0007606)

sensory)perception)of)
chemical)stimulus)

2.39E603)

GO:0004984)

olfactory)receptor)activity)

4.83E603)

Genes)
Gm10081,Gnat3,Kcnmb2,Olfr1087,Olfr1089,Olfr109,Olfr1111,Olfr1112,Olfr1257,Olfr13,Olfr13266
ps1,Olfr135,Olfr138,Olfr1431,Olfr146,Olfr1505,Olfr17,Olfr191,Olfr193,Olfr195,Olfr196,Olfr199,Olfr201,Olfr229,Ol
fr292,Olfr356,Olfr357,Olfr366,Olfr368,Olfr38,Olfr389,Olfr435,Olfr453,Olfr48,Olfr714,Olfr715,Olfr724,Olfr725,Olfr
736,Olfr738,Olfr743,Olfr744,Olfr76,Olfr794,Olfr796,Olfr855,Olfr890,Olfr891,Olfr936,Olfr945,Olfr948,Olfr972,Olfr
974,Rtp4,Tlr2,Tlr4,Trpa1)
Col11a1,Gm10081,Gnat3,Gpr98,Myc,Olfr1087,Olfr1089,Olfr109,Olfr1111,Olfr1112,Olfr1257,Olfr13,Olfr13266
ps1,Olfr135,Olfr138,Olfr1431,Olfr146,Olfr1505,Olfr17,Olfr191,Olfr193,Olfr195,Olfr196,Olfr199,Olfr201,Olfr229,Ol
fr292,Olfr356,Olfr357,Olfr366,Olfr368,Olfr38,Olfr389,Olfr435,Olfr453,Olfr48,Olfr714,Olfr715,Olfr724,Olfr725,Olfr
736,Olfr738,Olfr743,Olfr744,Olfr76,Olfr794,Olfr796,Olfr855,Olfr890,Olfr891,Olfr936,Olfr945,Olfr948,Olfr972,Olfr
974,Pcdh15,Rtp4,Sox2,Trpa1)
Cadm1,Cngb3,Col11a1,Gm10081,Gnat3,Gpr98,Kcnmb2,Myc,Olfr1087,Olfr1089,Olfr109,Olfr1111,Olfr1112,Olfr125
7,Olfr13,Olfr13266
ps1,Olfr135,Olfr138,Olfr1431,Olfr146,Olfr1505,Olfr17,Olfr191,Olfr193,Olfr195,Olfr196,Olfr199,Olfr201,Olfr229,Ol
fr292,Olfr356,Olfr357,Olfr366,Olfr368,Olfr38,Olfr389,Olfr435,Olfr453,Olfr48,Olfr714,Olfr715,Olfr724,Olfr725,Olfr
736,Olfr738,Olfr743,Olfr744,Olfr76,Olfr794,Olfr796,Olfr855,Olfr890,Olfr891,Olfr936,Olfr945,Olfr948,Olfr972,Olfr
974,Pcdh15,Rtp4,Sox2,Tlr2,Tlr4,Trpa1)
Gm10081,Gnat3,Olfr1087,Olfr1089,Olfr109,Olfr1111,Olfr1112,Olfr1257,Olfr13,Olfr13266
ps1,Olfr135,Olfr138,Olfr1431,Olfr146,Olfr1505,Olfr17,Olfr191,Olfr193,Olfr195,Olfr196,Olfr199,Olfr201,Olfr229,Ol
fr292,Olfr356,Olfr357,Olfr366,Olfr368,Olfr38,Olfr389,Olfr435,Olfr453,Olfr48,Olfr714,Olfr715,Olfr724,Olfr725,Olfr
736,Olfr738,Olfr743,Olfr744,Olfr76,Olfr794,Olfr796,Olfr855,Olfr890,Olfr891,Olfr936,Olfr945,Olfr948,Olfr972,Olfr
974,Rtp4,Trpa1)
Gm10081,Olfr1087,Olfr1089,Olfr109,Olfr1111,Olfr1112,Olfr1257,Olfr13,Olfr13266
ps1,Olfr135,Olfr138,Olfr1431,Olfr146,Olfr1505,Olfr17,Olfr191,Olfr193,Olfr195,Olfr196,Olfr199,Olfr201,Olfr229,Ol
fr292,Olfr356,Olfr357,Olfr366,Olfr368,Olfr38,Olfr389,Olfr435,Olfr453,Olfr48,Olfr714,Olfr715,Olfr724,Olfr725,Olfr
736,Olfr738,Olfr743,Olfr744,Olfr76,Olfr794,Olfr796,Olfr855,Olfr890,Olfr891,Olfr936,Olfr945,Olfr948,Olfr972,Olfr
974)
Gm10081,Gnat3,Grm7,Olfr1087,Olfr1089,Olfr109,Olfr1111,Olfr1112,Olfr1257,Olfr13,Olfr13266
ps1,Olfr135,Olfr138,Olfr1431,Olfr146,Olfr1505,Olfr17,Olfr191,Olfr193,Olfr195,Olfr196,Olfr199,Olfr201,Olfr229,Ol
fr292,Olfr356,Olfr357,Olfr366,Olfr368,Olfr38,Olfr389,Olfr435,Olfr453,Olfr48,Olfr714,Olfr715,Olfr724,Olfr725,Olfr
736,Olfr738,Olfr743,Olfr744,Olfr76,Olfr794,Olfr796,Olfr855,Olfr890,Olfr891,Olfr936,Olfr945,Olfr948,Olfr972,Olfr
974,Rtp4,Slc24a4,Tas2r114,Tas2r115,Tas2r122,Trpa1,V1ra8,Vmn1r53)
Gm10081,Olfr1087,Olfr1089,Olfr109,Olfr1111,Olfr1112,Olfr1257,Olfr13,Olfr13266
ps1,Olfr135,Olfr138,Olfr1431,Olfr146,Olfr1505,Olfr17,Olfr191,Olfr193,Olfr195,Olfr196,Olfr199,Olfr201,Olfr229,Ol
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GO:0007608)

sensory)perception)of)smell)

GO:0004930)

G6protein)coupled)receptor)
activity)

fr292,Olfr356,Olfr357,Olfr366,Olfr368,Olfr38,Olfr389,Olfr435,Olfr453,Olfr48,Olfr714,Olfr715,Olfr724,Olfr725,Olfr
736,Olfr738,Olfr743,Olfr744,Olfr76,Olfr794,Olfr796,Olfr855,Olfr890,Olfr891,Olfr936,Olfr945,Olfr948,Olfr972,Olfr
974)
Gm10081,Grm7,Olfr1087,Olfr1089,Olfr109,Olfr1111,Olfr1112,Olfr1257,Olfr13,Olfr13266
ps1,Olfr135,Olfr138,Olfr1431,Olfr146,Olfr1505,Olfr17,Olfr191,Olfr193,Olfr195,Olfr196,Olfr199,Olfr201,Olfr229,Ol
fr292,Olfr356,Olfr357,Olfr366,Olfr368,Olfr38,Olfr389,Olfr435,Olfr453,Olfr48,Olfr714,Olfr715,Olfr724,Olfr725,Olfr
736,Olfr738,Olfr743,Olfr744,Olfr76,Olfr794,Olfr796,Olfr855,Olfr890,Olfr891,Olfr936,Olfr945,Olfr948,Olfr972,Olfr
5.13E603) 974,Slc24a4)
Adora2b,Agtr1b,Agtr2,Calcr,Celsr1,Chrm3,Cxcr7,Cysltr1,Ednrb,Emr4,F2rl3,Fzd8,Gm10081,Gm9268,Gpr87,Gpr98,G
rm7,Hpgd,Htr1a,Htr2a,Lpar4,Nmur2,Npy2r,Npy6r,Olfr1087,Olfr1089,Olfr109,Olfr1111,Olfr1112,Olfr1257,Olfr13,O
lfr13266
ps1,Olfr135,Olfr138,Olfr1431,Olfr146,Olfr1505,Olfr17,Olfr191,Olfr193,Olfr195,Olfr196,Olfr199,Olfr201,Olfr229,Ol
fr292,Olfr356,Olfr357,Olfr366,Olfr368,Olfr38,Olfr389,Olfr435,Olfr453,Olfr48,Olfr714,Olfr715,Olfr724,Olfr725,Olfr
736,Olfr738,Olfr743,Olfr744,Olfr76,Olfr794,Olfr796,Olfr855,Olfr890,Olfr891,Olfr936,Olfr945,Olfr948,Olfr972,Olfr
974,P2ry10,P2ry14,Pth2r,S1pr1,Sstr1,Tacr1,Tas2r114,Tas2r115,Tas2r122,V1ra8,Vmn1r169,Vmn1r170,Vmn1r230,
Vmn1r231,Vmn1r3,Vmn1r5,Vmn1r53,Vmn1r6,Vmn1r64,Vmn1r65,Vmn1r68,Vmn1r69,Vmn1r71,Vmn1r72,Vmn2r1
8,Vmn2r19,Vmn2r20,Vmn2r23,Vmn2r24,Vmn2r53,Vmn2r54,Vmn2r55,Vmn2r6,Vmn2r63,Vmn2r7,Vmn2r77,Vmn2
4.86E602) r78,Vmn2r79,Vmn2r92,Vmn2r94)
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